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Abstract 
Hyaluronic acid (HA) is a glycosaminoglycan which exists ubiquitously in all organisms 
where it possesses a range of important functions.  Due to the rheological properties and 
biocompatibility of HA solutions, it has been employed in a variety of medical applications.  
The rheology of a HA solution is a consequence of the concentration and molecular weight 
of the HA present.  The current commonly used method for HA production is bacterial 
fermentation using Group C Streptococcus species which produce HA as a protective 
capsule in order to evade immune responses of their hosts.  These are fastidious organisms 
and the fermentation process requires strict regulation of culture parameters in order to 
obtain optimum yields.  A disadvantage of bacterial HA production is that the molecular 
weight of the product is often lower than the ideal range and the optimal yield is low at 5-10 
g/L.  The aim of this project is to investigate metabolic and genetic factors influencing HA 
capsule production in subspecies of the Group C Streptococcus equi.  The study identifies a 
novel strain of S. equi capable of producing high concentrations of HA under the conditions 
studied and evaluates a currently used industrial procedure.  Genomic and proteomic 
differences between subspecies of S. equi and mucoid/non-mucoid phenotypes have been 
investigated.  The effects of the antibiotic phosphomycin on growth and HA production 
have also been explored.  Collectively the results of this study have opened the scope of HA 
production research beyond the conventional methods used to date. 
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1. Introduction 
1.1.  Polysaccharides 
Polysaccharides are generally large carbohydrate molecules composed of 
monosaccharide units and are found ubiquitously in living organisms, with 
some examples being guar gum, pectin and alginate (plants and algae), 
chondroitin and chitosan (animal) and xanthan gum and dextran (microbial) 
(Bhatia, 2016).  They can be either linear in structure or possess branching 
groups of various size and structure and this variation in polysaccharide 
complexity correlates to the diverse functions observed such as energy storage, 
structural support, cellular protection and adherence to surfaces (Chakraborty et 
al., 2019).   
In prokaryotes, extracellular polysaccharides play a role in biofilm formation, 
cell migration and protection from environmental factors such as drying as well 
as protection from antimicrobial molecules and engulfment by phagocytes and 
predatory protozoa (Nwodo, Green and Okoh, 2012).  Additionally, bacteria 
can produce polysaccharides as virulence factors such as lipopolysaccharide 
(LPS) in gram negative bacteria (Lukacova, Barak and Kazar, 2008),  
galactofuranose of Mycoplasma (Jores et al., 2019), polysaccharide capsule of 
Enterococcus faecium (Ali, Blum and Sakiotanc, 2019) and polysialic acid 
(PSA) of group B streptococci, N. meningitidis, Mannheimia haemolytica and 
E. coli (Uchiyama et al., 2019).  Whilst the functions of extracellular 
polysaccharides are varied, some pathogenic bacteria have evolved to produce 
capsular polysaccharides which are identical to polysaccharides of their target 
host, such as N. meningitidis serogroup B, H. influenza (Hib) and some 
Streptococcus species.  These capsules provide a mechanism for evasion of the 
immune system of the host (Cress et al., 2014).  Many of these bacterial 
polysaccharides possess properties which make them suitable for industrial and 
medical applications such as dextran, xanthan, cellulose and alginate which 
have applications in food thickeners, biomaterials in tissue engineering, wound 
dressings, chromatography and pharmaceuticals (Rehm, 2010).  One such 
polysaccharide is hyaluronic acid which will be discussed further below and is 
produced by a variety of bacteria such as Streptococcus pyogenes (group A), 
Streptococcus dysgalactiae subsp. equisimilis (group B), subspecies of 
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Streptococcus equi (group C) and Pasteurella multocida (Necas et al., 2008; 
Wajima et al., 2016). 
 
1.2. Hyaluronic Acid 
1.2.1. Structure and Functions 
Hyaluronic acid (HA) is a glycosaminoglycan (GAG) consisting of two 
repeating components D-glucuronic acid and N-acetylglucosamine 
connected respectively by β-1, 3 and β-1, 4 glycosidic bonds (Figure 1) 
(Liu et al., 2011; Lu et al., 2016).  HA molecules are anionic in 
physiological pH (Tsepilov and Beloded, 2015).  They are produced as 
high molecular weight chains which tangle together and result in highly 
viscous solutions which are non-Newtonian in nature (Cowman et al., 
2015).  Non-Newtonian fluids are fluids which do not adhere to Newton’s 
law of viscosity and as such the viscosity of these fluids may either 
increase or decrease when stress is applied (Denn, 2004).  Solutions of HA 
demonstrate shear thinning, the loss of fluid viscosity when shear stress is 
applied such as passing the solution through a syringe, and at higher 
molecular weights the solutions also demonstrate elasticity resulting in HA 
being designated a pseudoplastic (Ambrosio et al., 1999).   
 
Figure 1 Hyaluronic acid disachharide.  A section of hyaluronic acid chain comprised of 
precursors D-glucuronic acid (left) and N-acetylglucosamine (right) (Kakehi, Kinoshita and 
Yasueda, 2003). 
In both eukaryotes and bacteria HA is produced by membrane integrated 
glycosyltransferases called hyaluronan synthases (HAS) which assemble 
and extrude the chains in a progressive manner across the cell membrane.  
Whilst there are three isoforms of HAS in mammals they are structurally 
related to all other HAS enzymes bar the HAS of Pasteurella multocida.  
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Thus there are two classes of HAS enzymes with the P. multocida HAS 
being Class II and all other HAS enzymes being Class I (Weigel and 
DeAngelis, 2007).  Within the body, HA is cleared from the ECM via the 
lymphatic system following either enzymatic degradation or fragmentation 
by reactive nitrogen and oxygen species. In an adult human, HA has a half-
life of 2-6 minutes and the bulk of the elimination occurs within the liver, 
turning over between 10-100 mg of the total body concentration in a day 
(Necas et al., 2008). 
Whilst it is present in almost all vertebrate tissues the most significant 
quantities of HA are found within the extracellular matrix (ECM) and is 
most abundant within connective tissue, joints and skin where it functions 
as a molecular sieve and as a cushioning and lubricating agent.  Its ability 
to function as these is considered to be due to its ability to bind up to 1,000 
times its weight in water (Monslow, Govindaraju and Pure, 2015).  High 
concentrations are also found within vitreous humour, umbilical cord and 
synovial fluid (Girish and Kemparaju, 2007).  In fact it is one of the main 
components of synovial fluid (Tamer, 2013) and reduction in the elasticity 
and viscosity of the synovial fluid is attributed to the pathophysiology of 
osteoarthritis (Balazs, 2009).  In addition to its role as a lubricant and space 
filler HA has been described as an organiser of the ECM and as a facilitator 
of cell migration through the provision of a suitable environment (Lee and 
Spicer, 2000).  Certainly these functions support the observation that HA 
performs a role in the promotion of wound healing, which requires 
reorganisation of tissues and migration of immune cells thought to be 
facilitated by a sharp increase in HA concentration which is observed at the 
site of wounds (Aya and Stern, 2014).  HA levels remain high in foetal 
wounds for a longer period of time than in adult wounds which is attributed 
to the lack of collagen accumulation and scar formation observed (Muto et 
al., 2019).  Wound healing is also facilitated by the binding of HA to 
molecules of the ECM and cell receptors, of which the major receptors are 
cluster determinant 44 (CD44), lymphatic vessel endothelial hyaluronan 
receptor (LYVE-1), hyaluronan receptor for endocytosis (HARE), receptor 
for hyaluronan-mediated motility (RHAMM) and toll-like receptor 4 
(TLR4) (Solis et al., 2012).  CD44 is present on the surface of a number of 
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cell types such as epithelial and endothelial cells, fibroblasts and 
leukocytes and as such CD44 binding to HA is possibly the most well 
studied (Kakehi, Kinoshita and Yasueda, 2003).  Due to the presence of 
CD44 on leukocytes which are one of the main classes of immune cells, it 
was indicated that a possible role exists for HA in modulation of the 
immune system and it has since been identified that low and high 
molecular weight HA molecules produce different responses upon 
signalling through CD44, with low molecular weight HA fragments 
indicating injury and as such are pro-inflammatory and high molecular 
weight HA having the opposite effect (Marcellin, Steen and Nielsen, 2014).  
An example of this is stimulation of  NF-κB activity through CD44 
signalling, which is promoted by HA fragments but inhibited by chains of 
≥ 1×106 Da (Lee and Spicer, 2000).  This is also the case for TLR4 where 
HA <900 kDa promote inflammatory responses whereas above this 
molecular weight the anti-inflammatory suppressor of cytokine signaling 3 
(SOCS3) is upregulated (Asari, Kanemitsu and Kurihara, 2010).   
Further to its role in cell signalling and migration, HA has been 
acknowledged to play a role in cancer development where it is speculated 
that the presence high concentrations of HA in the extracellular 
environment can contribute to facilitation of tumour angiogenesis and 
metastasis and as a result can effect prognosis of patients in a variety of 
cancer types (Chanmee, Ontong and Itano, 2016).  Once again this function 
appears to be dependent on the molecular weight with it being speculated 
that HA molecules below 500 kDa promote the development of cancer 
stem cells (CSCs) which are associated with chemotherapy resistance 
(Price, Lokman and Ricciardelli, 2018), while higher molecular weight HA 
is thought to infer a resistance to cancer development, a theory thus far 
supported by the naked mole rat which is extensively studied for its 
resistance to cancer attributed to the high molecular weight HA found in its 
tissues (Tian et al., 2013).  RHAMM is a HA receptor speculated to be 
involved in tumour migration but with certain functions in tissue repair as it 
is present on the surface of endothelial cells (Jiang, Liang and Noble, 
2011).  Like with CD44, HA interaction with RHAMM can induce 
intracellular signalling which activates pathways involved in processes 
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such as cell trafficking and orientation, cell-cell interaction and growth and 
differentiation which all play roles in wound healing, inflammation and 
other pathologies (Misra et al., 2015).   
Thus HA provides a variety of functions in homeostasis and pathogenesis 
that are molecular weight dependent, making it a suitable candidate for 
investigation into treatment and prevention of a variety of conditions.  
1.2.2. History and production methods 
Hyaluronic acid was first identified and isolated from the vitreous humour 
of a cow in 1934 by Karl Meyer and John Palmer where it was named due 
to the presence of uronic acid in the molecule, its chemical structure was 
then resolved in the 1950’s (Moscovici, 2015).  It was first used 
commercially as an egg white substitute in 1942 prior to the knowledge of 
its structure, before being used clinically in the 1950’s as an injectable 
substitution for the vitreous humour during eye surgery, a use it still holds 
to this day (Necas et al., 2008).   
Previous methods for production of HA have included extraction from 
human umbilical cords, bovine synovial fluid and vitreous humour and 
most recently extraction from rooster combs which contain a high 
concentration of HA, this technique is still being used (Kogan et al., 2007).  
However an increasing awareness of the threat of cross species virus 
transmission and contamination with animal protein has prompted the 
investigation of other avenues, as such bacterial fermentation particularly 
with Streptococcus species, where HA is produced as a protective capsule, 
is the primary method of HA production (Boeriu et al., 2013).  Other 
avenues under investigation include the metabolic and genetic engineering 
of non-pathogenic strains such as E. coli, B. subtilis and L. lactis with the 
hyaluronic acid synthesis machinery from Streptococcus species.  Some 
concern surrounding contamination from toxins in native HA producers 
prompted the development of these methods, however the molecular 
weight and concentrations are not yet adequate for production of HA for its 
many applications (Chong et al., 2005).  Due to the current production 
methods for HA for medical use, purification is of paramount importance 
in order to avoid contamination with pro-inflammatory molecules of either 
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animal or bacterial origin and often the purification processes are so 
rigorous that the ultimate yield and molecular weight of the product is 
affected (Choi et al., 2014).  Bacterial fermentation of HA will be 
discussed in more detail below.  
1.2.3. Uses 
As mentioned above HA is naturally present within the body, conserved 
between both eukaryotes and prokaryotes and possesses functions in a 
variety of biological processes involving cell migration and ECM 
remodelling.  Due to this it is biocompatible and is used in a variety of 
ways which are discussed below.  
1.2.3.1. Clinical 
HA is used topically for wound healing with studies showing that 
application of HA to burn wounds shortens the healing time by 
promoting reepithelialisation through promotion of cell migration to 
the wound site (Aya and Stern, 2013).  This promotion of healing is 
particularly useful in cases of impaired healing such as in aging, 
where senescence results in impaired cellular function (Fouda et al., 
2016) and diabetic wounds where healing is impaired due to a variety 
of factors including impaired collagen deposition, epidermal function, 
macrophage recruitment and angiogenic response (Brem and Tomic-
Canic, 2007).  HA produced by bacterial fermentation which was 
found to be free of problematic endotoxin concentration was found to 
accelerate wound contraction in rats in line with other claims of 
wound healing improvement upon topical application (Patil et al., 
2011). 
As well as maintaining the viscosity and elastic properties of the 
synovial fluid within joints, HA binds and preserves aggrecan, a 
molecule which supports cartilage in its function of load bearing 
(Knudson et al., 2019).  Whilst the main cause of osteoarthritic 
symptoms is degradation of cartilage within the joint, the molecular 
weight of HA in the synovial fluid of arthritic joints is reduced to as 
low as 50% of that in healthy joints, a condition with is likely caused 
by degradation by reactive oxygen species (ROS) (Pontes-Quero et 
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al., 2019).  Thus the injection of high molecular weight HA into the 
joints of patients has become an approach for relief of symptoms of 
osteoarthritis through replenishment of the viscoelastic properties of 
the synovial fluid and promotion of healing in a procedure termed 
viscosupplementation (Iannitti, Lodi and Palmieri, 2011).  Often 
viscosupplementation involves the injection of HA in conjunction 
with corticosteroids in an attempt to alleviate pain and joint stiffness 
and to this day these therapies are under development to include 
aspects of cell therapy (Im, 2019).   
As previously mentioned, the first clinical use of HA was as a 
cushioning agent for the vitreous humour during surgery.  Whilst the 
concentration of HA in the eye varies greatly it is one of the main 
components of the vitreous humour and contributes to viscosity 
(Kleinberg et al., 2011).  While it can be used to treat eye wounds, the 
most common use of HA and its derivatives is in ophthalmic surgery 
such as cataract surgery and cornea replacement surgery, where it is 
applied in order to protect the delicate structures within the eye from 
damage and to regulate intraocular pressure (Kim et al., 2017).  The 
molecular weight of HA is an important factor in ophthalmic medical 
devices (OVD) as higher molecular weight increases the viscoelastic 
properties and so efforts to improve devices by enhancing the 
molecular weight of the HA used are ongoing (Balazs, 2009). 
The fact HA is naturally occurring and thus is biocompatible and 
easily metabolised makes it suitable as a vehicle for drug delivery and 
due to its function as a ligand for CD44 receptors which are 
overexpressed on the surface of a variety of tumour cells it is 
particularly suited to targeted delivery for cancer therapies (Tripodo et 
al., 2015).  As such there has been a vast increase in literature over 
the last 25 years investigating the targeting capability of HA 
conjugated to either free drugs or carrier bound drugs (Dosio et al., 
2016) and the development of HA drug delivery vehicles paired with 
nanoparticles and other conjugates have been developed for delivery 
of chemotherapeutics such as doxorubicin as well as anti-viral drugs 
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like interferon α for targeted treatment of Hepatitis C (Lee et al., 
2012; Li et al., 2016).   
1.2.3.2. Tissue engineering 
The cell signalling and ECM organisation capabilities of HA make it 
an attractive molecule for use as a biomaterial and as such HA 
scaffolds have become common place in tissue engineering (Gallo et 
al., 2019).  HA molecules can be cross linked and chemically 
modified to produce versatile hydrogels for use in a variety of fields 
including the modelling of biological tissues and environments 
(Trombino et al., 2019).  Such materials can be used to either replace 
entire or partial biological structures or aid in restoration of function 
with the more common cross linkages involving the carboxyl, 
hydroxyl and acetyl groups of the HA molecule (Hemshekhar et al., 
2016).  HA hydrogels have also been used to model pathological 
tissues such as tumours in order to better assess drug efficacy (Arora 
et al., 2017).  Addition of HA to electrospun nanotube scaffolds 
designed for cartilage tissue engineering applications increases the 
hydrophilicity (Nikbakht et al., 2019) and improved cell proliferation 
and regeneration of tissues has been observed when biological 
scaffolds are coated with HA (Tiwari, Patil and Bahadur, 2018).  Thus 
the applications for HA in regenerative medicine and tissue 
engineering are numerous.  
1.2.3.3. Moisturisers and cosmetics 
Due to its hydrophilic nature, natural function as a space filler and 
free radical scavenging capability HA has been implemented in the 
cosmetics industry as a topical moisturiser in creams as well as 
components in fillers (Fallacara et al., 2018).  HA was found to be 
more effective than collagen at preserving cosmetic corrections when 
used in facial fillers (Kogan et al., 2007) and HA based fillers scored 
higher in client satisfaction than others as the flexibility of HA fillers 
produces results which are more natural in appearance (Solish et al., 
2019).  The use of HA subdermal fillers results in effects lasting 
approximately 6 months and is currently the most common type of 
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filler, whilst increasingly also being used in moisturisers and skin 
treatments (Salwowska et al., 2016). 
1.3. Microbial Fermentation for HA production 
Microbial fermentation is now the most common method for production of HA, 
most often using species of Group C streptococci (Chen et al., 2012).  Due to 
the rheological properties of HA it is currently only feasible to produce 
maximum concentrations of 5-10 g/L as the broth viscosity is too high for 
successful mass transfer above this, leading to inadequate dissolved oxygen 
concentration (Blank, McLaughlin and Nielsen, 2005).  HA fermentation is 
carried out in bioreactors under varying culture conditions which can influence 
the concentration and molecular weight of the product, such as temperature, pH 
level, dissolved oxygen content, metal ion content and nutrient types and 
availability (Pires, Eguchi and Santana, 2010).  Group C streptococci are 
fastidious bacteria and demanding with regards to nutrient requirements for 
growth (Armstrong, Cooney and Johns, 1997).  The most commonly used 
fermentation conditions for HA production to date include a temperature range 
of 30-37°C, a pH range of 6.5- 7.5 and a carbon source of glucose usually at 
concentration of 10-60 g/L (Armstrong and Johns, 1997).  Production of HA in 
these bacteria competes with growth and so fermentation conditions are often 
set to provide a tolerable stress, such as inadequate nutrient supply, in order to 
optimise the HA production without significantly inhibiting bacterial growth 
(Boeriu et al., 2013).  Group C streptococci are lactic acid producing bacteria 
and during fermentation approximately 80-85% of the carbon supply is utilised 
for lactic acid and acetic acid production with only 5-10% reserved for growth 
and capsule production (Lu et al., 2016).  In addition, increasing lactic acid 
concentrations inhibit growth and HA production and as such are a major 
hindrance in the fermentation process for HA production (Duan et al., 2008).  
Capsule synthesis and lactic acid production both occur during log phase of 
fermentation, whereas degradation of HA often occurs during stationary phase 
(Wu et al., 2009).   
The most common mode of fermentation is batch or fed batch, where the 
bacteria are fermented within a closed system until stationary phase is reached 
and the product is harvested.  This method is laborious due to the need for 
regular bioreactor turnover and it is speculated that continuous culture would 
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prevent stationary phase from being reached thus increasing yield and reducing 
the risk of degradation of the product (Chong et al., 2005).  However in practice 
a decline in HA production is observed independent of continuation of growth 
suggesting instability of HA production in continuous culture where a 
continuous supply of nutrients is provided to prevent stationary phase being 
reached.  As a result, batch fermentation remains the primary mode for HA 
production (Liu et al., 2011).  Efforts to produce hyaluronic acid by microbial 
fermentation using cheaper and more environmentally conscious methods have 
been made using soy, derivatives from agricultural sources, by products and 
discards from the fishing industry and even cashew apple juice (Pires et al., 
2010; Benedini and Santana, 2013; Oliveira et al., 2013; Vazquez et al., 2015).  
More recently a two-stage fermentation process was developed using a strain of 
S. equi subsp. zooepidemicus in order to optimise both molecular weight and 
yield as previously studies have focused on one or the other (Liu et al., 2018).  
Due to the pathogenic nature of Streptococci which will be discussed below 
there are some concerns around the use of these bacteria for HA production and 
so efforts to genetically engineer safer alternatives are ongoing.   
L. lactis is a species of bacteria which is commonly engineered to produce HA, 
however it was observed that the production of lactic acid resulted in reduced 
HA yield and molecular weight (Chauhan et al., 2014).  This challenge was 
overcome by engineering a lactate dehydrogenase-deficient strain which 
resulted in an increased production of ethanol and acetoin as well as a three-fold 
increase in both the molecular weight and yield of HA (Kaur and Jayaraman, 
2016).  However, although substantially increased in comparison to other L. 
lactis strains both the yield and molecular weight produced remain lower than 
that achieved by natural HA producing species. The same has been observed for 
E. coli strains engineered to possess the genes involved in HA production from 
S. pyogenes (Yu and Stephanopoulos, 2008).  The hyaluronan synthase gene 
from S. equi subsp. zooepidemicus was cloned into B. subtilis and rapidly 
mutated in order to produce a number of variants for screening for increased 
HA yield and molecular weight (Zhang et al., 2016), however once again the 
highest yield and molecular weight achieved were substantially lower than that 
achievable with Streptococci.   
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Therefore the replacement of Streptococcus species as the primary microbe for 
HA fermentation still requires vast improvements in order to be feasible.  
1.4. Streptococci 
Streptococci are a genus of gram-positive bacteria which are spherical in shape 
and grow in long chains.  The majority of the species are facultative anaerobes, 
do not produce catalase and have stringent and varying requirements with 
regards to nutrition and environmental conditions (Timoney, 2010).  This genus 
is classed as one of the most invasive in terms of disease, with 35 out of the 49 
species having been identified as causing invasive infection in humans, the 
most common of which are S. pyogenes, S. agalactiae and S. mutans (Krzyściak 
et al., 2013).  S. pyogenes is a member of Group A streptococci which is a 
common cause of disease and mortality throughout the world, responsible for a 
variety of conditions from pharyngitis to toxic shock syndrome, necrotizing 
fasciitis and sepsis (Lamagni et al., 2008). Conditions associated with this 
bacteria such as Scarlet Fever are on the increase, particularly in children of 
school age, who are the most common asymptomatic carriers. Penicillin is the 
main method of treatment, however reports of resistance are now common 
(Wong and Yuen, 2012).  S. pyogenes is one of the species which produce HA 
as a protective capsule (Kang et al., 2012) however due to its pathogenicity it is 
not suitable for use in industrial production of HA.   
In addition to Group A streptococci, HA is produced by others, notably S. 
uberis (a major cause of mastitis in dairy cows) (Field et al., 2003) and several 
Group C Streptococci which will be discussed below.  
1.4.1. Group C Streptococci 
Group C Streptococci are a group of gram-positive, facultative anaerobic, 
catalase negative and pathogenic bacteria which were previously described 
as comprising of four species, S. dysgalactiae subsp. dysgalactiae, S. 
constellatus subsp. pharynges, S. equi subsp. equi and S. equi subsp. 
zooepidemicus (Klos and Wojkowska-Mach, 2017).  These bacteria are 
capable of causing disease in both humans and numerous animal species 
such as horses, pigs, ruminants, dogs, birds, dolphins and rodents with 
some subspecies showing host-specificity.  They have also been identified 
amongst normal mucosal flora of all types of host (Sinner and Tunkel, 
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2015).  Infection is associated with the presence of virulence factors such 
as M-like protein, capsule, streptokinases, pyrogenic exotoxins, haemolysin 
and other proteases (Segura and Gottschalk, 2005).   
Subspecies of Streptococcus equi are responsible for severe instances of 
disease in domesticated animals. S. equi subspecies equi is the known 
causative agent of a frequently occurring upper respiratory disease in 
horses named Strangles.  Strangles is highly infectious, varies in severity 
and in a number of cases infection persists following resolution of 
symptoms, often due to lack of clearance in the guttural pouch (Timoney, 
2004; Waller, Paillot and Timoney, 2011).  The high risk of complications 
and lengthy quarantine of infected yards during an outbreak of the disease 
causes significant economic loss.  S. equi subsp. equi is restricted to the 
horse as its host, however is not the only member of S. equi to cause 
disease in horses.  S. equi subspecies zooepidemicus is a commensal 
organism found within the natural flora of the horse.  Mucosal disease is 
associated with opportunistic infection, and can also occur in other animals 
such as cattle, sheep, pigs, cats, dogs and goats (Steward et al., 2017).  
Instances of serious and invasive disease in humans have been reported in 
connection with this bacteria to such an extent that it was proposed to be an 
emerging problematic zoonotic (Pelkonen et al., 2013).  Certainly there is 
evidence to suggest that transmission to humans may occur from horses, 
dogs and ruminants either by direct contact or through the consumption of 
unpasteurised dairy products (Abbott et al., 2010).  This is not an 
implausible concept when considering the extent of similarities to the 
previously mentioned human pathogen S. pyogenes.  They share a number 
of genes and traits considered to pertain to virulence such as those for 
surface M proteins, antigens and the HA polysaccharide capsule.  This trait 
similarity is speculated to be due to their origination from a common 
ancestor (Klos and Wojkowska-Mach, 2017).  Additionally, mastitis in 
cows caused by S. pyogenes has been documented and thought to have 
arisen by transmission from humans to the animal (Wong and Yuen, 2012).  
S. equi subsp. equi is proposed to be descended from an ancestral strain of 
S. equi subsp. zooepidemicus and the two species share numerous virulence 
factors such as the ones listed above (Timoney, 2004).  The suggestion that 
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these two species are descended from a common ancestral strain would 
certainly explain the >98% genomic identity that is observed between 
them.  In addition to this, S. equi subsp. zooepidemicus shares >80% of its 
genetic identity with S. pyogenes (Holden et al., 2009), a trait which 
correlates with the observation that both can cause severe infections in 
humans such as rheumatic fever and glomerulonephritis (Pelkonen et al., 
2013). 
In 2004, previously unclassified gram positive cocci with >70% genetic 
identity with S. equi subsp. equi and S. equi subsp. zooepidemicus was 
isolated during a routine bacteriological study investigating causative 
agents of mastitis in small ruminants.  Following phenotypic, biochemical 
and genetic analysis the organism was proposed to be a new species and 
designated Streptococcus equi subsp. ruminatorum (Fernandez et al., 
2004).  Following this publication the strain was attributed to Strangles like 
disease affecting spotted hyenas and plains zebras in Tanzania, where 
several clones of the strain were identified throughout the wild population 
(Speck et al., 2008).  That same study attempted to establish differences 
and similarities of these wildlife strains to the originally isolated strain by 
Fernandez et al. (2004) as well as type strains of S. equi subsp. equi and S. 
equi subsp. zooepidemicus using biochemical and molecular biological 
methods.  Differences and similarities were reported however unfortunately 
not all data was presented.  Little more has been published about this novel 
subspecies of S. equi. 
1.4.2. Hyaluronic Acid Capsule of Streptococci 
1.4.2.1. Hyaluronic acid protection against phagocytosis 
For all of the Streptococcus species discussed above, the hyaluronic 
acid capsule is considered to be one of the main factors affecting 
virulence and pathogenicity (Wessels et al., 1991; Anzai et al., 1999; 
Dinkla et al., 2007).  It is speculated that production of capsule 
enables the bacteria to evade host immune responses such as 
identification by immune cells and deposition of complement factors 
allowing them to more effectively establish infection (Cress et al., 
2014; Fischetti and Dale, 2016).  Due to the natural presence of HA in 
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the ECM of the host, capsule produced by Streptococci behaves as a 
form of invisibility cloak, preventing identification from immune cells 
which will view the HA as ‘self’ and the presence of HA correlates 
positively with a reduced number of bacteria cells which undergo 
phagocytosis (Schommer et al., 2014).   
As previously mentioned, HA is one of the main virulence factors 
present in S. equi species, along with haemolytic exotoxin streptolysin 
S and the antiphagocytic M-like protein (Timoney, 2004).  
Antiphagocytic M-like protein functions by impeding the deposition 
of opsonic C3b molecules to the bacterial surface, resulting in reduced 
formation of membrane attack complex and thus reduced complement 
mediated bacterial death (Merant, Sheoran and Timoney, 2011) and 
both it and HA are required for resistance to phagocytosis (Dale et al., 
1996a).  While it is speculated that HA protects against phagocytosis 
by physically hindering opsonins and cell binding proteins as a result 
of its polyanionic and hydrophilic qualities which prevent penetration 
through the HA chains surrounding the bacteria cells (Dinkla et al., 
2007), this is not the generally accepted mechanism and there is the 
opinion that HA acts to physically inhibit the contact of phagocytes 
with deposited opsonins (Nizet, 2007).  Additionally it has been 
observed that encapsulated bacteria form aggregates which may aid in 
protection from reactive oxygen species produced during immune 
responses by reducing their infiltration (Henningham et al., 2015).  
1.4.2.2. Genetic basis of capsule synthesis 
Among Group C Streptococci, S. equi subsp. zooepidemicus has 
served as prototype for HA biosynthesis and regulation.  The 
production of HA involve five genes, the hyaluronan synthase (hasA) 
which is responsible for the assembly of the HA chain, UDP-glucose 
dehydrogenase (hasB) and UDP-glucose pyrophosphorylase 
(hasC/galU) which are responsible for the synthesis of the precursor 
UDP-glucuronic acid and N-acetylglucosamine-1-phosphate 
uridyltransferase (hasD/glmU) and phosphoglucoisomerase 
(hasE/pgi) which are responsible for the synthesis of UDP-N-
acetylglucosamine (Chen et al., 2014).  The has operon of S. equi 
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subsp. equi is interrupted by an insertion of approx. 11200 base pairs 
encoding a putative phosphotransferase system (PTS) between the 
first 3 genes (hasA, hasB and hasC) and hasD and hasE which are 
present within a separate operon, whereas in S. equi subsp. 
zooepidemicus all five genes are located within a single has operon.  
In addition in, a second copy of hasC is found in a separate operon in 
both strains along with a gene for NAD(P)+ dependent glycerol-3-
phosphate dehydrogenase (Blank, Hugenholtz and Nielsen, 2008).   
 
Figure 2 has operon of S. equi species.  The has operon of S. equi subsp. zooepidemicus 
contains all five genes involved in HA synthesis.  In S. equi subsp. equi the operon has been 
interrupted, separating glmU (hasD) and pgi (hasE) from hasA, hasB and hasC (Blank, 
Hugenholtz and Nielsen, 2008).  
A study assessing the effects of over expressing the 5 genes of the has 
operon using a nisin inducible vector in a S. equi subsp. 
zooepidemicus strain on the yield and molecular weight of HA 
capsule revealed the importance of individual genes (Chen et al., 
2009b).  Overexpression of the hasA gene increased the yield of HA, 
however reduced the molecular weight in comparison with the 
wildtype strain.  Contrastingly overexpression of hasC resulted in a 
decreased yield as did expression of both hasD and hasE 
simultaneously.  Additional significant findings of this study were that 
overexpression of hasE increased the molecular weight of the HA 
product as did the presence of the empty vector plasmid control.   
The above outcomes prompted an investigation into the effects of the 
empty plasmid on gene expression and hyaluronic acid synthesis 
(Marcellin, Chen and Nielsen, 2010).  The unexpected result of this 
follow on study was that a downregulation of MurA activity was 
identified and further investigation concluded that overexpression of 
this enzyme caused the molecular weight of HA produced to decrease.  
MurA is an enzyme which catalyses the first step in the pathway of 
peptidoglycan synthesis.  This step involves the relocation of an 
enolpyruvate residue from phosphoenolpyruvate (PEP) to position 3 
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of UDP-N-acetylglucosamine (Zoeiby, Sanschagrin and Levesque, 
2003).  As mentioned previously, N-acetylglucosamine is one of the 
components of the hyaluronic acid chain and thus this step of the 
peptidoglycan synthesis pathway is in direct competition with 
hyaluronic chain synthesis.  Thus it brings to reason that down-
regulation of the MurA enzyme would enhance availability of the N-
acetylglucosamine supply for hyaluronic acid synthesis.  Prior to the 
identification of this effect of MurA downregulation it had been 
concluded that HA molecular weight was dependent on the ratio of 
available precursors and that N-acetylglucosamine was the limiting 
component (Chen et al., 2009b).   
1.4.2.3. Hyaluronan synthase 
As mentioned above the hyaluronan synthase enzyme is responsible 
for the synthesis of the HA chain.  This enzyme is a membrane-
integrated glycosyltransferase which extrudes the HA chain through 
the bacterial membrane as it assembles it (Weigel, 2015).  Only 
hyaluronan synthase is required in order to assemble the HA chain 
and this is due to the fact the HAS enzyme functions with two 
different glycosyl transferase activities (Weigel, 2002).  The structure 
and topology of the HAS enzyme within the membrane has been 
elucidated (Heldermon, DeAngelis and Weigel, 2001) and 
mutagenesis studies on the hasA enzyme have been attempted in 
various strains in order to manipulate the yield and molecular weight 
of HA (Heldermon et al., 2001; Weigel and Baggenstoss, 2012).  In 
addition it has been observed that the enzyme is associated with 
molecules of cardiolipin and that this interaction is required for 
synthase activity (Tlapak-Simmons et al., 1998).  Cardiolipin is a 
phospholipid found in the membranes of mitochondria of eukaryote 
cells and bacteria which has been associated with the stability of 
numerous other integral membrane proteins (Musatov and Sedlák, 
2017).  However further investigations into the importance of this 
relationship are yet to be published.  
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1.5. Project aims 
With HA being an increasingly important biomedical product as well as a 
virulence factor for this pathogenic species of bacteria, its role in the bacterial 
metabolism, infection establishment and the factors which influence its 
production are key topics for research.  Previous investigations into HA 
production in Streptococcus focus on fermentation parameters and mutation of 
the genes within the has operon and often focus on a single strain.  This study 
aims to investigate HA production from the perspective of the evolutionary 
necessity for streptococcal synthesis of HA and to use mucoid and non-mucoid 
strains to attempt to explore factors out with the immediate HA synthesis 
machinery.  Specific aspects addressed are: 
• Evaluation of current procedures for HA production from S. equi subsp. 
equi. 
• Comparison of HA production in alternative Group C Streptococcus 
subspecies. 
• Genomic comparison of S. equi strains and mucoid/non-mucoid 
phenotypes. 
• Assessment of competing essential metabolic processes on HA 
production. 
• Transcriptional and proteomic variations between Group C 
Streptococcus subspecies and HA producing and non-producing variants. 
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2. Growth Parameters and Permutations in HA production by Streptococcus equi 
subspecies 
2.1. Introduction 
Although it is more efficient and ethical than extraction from animal tissues, 
bacterial production of HA poses some challenges, including culture of source 
organisms.  Lancefield group C bacteria such as S. equi subsp. equi and S. equi 
subsp. zooepidemicus are the most common native producing bacteria used to 
produce HA (Kim et al., 1996; Chen et al., 2009a; Choi et al., 2014).  While 
batch culture appears to be the most conventional mode of fermentation for HA 
production, there are arguments that continuous culture prevents progression 
into stationary phase thus avoiding the production of degrading enzymes and 
release of contaminating intracellular proteins and toxins which make the 
purification process more complicated (Chong et al., 2005).  However, in 
practice continuous culture has been unattainable due to the instability of the 
HA producing phenotype and subsequent tendency for HA production to 
decline over time,  therefore the prevailing method of fermentation for HA 
production remains batch culture (Armstrong and Johns, 1997; Liu et al., 2011).  
A stable continuous culture of S.equi subsp. zooepidemicus ATCC 35246 was 
developed which operated at a dilution rate of 0.4 h-1 in an arginine limited 
chemically defined media (CDM) for 74 hours before a non-mucoid phenotype 
emerged. However CDM is regarded as too expensive for use in commercial 
production (Blank, McLaughlin and Nielsen, 2005).  Fermentation conditions 
including temperature, pH and oxygen and nutrient availability can all have an 
impact on product characteristics and yields and they need to be monitored and 
controlled (Pires, Eguchi and Santana, 2010).  
Continuous culture is the method currently employed by Hyaltech Ltd.  This 
company uses NCIMB S. equi strain 40327 (designated SE40327 in this study) 
for production of hyaluronic acid to be used in medical solutions for ophthalmic 
viscosurgical devices (OVDs) for cataract surgery, bone fillers and 
viscosupplements used in osteoarthritis treatment.  Bacterial fermentation is 
performed in volumes of between 80-130 L of the fermentation media described 
in the methods section (Table 1).  Use of the strain for HA production was 
patented in 1992 (International Publication Number WO1992008799A1).  As a 
result no available data exists that could be used to compare it to other strains of 
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group C Streptococci in regards to HA production,  therefore it was decided that 
this study would focus on characterisation of SE40327 as a HA producer in 
comparison to other encapsulated strains. 
The following strains were acquired from DSMZ for comparison to SE40327.  
DSMZ-20561 is a type strain of S. equi subsp equi which was isolated from a 
submaxillary abscess of a foal displaying symptoms of Strangles.  DSMZ-
20727 is a type strain of S. equi subsp zooepidemicus isolated from a case of 
bovine mastitis.  Both of these strains are recommended by ATCC for use as 
quality control strains.  DSMZ-17037 was first isolated in 2004 from the 
mastitis of ruminants and following phenotypic and molecular analysis was 
proposed to be a novel subspecies of S. equi, designated S. equi subsp. 
ruminatorum (Fernandez et al., 2004).  All three type strains were 
biochemically analysed and found to produce capsule (Speck et al., 2008) and 
so were considered suitable candidates for comparison.  
It is argued that continuous culture is the most suitable way of studying the 
physiology of bacteria without the interference from external growth 
determinants such as the eventual limitation of nutrients which induce the 
development of stationary phase observed in batch culture (Hoskisson and 
Hobbs, 2005).  However, it has been claimed that this mode of culture is not a 
reliable approach for HA production due to the previously mentioned tendency 
of naturally HA producing bacteria to switch to a non-mucoid phenotype.  This 
is a drawback that is seen in practice with SE40327, with the concentration of 
HA declining over time regardless of the stability of the biomass in a 
continuous system.  An outcome which suggests that not all changes to growth 
physiology can be prevented by the continuous culture mode.   
Whilst continuous culture and the use of chemostats is most certainly an 
important tool for assessing the effects of culture conditions on growth and 
production of molecules by bacteria, even in smaller vessels they can require 
large volumes of media and can be time consuming to set up and monitor.  For 
the purpose of this work a small scale model of batch fermentation was 
developed using multi-well plates to compare strains of group C Streptococci in 
regards to HA production, as even shake flask culture can swiftly use up media 
resources.  By comparison, use of multiwell plates (e.g. 96 well plates) 
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enhances experimental multiplexing, replicability and sample monitoring across 
multiple parameter permutations.   
The fermentation parameters which influence HA production have been the 
focus of many research studies already (Kim et al., 1996; Armstrong, Cooney 
and Johns, 1997; Armstrong and Johns, 1997; Blank, McLaughlin and Nielsen, 
2005; Kim, Park and Kim, 2006; Duan et al., 2008; Huang, Chen and Chen, 
2008; Liu et al., 2008; Chen et al., 2009a; Zhang, Duan and Tan, 2010; Chen et 
al., 2012).  However, despite use in biomanufacturing, no data or protocols 
were readily available for SE40327 growth and HA production in batch mode 
or in small scale culture.   
For fermentation of SE40327 the culture temperature and pH used are 37°C and 
6.1.  This pH was considered a low starting pH for batch culture as group C 
streptococci are lactic acid producing bacteria (Smith and Sherman, 1942; 
Papadimitriou et al., 2016) which were expected to rapidly reduce the pH of the 
culture media.  So experiments were proceeded at pH 7 which is commonly 
used for HA production in other strains of Streptococci (Liu et al., 2011).   
The set of experiments described in this chapter aimed to develop a 
reproducible and reliable protocol that would allow comparisons of HA 
producing strains in a small scale 96 well format.  This adapted the 
fermentation media normally used in continuous fermentation of SE40327, 
optimising it for use in small scale batch conditions and comparing it to other 
media types to find the optimal conditions for growth and HA production for 
each subspecies. 
2.2. Materials and Methods 
2.2.1. Culture media and Bacteria Strains  
2.2.1.1. Fermentation media 
Fermentation Media (FM) and Sulphur Limited Broth (SLB) were 
prepared in accordance with standard operating procedures acquired 
from Hyaltech Ltd containing the concentrations below.  All 
ingredients were provided by Hyaltech Ltd unless otherwise stated as 
were solutions of trace salts, sodium molybdate and calcium 
carbonate.  Original supplier details for these ingredients are not 
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available.  Hydrochloric acid was sourced from Merck.  The 
ingredients were dissolved one at a time in the order below in 
deionised water with stirring.  Fermentation Media was filter sterilised 
using Millipore 0.22 µm Steritop and Stericup.  Sulphur Limited 
Broth was autoclaved at 121°C for 15 minutes.  The pH of each was 
adjusted prior to sterilisation by addition of 16% NaOH.  
Fermentation Media was adjusted to pH 7 and Sulphur Limited Broth 
to pH 6.6. 
 Fermentation media 
 
Ingredient g/L 
Citric Acid 0.5 
Sodium Dihydrogen Phosphate 2.4 
Ammonium Chloride 2.5 
Potassium Chloride 0.8 
Magnessium Oxide 0.5 
Hydrochloric Acid 2.4 
Calcium Carbonate Stock 1.2 
Sodium Molybdate Stock 1.1 
Trace Salts Stock 0.5 
Yeast Extract 7.5 
Glucose 74 
 
 Sulphur Limited Broth 
 
Ingredient g/L 
Hydrochloric acid 3.9 
Magnesium Oxide 0.7 
Ammonium Chloride 75 
Citric Acid 6 
Sodium Dihydrogen Phosphate 40 
Potassium Chloride 5 
Potassium Dihydrogen Phosphate 19 
Dipotassium Hydrogen Phosphate 22 
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Ingredient mL/L 
Sodium Molybdate Stock 1.5 
Calcium Carbonate Stock 15 
Trace Salts Stock 7.5 
 
 Trace Salts Stock Solution 
 
Ingredient g/L 
Zinc Oxide 1.6 
Ferric Chloride Solution 45.9 
Manganous Chloride 8 
Cupric Chloride 0.7 
Cobaltous Chloride 1.9 
Hydrochloric Acid 17.2 
 
 Calcium Carbonate Stock Solution 
 
Ingredient g/L 
Calcium Carbonate 10 
Hydrochloric Acid 23.2 
 
 Sodium Molybdate Stock Solution 
 
Ingredient g/L 
Sodium Molybdate 4.8 
Hydrochloric acid As required 
 
 Sulphur Limited Broth 
 
Ingredient g/L 
Stock Solution for SLB 70 
Yeast Extract 5 
Glucose 2.4 
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2.2.1.2. Brain Heart Infusion Media and Agar plates 
Brain Heart Infusion (BHI) media and agar were sourced from Sigma-
Aldrich Ltd and prepared in accordance with the instructions with one 
amendment.  The BHI media was filter sterilised using Millipore 0.22 
µm Steritop and Stericup (Merck).  Sulphur Limited Agar (SLA) and 
5% Horse Blood Agar plates were sourced from Southern Group 
Laboratory Ltd. 
2.2.1.3. Bacteria Strains 
S. equi NCIMB 40327 (SE40327) was received from Hyaltech Ltd as 
colonies on sulphur limited agar plates.  S. equi subsp. equi DSMZ 
20561 (SEE20561), S. equi subsp. zooepidemicus DSMZ 20727 
(SEZ20727) and S. equi subsp. ruminatorum DSMZ 17037 
(SER17037) were acquired from DSMZ as ampoules of freeze dried 
culture which were revived in BHI media overnight at 37°C.  Frozen 
25% glycerol stocks of all strains were prepared by mixing 1ml of 
50% glycerol solution with 1ml of bacteria culture in BHI media. 
Glycerol stocks were stored frozen at -80°C. 
2.2.2. Establishing growth in fermentation media in comparison to other 
high nutrient media 
2.2.2.1. Revival of Glycerol Stocks and Inoculum preparation 
Frozen glycerol stocks of bacteria were removed from -80 freezer and 
streaked onto sulphur limited agar plates.  The plates were incubated 
at 37°C for 48-72 hours in accordance with Hyaltech standard 
operating procedure.  Single mucoid colonies were selected and 
inoculated into 50ml pre-equilibrated, sterile sulphur limited broth.  
The broth cultures were incubated at 37°C overnight prior to use. 
2.2.2.2. Multi-well plate growth curve set up 
Inocula were prepared as described previously (2.2.2.1) for the four 
strains of S. equi described above. All media was equilibrated to 37°C 
prior to use. The optical density (OD) at 660 nm was measured for 
each overnight culture and was diluted to 0.05 in the selected media.  
The samples were then seeded into a flat bottomed, untreated 96-well 
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plate in replicates of 15.  Each well was filled with 200 µl of sample 
and uninoculated media was used for blank wells.  Plates were 
covered with a Breathe-Easy® sealing membrane (Sigma-Aldrich) 
and placed in a FLUOstar Omega Microplate reader (BMG Labtech).  
The plate was incubated at 37°C for 20 hours.  Optical density 
readings at 660 nm were taken every 30 minutes with 200 RPM of 
shaking for 1 second prior to each reading.  Data was plotted as 
averages and standard deviations of blank corrected time point OD 
readings.  
2.2.3. pH control using HEPES, PIPES and Tris buffers 
Inocula were prepared as described previously (2.2.2.1) with S. equi 
NCIMB 40327.  The OD of the inoculum was measured at 660 nm and 
corrected to 0.05 in fermentation media supplemented with concentrations 
of 0, 10, 25 and 50 mM HEPES buffer solution (1M, pH 7-7.2) (Sigma-
Aldrich).  Each sample was seeded (200 µl in each well) in replicates of 15 
and uninoculated, buffered media was used for blank wells.  Plates were 
incubated in a FLUOstar Omega Microplate reader (BMG Labtech) under 
conditions described previously (2.2.2.2).  Data were plotted as averages 
and standard deviations of blank corrected time point OD readings.  The 
same protocol was used for PIPES (1M, pH 6.0) (VWR) and Trizma base 
(1M in H2O, pH 10.5-12) (Sigma-Aldrich).  Dilutions were carried out as 
follows.  To obtain media with 10, 25 and 50 mM buffer concentrations a 
1M stock solution was diluted 1/10, 1/4 and 1/2 in media to produce 
concentrations of 100, 250 and 500 mM.  These were then diluted 1/10 to 
obtain media for inocula at concentrations of 10, 25 and 50 mM.  
2.2.4. pH monitoring of S. equi cultures 
Inocula were prepared as described previously (2.2.2.1) with S. equi 
NCIMB 40327.  A 1 in 10 dilution of the inoculum in 37°C fermentation 
media (pH 7) was prepared in a series of tubes, 3 for each 2 hour time 
point. The tubes were incubated at 37°C at 150 RPM shaking, the lids were 
left loose to allow for some gas transfer.  Every 2 hours the optical density 
was measured by removing a set of tubes and transferring media to 
cuvettes. The pH of the culture in each tube was then measured using a pH 
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meter. The cultures were discarded following pH measurement.  Growth 
and pH were monitored for 8 hours, where stationary phase had previously 
been shown to have been reached.  
2.2.5. Capsule production analysis 
Inocula for all four Streptococcus equi strains were prepared as described 
previously (2.2.2.1) and multi-well plates set up for growth in fermentation 
media (pH 7) as described previously (2.2.2.2).  Optical density readings at 
660nm were carried out against a blank of un-inoculated sulphur limited 
broth.  The optical density for each culture was adjusted to 0.05 in fresh 
medium as described previously (2.2.2.2).  The cultures were seeded 200 
μL per well in a 96 well plate along with single well blanks of 200 μL un-
inoculated media per strain.  Plates were then sealed with a Breathe-Easy® 
sealing membrane (Sigma-Aldrich), placed in either the Omega FLUOstar 
plate reader and incubated until stationary phase was reached (max 8 
hours) under conditions described previously (2.2.2.2).  Following 8 hours 
of growth the plate was removed and the cultures pooled.  The cultures 
were drawn into a 5 mL syringe and filtered through 1.0 μm and 0.45 μm 
syringe filters (Whatman®) consecutively.  The supernatant samples were 
stored at -20°C until thawed for analysis by HPLC using a size exclusion 
column which was carried out at Hyaltech Ltd as per their standard 
operating procedure where retention time and HA concentration are 
measured for quality control purposes. 
2.3. Results 
2.3.1. Colony morphology of SE40327 compared to other S. equi strains 
The colony morphology of SE40327 was compared to the other S. equi 
strains on sulphur limited agar plates and 5% horse blood agar plates.  On 
sulphur limited agar all strains grew as translucent to opaque colonies, 
however while SE40327 and SER17037 colonies were large, rounded and 
glossy in appearance both SEE20561 and SEZ20727 appeared matte and 
less domed in shape (Figure 3).  On horse blood agar the colonies of all 
strains appeared glossy in appearance and all displayed β-haemolysis.  The 
strain which most closely matched SE40327 in morphology in both cases 
was SER17037. 
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Figure 3 Colony morphology of the four selected strains of S. equi on 5% horse blood agar 
plates (left) and sulphur limited agar plates (right).  The strains pictured are SE40327 (A), 
SEE20561 (B), SEZ20727 (C) and SER17037 (D).  Bacterial stocks were streaked onto agar plates 
which were incubated for 48 hours at 37 °C. 
 
To assess whether the use of sulphur limited agar promotes capsule 
production, the strains were grown on both SLA plates and BHI agar plates 
in order to compare the colony morphology.  Figure 4 shows SE40327 
cultured on both media.  From the pictures it is apparent that whilst the 
colonies on SLA are indeed mucoid in appearance, they are not as large or 
glossy as on BHI media.  Growth on BHI agar was also much more rapid 
than SLA, with distinct colonies being visible after 24 hours and colonies 
appearing to begin drying after 48 hours.  The same observation can be 
made for the other 3 strains (figures 5-7), with colonies appearing larger 
and mucoid on BHI compared to SLA after 48 hours of growth.  Of 
particular interest is SER17037 in Figure 5 which appears to display both 
mucoid and non-mucoid variant colonies on both SLA and BHI agar.  Non-
mucoid colonies appear much smaller and matte white in colour.  The 
mucoid colonies on SLA are larger and appear domed and glossy, whilst on 
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BHI agar single colonies are indiscernible with growth appearing as areas 
of slimy, mucoid puddles. 
 
Figure 4 Colony morphology of S. equi NCIMB40327 on Sulphur limited agar (left) and Brain 
Heart Infusion agar (right).  Bacterial stocks were streaked onto agar plates and incubated for 48 
hours at 37°C. 
 
Figure 5 Colony morphology of S. equi subsp equi 20561 on sulphur limited agar (left) and 
brain heart infusion agar (right).  Bacterial stocks were streaked onto agar plates and incubated 
for 48 hours at 37°C. 
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Figure 6 Colony morphology of S. equi subsp zooepidemicus 20727 on sulphur limited agar 
(left) and brain heart infusion agar (right).  Bacterial stocks were streaked onto agar plates and 
incubated for 48 hours at 37 °. 
 
Figure 7 Colony morphology of S. equi subsp ruminatorum 17037 on sulphur limited agar (left) 
and brain heart in fusion agar (right).  Bacterial stocks were streaked onto agar plates and 
incubated for 40 hours at 37°C.  
 
2.3.2. Growth variations between subspecies of S. equi in different media 
In order to compare growth of the industrial biomanufacturing strain 
(SE40327) against other S. equi strains a multi-well plate culture method 
was used.  Growth of all strains in industrial fermentation media was 
compared to that of BHI, a nutrient rich media suitable for the growth of 
fastidious organisms.  As can be seen in Figure 8, growth between the 
strains is not significantly different in fermentation media, although 
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SEE20561 reaches a lower maximum optical density.  The error bars 
indicate that growth varies between biological replicates, an observation 
which has also been made at industrial fermentation culture volumes.  
Growth of all strains follows a similar trend until late log to stationary 
phase (8-10 hours), with SE40327 and SEZ20727 following the most 
similar growth curve.   
In contrast, Figure 9 displays the growth profiles for the four strains in 
BHI.  While variation between biological replicates appears to be greater in 
comparison to fermentation media, indicated by the larger error bars, the 
final OD reached for all four strains including SEE20561 are not 
significantly different.  Stationary phase appears to be more stable in BHI 
media than in fermentation media, where small increases in OD are 
observed even up to 20 hours of growth.  In addition, the time at which 
stationary phase is reached by each strain appears to vary more in BHI (9-
13 hours).  Surprisingly, SE40327 appears to be most similar in growth 
profile to SEZ20727 and SER17037, although overall the growth curves 
are similar for all strains.    
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Figure 8 Comparison of growth over time of S. equi strains in fermentation medium.  The 
strains represented are S. equi strain 40327 (SE40327), S. equi subsp equi DSMZ20561 (SEE20561), 
S. equi subsp zooepidemicus DSMZ20727 (SEZ20727) and S. equi subsp ruminatorum DSMZ17037 
(SER17037).  The curves plotted are optical density at 660 nm over time.  Points on the graph are 
representative of mean values over 3 biological replicates and error bars are standard deviation. 
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Figure 9 Comparison of growth over time in S. equi strains in BHI medium.  The strains 
represented are S. equi strain 40327 (SE40327), S. equi subsp equi DSMZ20561 (SEE20561), S. 
equi subsp zooepidemicus DSMZ20727 (SEZ20727) and S. equi subsp ruminatorum DSMZ17037 
(SER17037).  The curves plotted are optical density at 660 nm over time.  Points on the graph are 
representative of mean values over 3 biological replicates and error bars are standard deviation. 
In order to observe variations in growth between media type growth curves 
were plotted of single strains in fermentation media and BHI media 
(Figures 10-13).  It is apparent that no significant difference of the growth 
curves of SE40327 can be observed between the two media (Figure 10).  
This is in contrast to SEE20561 (Figure 11) in which a reduced lag time 
and increased maximum OD are visible, though the difference does not 
appear to be significant.  Interestingly, SEE20651 reaches a lower average 
OD than SE40327 in both media types.  Meanwhile the curves for 
SEZ20727 (Figure 12) appear to be very similar to SE40327 in that they do 
not differ significantly between media and similar lag time and stationary 
phase profile are observed.  As in the growth curves above a notable small 
increase in OD is present during stationary phase for both SE40327 and 
SEZ20727 in fermentation media, whereas the curves in BHI level off in 
stationary phase in a more pronounced manner. For SER17037 (Figure 13), 
while no significant difference in final OD is observed between the two 
media the growth curves are different in shape. Lag time appears to be 
extended in BHI compared to fermentation media and larger error bars 
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indicate greater variation in growth between replicates. As with SE40327 
and SEZ20727, stationary phase appears more distinct in BHI media with 
small increases in OD observable after initial stationary phase appears to 
have been reached.  However, lag time for this strain appears to be 
significantly extended in BHI compared to fermentation media, which is 
not noted in the other strains. Overall, growth does not appear to be 
significantly different between fermentation media which is prepared 
specifically for industrial production of HA and BHI media which is 
recommended for the culture of fastidious pathogenic organisms.  
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Figure 10 S. equi NCIMB 40327 growth in varying media.  The curves plotted are optical density 
at 660 nm over time.  Points on the graph are representative of mean values over 3 biological 
replicates and error bars are standard deviation.  Data is taken from the SE40327 data in figures 8 
and 9.  
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Figure 11 S. equi subsp equi (SEE20561) growth in varying media.  The curves plotted are 
optical density at 660 nm over time.  Points on the graph are representative of mean values over 3 
biological replicates and error bars are standard deviation.  Data is taken from the SEE20561 data in 
figures 8 and 9.  
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Figure 12 S. equi subsp zooepidemicus (SEZ20727) growth in varying media.  The curves plotted 
are optical density at 660 nm over time.  Points on the graph are representative of mean values over 
3 biological replicates and error bars are standard deviation.  Data is taken from the SEZ20727 data 
in figures 8 and 9.  
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Figure 13 S. equi subsp ruminatorum (SER17037) growth in varying media.  The curves plotted 
are optical density at 660 nm over time.  Points on the graph are representative of mean values over 
3 biological replicates and error bars are standard deviation.  Data is taken from the SER17037 data 
in figures 8 and 9.  
2.3.3. pH control and buffering 
S. equi are lactic acid producing bacteria and industrial fermentation 
requires pH control to limit growth inhibition caused by a decline in pH.  In 
order to assess the effects of acid production on the decline of pH of the 
culture medium, alteration in pH was assessed against growth over time, 
Figure 14 displays the results of these analyses. The starting pH of the 
fermentation media is 7, from the graph it is observed that following two 
hours of growth this drops to almost 6.  Both growth and pH follow 
consistent trends over biological replicates.  Overall an inverse relationship 
is evident between pH and growth, as was anticipated. 
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Figure 14 Growth vs pH over time of SE40327 culture in fermentation media.  Optical density 
readings were performed at 660 nm.  The points plotted represent mean over 3 biological replicates.  
Standard deviation was used for error bars.  
The fermentation process which the small scale culture aims to mimic 
controls pH of the culture media by way of in situ pH monitoring and 
addition of 32% w/v sodium hydroxide solution (NaOH). In order to 
establish better pH control in small scale fermentation of HA, the effects of 
a series of widely-used biological buffers on growth of the bacteria was 
investigated. The buffers investigated were HEPES (effective pH range: 
7.0-7.6, pH 7-7.2), Trizma base (effective pH range: 7-9, pH 10.5-12) and 
PIPES (effective pH range: 6.1- 7.5, pH 6).  
Figure 15 displays the effect on growth of strain SE40327 of HEPES 
buffering of fermentation media at concentrations of 0, 10, 25 and 50 mM.  
While no significant difference on log phase growth can be observed 
between buffer concentrations, a significant difference in the final OD 
reached is seen between 0 and 50 mM HEPES concentrations. The increase 
is by approximately 0.1 OD, with the average OD at 20 hours of growth 
without buffering being 0.52 compared to 0.62 with 50 mM HEPES. With 
regards to the average maximum OD, buffering with 50 mM HEPES 
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increased this from 0.52 to 0.65.  From the graph it is evident that 50 mM 
was the optimum HEPES concentration from those tested.   
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Figure 15 Effect of increasing HEPES buffer concentration on S. equi NCIMB 40327 growth.  
Growth was assessed in fermentation media (starting pH 7) with 0, 10, 25 or 50 mM HEPES buffer 
solution.  The curves plotted are optical density at 660 nm over time.  Points on the graph are 
representative of mean values over 3 biological replicates and error bars were calculated using 
standard deviation. 
Following the results of the HEPES buffer concentration analysis, the 
growth of all four strains of interest was investigated in the maximum 
HEPES concentration tested (50 mM).  From figure 16 an improvement in 
maximum OD is observed for all strains in comparison to culture in non-
buffered fermentation media (Figure 8).  It is also apparent that the strains 
display differences in both lag time and the time point at which stationary 
phase is reached.  SEE20561 still does not reach as high a maximum OD as 
the other three strains and appears to have a slightly longer lag time than 
two of the strains. Whereas SE40327 appeared to display the longest lag 
time, yet reached a much higher final OD. SEZ20727 and SER17037 
appear to have similar lag and log profiles, but SEZ20727 reaches a 
significantly higher OD upon reaching stationary phase. No significant 
difference between final OD is noted between SE40327 and SEZ20727 
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however. Whilst buffering with HEPES has increased the OD reached by 
all strains, it has emphasised differences in growth profiles between them 
which were not as evident in fermentation media without HEPES buffering 
or BHI media (Figures 8 and 9). 
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Figure 16 Comparison of strain growth in fermentation media supplemented with 50 mM 
HEPES buffer.  Starting pH of the media was 7.  The strains represented are S. equi strain 40327 
(SE40327), S. equi subsp equi DSMZ20561 (SEE20561), S. equi subsp zooepidemicus DSMZ20727 
(SEZ20727) and S. equi subsp ruminatorum DSMZ17037 (SER17037).  The curves plotted are 
optical density at 660 nm over time.  Points on the graph are representative of mean values over 3 
biological replicates and error bars were calculated using standard deviation. 
The following four graphs (Figures 17-20) more clearly display the 
differences in growth profiles for each strain when cultured in buffered or 
non-buffered media. From all of the graphs it is clear that a significant 
increase in maximum OD occurs when the culture is buffered with HEPES.  
In the case of SEE20561, variation of growth between biological replicates 
appears reduced in buffered media, whereas for SEZ20727 the opposite is      
apparent.  Only SEZ20727 and SER17037 experience a change in overall 
growth profile, with the lag time for both strains being slightly shorter in 
buffered media compared to non-buffered.  
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Figure 17 SE40327 growth in buffered and non-buffered fermentation.  The graph displays 
growth of SE40327 presented as mean OD values versus time in hours at 37°C.  Standard deviation 
was calculated for the error bars.  Conditions presented are fermentation media only (SE40327 FM) 
and fermentation media supplemented with 50 mM HEPES solution (SE40327 FM).  Data was taken 
from the SE40327 data in figures 8 and 16.  The starting pH of both media was 7.  
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Figure 18 SEE20561 growth in buffered and non-buffered fermentation media.  The graph 
displays growth of SEE20561 presented as mean OD values versus time in hours at 37°C.  Standard 
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deviation was calculated for the error bars.  Conditions presented are fermentation media only 
(SEE20561 FM) and fermentation media supplemented with 50 mM HEPES solution (SEE20561 
FM HEPES).  Data was taken from the SEE20561 data in figures 8 and 16.  The starting pH of both 
media was 7.  
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Figure 19 SEZ20727 growth in buffered and non-buffered fermentation media.  The graph 
displays growth of SEZ20727 presented as mean OD values versus time in hours at 37°C.  Standard 
deviation was calculated for the error bars.  Conditions presented are fermentation media only 
(SEZ20727 FM) and fermentation media supplemented with 50 mM HEPES solution (SEZ20727 
FM HEPES).  Data was taken from the SEZ20727 data in figures 8 and 16.  The starting pH of both 
media was 7.  
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Figure 20 SER17037 growth in buffered and non-buffered fermentation media.  The graph 
displays growth of SER17037 presented as mean OD values versus time in hours at 37°C.  Standard 
deviation was calculated for the error bars.  Conditions presented are fermentation media only 
(SER17037 FM) and fermentation media supplemented with 50 mM HEPES solution (SER17037 
FM HEPES).  Data was taken from the SER17037 data in figures 8 and 16.  The starting pH of both 
media was 7.  
Figure 21 displays the effect on growth of SE40327 with buffering at 
various concentrations of Tris buffer.  Whilst an increase in final OD 
compared to non-buffered growth is observed at concentrations of 10 and 
25 mM, the growth curves appear to become increasingly variable as 
Trizma concentration is increased.  Furthermore, a concentration of 50 mM 
appears to have caused cessation of growth entirely. 
The same concentrations of PIPES buffer were tested on growth of 
SE40327.  No growth occurred in any concentration of PIPES, suggesting 
this buffer solution is inhibitory for this strain.  
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Figure 21 Effect of increasing Tris buffer concentration on S. equi NCIMB 40327 growth. 
Growth was assessed in fermentation media with 0, 10, 25 or 50 mM Trizma base buffer solution.  
The curves plotted are optical density at 660 nm over time.  Points on the graph are representative of 
mean values over 3 biological replicates and error bars were calculated using standard deviation.  
The starting pH of the media was 7.  
 
2.3.4. Influence of media on capsule production of S. equi strains 
The results of size exclusion HPLC analysis of filtered 8 hour culture 
samples are displayed in Tables 7 and 8.  Only two of the strains were 
found to produce HA, with SEE20561 and SEZ20727 consistently failing 
to produce detectable concentrations.  The concentrations from each 
biological replicate were corrected to the maximum OD achieved in order 
to normalise the data, as final OD and HA concentration varied 
substantially in some cases.  The retention time consistently measured 
between 3.7 and 4 minutes which is within expected range for HA, whereas 
concentrations varied between approximately 60-200 ng/µL before 
correction for OD.  For each strain the HA concentrations were analysed 
between the different media were analysed in Minitab 17 Statistical 
software.  For SE40327, there was a significant difference between mean 
corrected HA concentrations for buffered and non-buffered fermentation 
media (One-Way ANOVA, f = 7.03, df = 2, 6, p = 0.027).  However, HA 
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concentration in BHI media was not significantly different from either 
buffered or non-buffered fermentation media.  In contrast for SER17037, 
HA concentrations were found to have no significant differences between 
all three media tested (One-Way ANOVA, f = 3.58, df = 2; 6, p = 0.095).  
The variation in HA concentrations between strains was also analysed for 
each media type. No significant differences were found between strains in 
fermentation media (two-sample t-test, t = -2.14, df = 2, p = 0.166), BHI 
media (two-sample t-test, t = -1.87, df = 4, p = 0.134) or fermentation 
media buffered with HEPES (two-sample t-test, t = -1.64, df = 2, p = 
0.242).  
     
 
Table 7. Hyaluronic acid concentration produced by SE40327.  The table displays the results of 
HPLC analyses on cell stripped culture following 8 hours of growth in different media.  
Fermentation media (FM), fermentation media buffered with 50 mM HEPES buffer (FM HEPES) 
and Brain Heart Infusion media (BHI).  Final optical density values are displayed along with the 
measured hyaluronic acid concentration and retention time for each analysed sample.  
Concentrations were corrected to the maximum OD reached for each media.  Each entry represents a 
single biological run of 15 pooled technical replicates (wells).  
     
 
Table 8. Hyaluronic acid concentration produced by SER17037.  The table displays the results 
of HPLC analyses on cell stripped culture following 8 hours of growth in different media.  
Fermentation media (FM), fermentation media buffered with 50 mM HEPES buffer (FM HEPES) 
and Brain Heart Infusion media (BHI).  Final optical density values are displayed along with the 
measured hyaluronic acid concentration and retention time for each analysed sample.  
SE40327
Media Retention time (min) HA concentration (ug/ml) Final OD660 Corrected concentration to max OD (ug/ml)
FM 3.769 72.7 0.31 90.36
FM 3.892 89.46 0.35 100.2
FM 3.874 96.75 0.39 96.75
FM HEPES 3.809 60.15 0.19 209.22
FM HEPES 3.916 89.00 0.33 176.32
FM HEPES 3.9 125.14 0.66 125.14
BHI 3.893 97.80 0.36 107.16
BHI 3.913 90.06 0.29 122.95
BHI 3.961 92.73 0.39 92.73
SER17037
Media Retention time (min) HA concentration (ug/ml) Final OD660 Corrected concentration to max OD (ug/ml)
FM 3.797 65.7 0.11 200.23
FM 3.867 96.60 0.24 133.26
FM 3.876 117.53 0.32 117.53
FM HEPES 3.783 58.96 0.073 387.26
FM HEPES 3.94 110.37 0.24 224.12
FM HEPES 3.862 207.12 0.48 207.12
BHI 3.932 131.15 0.36 141.52
BHI 3.92 76.00 0.16 183.3
BHI 3.947 103.14 0.39 103.14
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Concentrations were corrected to the maximum OD reached for each media. Each entry represents a 
single biological run of 15 pooled technical replicates (wells). 
 
2.4. Discussion and Conclusions 
2.4.1. Sulphur limited media and its effect on HA production 
From the original patent submission (WO1992008799A1), the use of media 
containing a limited sulphur supply was described as an attempt to limit the 
growth rate of these bacteria without inhibiting HA production.  In that 
patent, it is also stated that limiting other crucial components such as 
carbon, nitrogen, sodium, phosphorus, potassium, magnesium, iron, 
manganese and zinc as an alternative to sulphur was acceptable.  Since no 
explanation or reason was given for requiring this limitation of growth 
during colony screening or inoculum preparation, this might be considered 
an attempt to divert the metabolism of glucose away from biomass and 
towards HA production.   
For the experimentation described, the sulphur limited agar plates were 
acquired from the same source as used by the company and the same 
sulphur limited broth recipe was used in order to replicate the 
manufacturing process as closely as possible.  Whether limiting sulphur in 
the growth media is an effective method of promoting HA production is 
questionable from the colony morphology of the strains when cultured on 
sulphur limited agar in comparison to BHI agar plates, with colonies 
appearing exceptionally more mucoid on BHI.  This suggests that the use 
of sulphur limited agar/broth could have an opposing effect to the one 
intended.  In addition to this, the results of the HA concentration analyses 
presented in Tables 7 and 8 shows that HA production does not differ 
significantly between fermentation medium and BHI medium.  The most 
obvious distinct feature of the fermentation medium is the high glucose 
concentration of 74 g/L (411 mM).  Previously it has been suggested that 
glucose is one of the limiting nutrients in HA fermentation, making the 
lack of significant difference in HA yield between such a high 
concentration in fermentation media and the 2 g/L concentration of BHI an 
unexpected result.  Of course neither media are chemically defined, thus 
the role of other unknown factor(s) being at play is possible as the vitamin, 
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nitrogen, amino acid, and carbon concentrations within yeast extract, calves 
brain and beef heart preparations are variable.  As such the isolated effect 
of any one component of these extracts cannot be observed.  As previously 
mentioned a number of studies have been conducted to investigate the 
effects of variation to culture parameters on HA fermentation in 
Streptococcus. There have also been attempts to identify vital media 
components for growth and HA production.  The development of a 
chemically defined media (CDM) enabled the identification of 11 amino 
acids which were essential for growth of Streptococcus equi subsp. 
zooepidemicus ATCC 35246 (Armstrong, Cooney and Johns, 1997).  The 
CDM developed did not significantly increase HA production compared to 
a complex media containing yeast extract, however it did result in a 
significant increase in HA molecular weight.  Another study investigated 
the impact of variation of mineral ion concentrations in media on growth 
and HA production in Streptococcus equi subsp. zooepidemicus ATCC 
39920 (Pires, Eguchi and Santana, 2010).  The results showed that absence 
of sodium ions (Na+) alone induced an increased HA production of 22% 
compared to controls.  However the addition of Na+ to the media increased 
the molecular weight of the HA produced by over 20%, suggesting that 
production and molecular weight of HA are enhanced by opposing 
conditions.   
However, glucose is still a media component to consider when developing 
an optimised system for HA production, with the reported concentrations 
used being 10-60 g/L (Chong et al., 2005).  An investigation into the 
effects of initial glucose concentration (IGC) on HA production revealed 
that whilst bacterial growth was unaffected by its presence or absence, the 
highest molecular weight and lowest concentration of HA was achieved in 
complete absence of glucose.  In these conditions metabolism switched to 
mixed acid and lactate production was reduced (Pires and Santana, 2010).  
HA molecular weight was lowest with the introduction of glucose but 
gradually increased between concentrations of 5-45 g/L, with 25 g/L being 
optimum for HA synthesis over cell growth from the glucose supply.  HA 
concentration (g/L) remained consistent with increasing glucose 
concentrations 5-45 g/L.  In another investigation the IGC at which both 
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HA concentration and molecular weight were highest was found to be 40 
g/L with a further increase of 50-60 g/L being inhibitory for production 
(Don and Shoparwe, 2010).  This was speculated to be due to cells reacting 
to increased osmotic pressure at 40 g/L compared to 10-30 g/L and the 
occurrence of interference from competing pathways such as lactic acid 
and peptidoglycan production at glucose concentrations above 50 g/L.  In 
addition to concentration, the source of glucose is a consideration to be 
made in the preparation of HA fermentation media.  During the 
development of a serum free medium for growth and HA production by S. 
zooepidemicus NJUST01 the use of starch as the carbon source in place of 
glucose was found to be optimum for HA production.  This result was 
associated with the observation that a slower and less severe decline in pH 
occurred when starch was used as the glucose source, which was 
speculated to be due to a reduction in lactic acid production (Zhang et al., 
2006).  A re-examination of the current fermentation media components 
and the influence of each on HA production could provide beneficial 
information about the effectiveness of the recipe.  Whilst the development 
of a CDM may enhance HA production and molecular weight in this strain, 
as previously mentioned it is considered not cost effective for industrial 
scale production of HA.  
2.4.2. Selecting an appropriate buffer for pH control in small scale 
fermentation 
Under manufacturing conditions HA fermentation is performed in volumes 
of 80-130 L.  For research purposes such volumes are unnecessary and 
wasteful of resources, thus a protocol for ‘small scale fermentation’ was 
developed.  The use of 96 well plates was preferred to shake flask, mainly 
due to the lower volume requirements, increased ease of optical density 
monitoring in a plate reader and the ability to analyse more than one 
media/strain/antibiotic concentration at a time.   
Streptococci are lactic acid producing bacteria, a characteristic which is 
employed as an offensive strategy against competing bacteria in the 
environment.  In in vitro culture conditions however, lactic acid production 
may rapidly decrease the pH of the culture media and autoacidification 
rather than nutrient depletion is a common cause of premature cessation of 
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growth of lactic acid producing bacteria (Papadimitriou et al., 2016). The 
small increases in OD observed in all strains during stationary phase when 
cultured in fermentation media could possibly indicate that attenuation of 
growth is not a result of exhaustion of nutrients but of autoacidification, 
highlighting the importance of pH control.  When performing fermentation 
at large volumes in chemostats it is possible to continuously monitor and 
maintain the culture pH.  In the case of the manufacturing process in 
question this is done by controlled addition of 16% sodium hydroxide 
solution (NaOH).  Unfortunately this method of pH control is problematic 
outwith chemostat operation and so for multi-well plate culture it was more 
suitable to identify an appropriate buffering agent to reduce the effects of 
autoacidification.   
The starting pH of the fermentation media was pH 7. Therefore buffers for 
which included this pH in the effective range were selected for trial 
purposes.  The buffers were HEPES, PIPES and Tris which are widely used 
with biological systems.  HEPES is a widely used buffering agent for the 
culture of a variety of organisms; PIPES buffer is an organic buffer with a 
useful pH range of 6.1-7.5 and Trizma base buffer is commonly used in 
cell culture media and has an effective pH range of 7-9.  Therefore all were 
considered as suitable candidates for pH control of the cultures in 96 well 
plates. 
HEPES has a stated effective range of pH 6.8 – 8.2 with the fermentation 
media at pH 7 falling at the lower end of this.  The recommended 
concentration range for growth media is 10 – 25 mM, although 
concentrations as high as 100 mM have been used for other Streptococcus 
species (Tremblay et al., 2009) so growth at 50 mM was also investigated.  
Rather than negatively affecting growth, 50 mM HEPES concentration 
provided the greatest benefit of the three concentrations tested (10, 25 and 
50 mM), suggesting it is not detrimental to growth of this strain.  Although 
a greater maximum OD was reached when media was buffered with 
HEPES compared to non-buffered media, log phase did not appear to be 
significantly extended, suggesting that either autoacidification still occurs 
although at higher cell density and/or that nutrient deprivation occurs at the 
same time point regardless of the rate of pH decline.  PIPES buffer, as 
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mentioned, is an organic buffer with a useful pH range of 6.1-7.5.  The pH 
of the fermentation media falls more centrally within this range compared 
to the range of HEPES and so PIPES was considered a potentially more 
suitable candidate for pH control of the cultures.  Having previously been 
investigated in S. thermophilus (Somkuti and Gilbreth, 2007) it was 
expected that this buffer would also be suitable for growth of the strain of 
interest.  Unfortunately this was not the case and growth of S. equi was 
completely inhibited under conditions tested (data not shown).  This was an 
unexpected result considering that previously PIPES has been used at 
concentrations as high as 100 mM for culture of other Streptococcus 
species (Dierksen, Ragland and Tagg, 2000), but unfortunately it does not 
appear to be suitable for SE40327 (and presumably other S. equi) at the 
ranges tested in a 96 well plate format. Tris buffer is commonly used in cell 
culture media and was readily available to be tested in the strain of interest, 
the useful pH range of Trizma base is 7-9.  Whilst an increase in final OD 
was observed for concentrations of 10 and 25 mM Trizma base compared 
to non-buffered media the effect was not significantly different to that seen 
at the same concentrations of HEPES buffer.  In addition Trizma appeared 
to have a detrimental effect on growth of S. equi at a concentration of 50 
mM.  This contrasts to 50 mM HEPES which produced the greatest 
increase in final OD in this strain.  Due to the fact the useful range of 
HEPES was more suitable to the fermentation media at pH 7, it was chosen 
over Trizma base as the more suitable candidate for pH control in this 
study.   
Currently pH control is carried out at production scale by the addition of 
NaOH.  Whilst NaOH addition alone is likely more cost effective 
(approximately £83 for 5L of 32% NaOH solution versus approximately 
£600 for 4L HEPES) than HEPES buffering, the use of NaOH may 
contribute to environmental pollution when it is discarded within waste 
fermentation media and demonstrates a significant hazard should large 
quantities be introduced into the environment (EnvironmentAgency, 2018).  
The addition of HEPES or another suitable buffering agent to the 
fermentation media may allow a reduction in the quantity of NaOH used to 
maintain steady pH during a fermentation cycle.  Even a change of 0.5 of 
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pH level was found to decrease the molecular weight and concentration of 
HA produced during fermentation of S. equi ATCC 6580 (Kim et al., 1996) 
so even fluctuations in pH may have influence over product properties.  
2.4.3. Hyaluronic acid production in S. equi strains 
As SE40327 is a strain of S. equi subsp. equi it was expected that of the 
three S. equi strains selected for comparison it would most closely resemble 
S. equi subsp. equi 20561 (SEE20561) in growth profile and colony 
morphology.  This was not revealed to be the case, with SEZ20727 being 
the closest in growth profiles in both fermentation and BHI media.  All 
strains however were very similar, with only SEE20561 deviating 
significantly from the rest in growth profile.  Previously, both SEE20561 
and SEZ20727 were described as encapsulated (Speck et al., 2008), 
however HPLC analysis for HA did not reveal detectable concentrations in 
either of these two strains under the growth conditions investigated, nor did 
their colony morphology appear  mucoid on sulphur limited or horse blood 
agar in comparison to SE40327 and SER17037.  SER17037 was also 
previously described as mucoid when it was first isolated in 2004 
(Fernandez et al., 2004), however its capability as a HA producer has never 
before been investigated.  From the results of the HPLC analysis it is clear 
that SER17037 is just as, if not more, capable of producing appropriate 
concentrations of HA than the currently favoured strain.  Whilst the p-
values from the statistical analyses of the results indicated that no 
significant difference exists between HA concentrations produced by each 
strain in the same media, it is clear from the data that SER17037 is capable 
of producing higher concentrations of HA in comparison to SE40327 under 
the conditions tested, typically in excess of 100 ng/µL.  In addition, the 
increase in average concentration/yield of HA observed in buffered 
fermentation medium compared to non-buffered is likely a result of 
increased cell numbers prior to the beginning of stationary phase as 
indicated by the greater maximum OD.   
From the data presented and the similarity of HA concentration between 
fermentation media and BHI media it is proposed that the glucose 
concentration in the current fermentation media recipe could be reduced 
without detriment to HA yield, as average concentration is not significantly 
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increased compared to BHI media which contains a much lower 
concentration of glucose. In addition it may be beneficial to investigate the 
batch to batch variation in the media as components like yeast extract are 
not chemically defined and variations in trace elements, amino acids and 
vitamins will occur.  This knowledge would provide the first step towards 
developing a more defined media for HA production with this strain.  The 
caveat to undertaking this work is that development of CDM is time 
consuming and as previously mentioned not cost effective for large scale 
production.  However a greater knowledge of the components of the media 
may be useful for future.  With regards to pH control, whilst the use of 
buffers is a suitable alternative to NaOH addition for a small scale model of 
fermentation, whether its use in manufacturing scale culture would be cost 
effective and necessary is uncertain.  S. equi subsp. ruminatorum has been 
previously characterized in terms of biochemical and sequence analyses 
(Fernandez et al., 2004; Speck et al., 2008).  However its capability as a 
HA producer has not yet been investigated despite its close relation to other 
S. equi subspecies which are commonly used for HA fermentation (Boeriu 
et al., 2013).  From the data presented it can be concluded that this strain is 
capable of producing similar concentrations of HA than a currently used 
industrial strain and may be a candidate strain for HA production in the 
future.  
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3. Comparative Genomics of S. equi subspecies 
3.1. Introduction 
The Streptococcus equi strain SE40327 has been in use for the industrial 
manufacture of HA containing medical devices for the last 30 years.  In that 
time genome sequencing has become a useful resource in the analysis of 
bacterial processes.  To this point, the genome of this strain had not been 
sequenced, nor had that of the reference strains selected for this study S. equi 
subsp equi 20561 (SEE20561) and S. equi subsp. zooepidemicus 20727 
(SEZ20727).  Thus the project aimed to extract the DNA of these strains for 
genome sequencing and analysis.  The genome of S. equi subsp. ruminatorum 
17037 (SER17037) has previously been sequenced and is available in NCBI 
under the strain number CECT 5772 (Genbank accession GCA_000706805.1).  
In addition, mucoid and non-mucoid phenotypes were identified for SE40327 
which did not revert following repeated passages on agar (see Chapter 2) both 
variants were to be submitted for sequencing in an attempt to identify any 
mutations which have occurred which may have an effect on HA production. 
As noted previously, HA biosynthesis is conferred by multiple genes encoded 
in one or two operons in S. equi subsp. zooepidemicus and S. equi subsp. equi 
respectively.  In addition, growth phase-dependent production of hyaluronidase 
can play a role in HA production. HA biosynthetic genes and hyaluronidase are 
the main focus of this investigation although selected other notable genomic 
differences are considered.  
It has been shown that the has operons of S. equi subsp. equi and S. equi subsp. 
zooepidemicus species were different in that all five genes required for HA 
production, hyaluronan synthase (hasA), UDP-glucose dehydrogenase (hasB), 
UDP-glucose pyrophosphorylase (hasC/galU), (hasD/glmU) and 
phosphoglucoisomerase (hasE/pgi) were contained within the zooepidemicus 
operon, whereas in equi a separate operon contains hasD and hasE (Blank, 
Hugenholtz and Nielsen, 2008).  The structure of this operon in SER17037 has 
not previously been investigated and is unknown for SE40327.  Therefore 
confirmation of the operon structure in these two strains will aid in the 
investigation into capsule production within these strains.  In addition to this 
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any differences observed between the sequences of the has operon genes 
between strains may provide avenues to follow.  
It has previously been suggested by Speck et al. (2008) that SER17037 is 
hyaluronidase negative whereas SEE20561 and SEZ20727 are hyaluronidase 
positive.  However the presence or absence of hyaluronidase genes within 
SE40327 is unknown.  Sequencing of the genomes of this strain and the 
reference strains will aid in the elucidation of hyaluronidase genes, whether 
functional or not.  
Finally, sequencing of the genome of the strains will facilitate the design of 
molecular experiments which will be discussed in chapter 4 and will provide a 
more accurate database for proteomic investigations discussed in chapter 5.  
Seven strains were submitted for sequencing, these were a working stock and 
master stock of SE40327 (40327W and 40327M), the original strain submitted 
to NCIMB at time of patent (30100), SEE20561, SEZ20727 and the mucoid 
and non-mucoid phenotypes isolated in one of the stocks of 40327 (40327MV 
and 40327NMV).  The genome of SER17037 was already available.  
3.2. Materials and Methods 
3.2.1. DNA extraction and sequencing 
DNA extraction of samples was carried out using the MasterPure™ DNA 
Purification Kit (Epicentre).  Bacteria were grown on sulphur limited agar 
plates at 37°C for 48 hours.  Single colonies were inoculated into 50 mL of 
37°C BHI media and incubated over night with 150 RPM shaking.  Mucoid 
strains were further incubated for 30 minutes following addition of 1x 
volume of 0.2 mg/mL hyaluronidase (Sigma-aldrich) in BHI to degrade the 
capsule.  Bacteria were pelleted at 4,969 x g for 10 minutes and the pellets 
were washed 3 times with 500 µL PBS.  All liquid was removed from the 
pellets which were then resuspended in 300 µL of Tissue and Cell lysis 
solution containing 1 µL of Proteinase K (20mg/mL) (Qiagen).  The 
samples were incubated at 65°C for 15 minutes and vortexed briefly 3 
times during this time. Samples were left to cool on the bench for 15 
minutes before 1 µL of RNase (Merck) was added and samples incubated 
at 37°C for 30 minutes. Protein was removed by adding 175 μl of MPC 
Protein Precipitation Reagent, vortexing for approximately 10 seconds and 
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centrifuging at 4°C for 10 minutes at 10,000 x g. The supernatant was 
transferred to a clean Eppendorf tube and the pellets were discarded. To the 
new samples, 500 µL of isopropanol was added and the tubes were inverted 
several times to mix thoroughly. The samples were centrifuged at 4°C for 
10 minutes at 15,000 x g and the isopropanol carefully poured away. The 
pellets were washed twice with ice cold 70% ethanol with brief 
centrifugation to prevent the pellet from dislodging. The ethanol was 
removed and the tubes left open and horizontal for 5 minutes to dry the 
pellets. The DNA was then resuspended in 60 µL of HyClone™ Molecular 
Grade Water (Fisher Scientific). DNA concentration and purity was 
measured on NanoDrop 2000. A minimum 260/280 ratio of 1.8 was 
considered acceptable. Samples were stored at -80 °C until submitted to 
Edinburgh Genomics for sequencing via Illumina paired-end sequencing. 
3.2.2. Genome assembly, annotation, species comparison and MLST typing 
Sequence data was assembled into contigs using CLC Genomics 
Workbench 9.0 (https://www.qiagenbioinformatics.com/). The sequences 
were then uploaded to the RAST annotation server (http://rast.nmpdr.org/) 
for gene annotation. The RAST SEED Viewer was used to compare 
genomes at sequence level.  
3.2.3. Analysis of hyaluronidase genes of each S. equi species 
The sequences of genes annotated by RAST as “Hyaluronate lyase (phage 
associated)”, “Hyaluronoglucosaminidase”, “Hyaluronate lyase precursor” 
and “Phage hyaluronidase” were blasted using NCBI BLAST 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi), InterPro 
(https://www.ebi.ac.uk/interpro/) and Pfam (https://pfam.xfam.org/) in 
order to confirm the annotation.  Only RAST annotated genes which also 
matched to Hyaluronidase protein families in NCBI, InterPro and Pfam 
were considered true hyaluronidase enzymes. In addition, genes which 
matched to beta-N-acetylglucosaminidase in the above databases were 
separately considered for further analyses.  Gene protein and nucleotide 
sequences were compared using Multalin 
(http://multalin.toulouse.inra.fr/multalin/).  Phylogenetic trees were 
constructed using MAFFT (https://mafft.cbrc.jp/alignment/server/). 
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3.2.4. Identification of hyaluronic acid associated genes in strains of 
interest 
The genome of reference strain S. equi subsp. equi 4047 has been 
completely sequenced and is available in NCBI (accession number 
FM204883.1), this was uploaded to RAST in order to obtain a RAST 
annotated spreadsheet of this genome.  The sequences pertaining to the has 
operon were identified within the RAST annotation by searching for the 
amino acid sequence of SEQ_0269 (hyaluronan synthase) identified in 
NCBI (Steward, Robinson and Waller, 2016).  From this position the other 
capsule production associated genes downstream were identified in the 
RAST annotation.  The amino acid sequences of the identified genes in S. 
equi subsp. equi 4047 were then used to search for and isolate the 
corresponding gene in the sequenced strains of interest.  Promoter systems 
were identified using BPROM 
(http://www.softberry.com/berry.phtml?topic=bprom&group=programs&s
ubgroup=gfindb). 
3.2.5. Comparison of genes between strain phenotypes 
 The RAST annotations of the genomes of mucoid and non-mucoid variants 
of NCIMB 40327 were compared using the sequence based comparison 
tool in the RAST SEED viewer.  The table was exported to Microsoft excel 
and genes sorted by their percentage identity between sequences.  Genes 
absent in one or other variants genome sequence were identified.  Genes 
known to be involved in HA synthesis were examined for any differences 
in sequence identity between mucoid and non-mucoid phenotype.  
Sequences were compared using Multalin (http://multalin.toulouse.inra.fr/). 
3.2.6. Comparison of hasC paralogs 
The paralogs of hasC were identified in the RAST annotated genomes of 
interest using the sequences from the type strain S. equi subsp. equi 4047 
where possible.  The protein and nucleotide sequences were compared 
using Multalin.   
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3.3.  Results 
Genome information of the sequenced strains is presented in table 9.  
Additional strains obtained from NCBI are included for comparison.  
 
Table 9 Genome information of sequenced strains.  The information presented within the table includes 
the genome size in number of base pairs (bp), the number of contigs assembled for each genome and the 
guanine and cytosine content of the genome (GC%).  Shaded boxes indicate strains which were not 
sequenced in this project for comparison.  These genomes are available on NCBI 
(https://www.ncbi.nlm.nih.gov/).  
 
3.3.1. Hyaluronidase gene distribution across pathogenic Group C   
Streptococci species 
For SE40327 four genes were annotated by RAST as Hyaluronate lyase 
(phage associated), one was identified as Hyaluronoglucosaminidase, two 
as Hyaluronate lyase precursors and four as Phage Hyaluronidases.  Two of 
the “hyaluronate lyase (phage associated)” genes matched to bacterial 
hyaluronidase (IPR009860) in Interpro and hyaluronidase 1 (HylP) in Pfam 
(PF07212).  They also matched in NCBI Blast to S. equi 
hyaluronoglucosaminidase and so for the purpose of this study were 
designated SE40327Hyal1 and SE40327Hyal2.  The RAST annotated 
hyaluronoglucosaminidase gene matched in both Interpro and Pfam to 
beta-N-acetylglucosaminidase and also matched to hyaluronidase in NCBI 
Blast, this was designated SE40327bNAG.  The other genes did not match 
to hyaluronidases or beta-N-acetylglucosaminidases in the databases 
mentioned.  A comparison of the protein sequences of the three selected 
genes is shown in figure 22.   
Strain genome size (bp) no. contigs GC content (%) 
30100 2,128,502 183 41
40327M 2,146,851 240 41
40327W 2,131,047 213 41
SEE20561 2,621,643 1171 44.8
SEZ20727 2,078,314 194 41.5
40327MV 2,156,647 259 40.7
40327NMV 2,210,074 380 41.8
SER17037 2,138,288 117 41.4
SE4047 2,253,793 1 41.3
SEZ35246 2,167,264 1 41.6
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Figure 22 Comparison of the protein sequences of hyaluronidase and beta-N-
Acetylglucosaminidase genes of SE40327.  Sequences were identified and confirmed as described 
using the RAST annotated genome.  Comparison was carried out using Multalin software 
(http://multalin.toulouse.inra.fr/multalin/).  Sequence variation is observed between all genes and 
SE40327bNAG appears to be longer in sequence than the other genes.  
S. equi subsp equi 4047 is a strain which was identified as the cause of 
strangles in a horse in England in 1990 (Kelly et al., 2006).  The whole 
genome of this strain is available from NCBI (accession FM204883).  This 
was submitted to RAST for annotation in order to compare sequences to 
SE40327.  As with SE40327, four genes were annotated as Hyaluronate 
lyase (phages associated), one as Hyaluronoglucosaminidase, two as 
Hyaluronate lyase precursors and four as Phage Hyaluronidases.  One of 
the Hyaluronate lyase (phage associated) genes matched to hyaluronidase 
and the Hyaluronoglucosaminidase gene matched to beta-N-
acetylglucosaminidase in both Interpro and Pfam.  Both genes also 
matched identity in NCBI Blast to hyaluronidase and 
hyaluronoglucosaminidase.  They were designated SE4047Hyal1 and 
SE4047bNAG and were compared to the three genes identified from 
SE40327.   SE40327Hyal1 was identical at both protein and nucleotide 
level to the SE4047Hyal1.  However SE40327Hyal2 displayed protein 
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sequence variation from both SE40327Hyal1 and SE4047Hyal1 (fig 23).  
The most notable feature between the sequences is a series of sequence 
variation between amino acid positions 1-80.  In NCBI the section of 
protein sequence annotated as hyaluronidase of the genes is amino acids 
94-372.  Within this region sequence similarity is greater, with two regions 
of divergence at positions 154-160 and 361-373.   
 
Figure 23 Hyaluronidase protein sequences of SE40327 compared to the sequence of SE4047.  
Two hyaluronidase sequences obtained from the RAST annotated genome sequence of SE40327 
(SE40327Hyal1 and SE40327Hyal2) were compared to the sequence from SE4047 (SE4047Hyal1).  
Sequences were compared using Multalin software (http://multalin.toulouse.inra.fr/multalin/).  
Variations in sequence are observed throughout between Hyal1 and Hyal2 genes, with larger 
stretches of variation observed at both protein terminals.  
The protein sequence of SE40327bNAG and SE4047bNAG were found to 
be 100% identical, as were the nucleotide sequences (data not shown).  
Upon comparing to two strains of S. equi subsp. zooepidemicus, SEZ20727 
and ATCC 35246 a series of single amino acid substitutions throughout the 
sequence were observed.  Some of these single amino acid differences were 
observed between SE40327 and one of the SEZ strains but not the other 
(fig 24).   
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Figure 24 Protein sequences of beta-N-acetylglucosaminidases of SE40327, SEZ20727 and 
SEZ35246.  Sequences were identified using the RAST annotated genomes of the strains and 
compared using Multalin software (http://multalin.toulouse.inra.fr/multalin/).  Observed is a number 
of single amino acid differences between strains throughout the sequences.  
Previously it was reported that SER17037 (CECT5772) tested negative for 
hyaluronidase activity (Speck et al., 2008).  Whilst a definitive 
hyaluronidase gene was not identified from the RAST annotated genome of 
this strain, a beta-N-acetylglucosaminidase was.  A comparison of the 
amino acid sequence to that of the beta-N-acetylglucosaminidases 
identified in SE40327 and SEZ20727 revealed identities of 95.21% and 
98.23% respectively.  
3.3.2. Identification of hyaluronic acid associated genes 
The hyaluronan synthase genes for all strains of interest were identified 
from the sequence of SE4047 hasA.  The amino acid sequence of SE40327 
was identical to the sequences of SEE20561 and SE4047.  When compared 
to SEZ20727 and SER17037 some amino acid substitutions were observed 
although not at the same positions for each strain as observed in figure 25.  
Streptococcal HasA contains four predicted active sites (Heldermon, 
DeAngelis and Weigel, 2001).  None of the amino acid substitutions noted 
between the strains were within any of the sites.  By comparing the 
nucleotide sequences it was determined that the differences in amino acids 
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between strains is a result of single base substitutions.  The remaining 
hyaluronan related genes hasB, hasD, hasE and both paralogs of hasC were 
also searched for in the sequenced strains using the amino acid sequences 
from S. equi 4047.  The genes of hasB, hasD and hasE were identified in 
SE40327, along with a partial sequence for hasC1 and the whole of hasC2.  
In SEE20561 hasB and hasD were identified along with hasA, however no 
sequences were identified as hasE or either paralog of hasC.  All genes 
were identified in SEZ20727 including both copies of hasC and for 
SER17037 hasB, hasD and hasE were all identified, but neither copy of 
hasC.   
 
Figure 25 Amino acid sequences of hyaluronan synthase in the genomes of the S. equi strains 
of interest.  Sequences were obtained from the RAST annotation of the genome sequences of the 
strains and were compared using Multalin (http://multalin.toulouse.inra.fr/multalin/).  Single amino 
acid differences between the strains are observed throughout the length of the genes.  
The organisation of the has operons of two subspecies, S. equi subsp. 
zooepidemicus ATCC 35246 (SEZ35246) and S. equi subsp. equi 4047 
(SE4047), of which the whole genomes were available were observed.  
These are presented in figure 26, along with what was available of the 
operon of the strain of interest SE40327.  The same genes were observed 
upstream in all strains, with a hypothetical protein present immediately 
upstream of the hasA gene which is the first in the operon.  All five genes 
required for HA synthesis were present within the has operon in 
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SEZ35246, whereas in SE4047 the operon appears to consist only of hasA-
C, with hasD and hasE observed downstream and on the opposite strand 
contiguous to the second paralog of hasC and a gene for glycerol-3-
phosphate dehydrogenase.  Due to incomplete sequencing the contig ends 
following the hasB gene in SE40327 and so the remaining operon structure 
could not be deduced.  
 
Figure 26 Diagram of the has operon of S. equi subspecies.  The diagram displays the operons 
from strains of S. equi subsp. zooepidemicus (SEZ35246), S. equi subsp. equi (SE4047) and the 
industrial strain of interest S. equi (SE40327).  Gene directions are as observed from the RAST 
annotations of the genomes and are left to right 5’ to 3’.  The enzymes of the operon are labelled 
hasA-E.  Also presented is the preceding gene for a hypothetical protein (hypo).  The operon in 
SEZ35246 is complete and contiguous, whereas for SE4047 it is separated into two parts as 
observed by Blank, Hugenholtz and Nielsen (2008).  A GlpG protein (glpG) is the first in the series 
of genes which separate the has operon genes.  The genes for the paralog of hasC (hasC2) and a 
glycerol-3-phosphate dehydrogenase (g3pd) are also observed to be neighbouring hasD and hasE.  
In SE40327, the contig ends following hasB. 
The upstream sequences from the start codon site of the has operon were 
analysed in order to identify possible regulatory elements.  In SE4047 the 
ribosome binding site (AGGAGG) was observed 13 bases upstream of the 
start codon (ATG).  Additionally possible sigma factor binding sites -10 
and -35 were identified 102 and 129 bases upstream of ATG respectively.  
In SEZ35246 a possible ribosome binding site (AGG) was identified 16 
bases upstream of ATG, whilst the same -10 and -35 sequences were 
observed at the same upstream positions as SE4047.  In SE40327 a 
possible ribosome binding site (AGG) was observed 21 bases upstream 
from ATG and the possible -10 (TTGTACCAT) and -35 (TTGCTA) 
sequences were identified 43 and 65 bases upstream respectively.  A 
diagram of these elements in SE4047 and SE40327 is presented in figure 
27. 
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Figure 27 Upstream promoter sequences of the has operons of S. equi subsp. equi strains.  
Identified are the possible ribosome binding sequences (RBS) and the -10 and -35 regulatory 
sequences for strains S. equi subsp. equi 4047 (SE4047) and the industrial strain of interest S. equi 
40327 (SE40327).  Coding sequence denotes the hasA gene and beginning of the has operon.  
3.3.3. Gene discrepancies between phenotypes 
Comparing the RAST annotated gene content of the mucoid variant of 
SE40327 (40327MV) to the non-mucoid (40327NMV) did not reveal the 
absence of any genes in 40327NMV which stand out as potential capsule 
production related candidates for further investigation.  Genes with 
between 0 and 100 percent identity between variants were assessed and 47 
genes were identified which were present but did not completely match in 
sequence identity between the two phenotypes.  Some of the differences 
which were investigated further were found to be due to genes annotated at 
the end of contigs, meaning part of the sequence in one or both of the 
phenotypes has been lost during sequencing, assembly and annotation.  
Those which appeared to be genuine differences occurring in genes not 
found at the end of contigs were investigated further if considered to be of 
interest with regards to capsule production.  Three genes in particular 
located adjacent to the has operon were investigated.  In both strains the 
first two genes described below were located on the same contig as the has 
operon and not near the ends of the contigs.  The third was located in the 
middle of a contig containing another gene annotated as a hyaluronan 
synthase but not within the has operon.  A BLAST of this gene identified it 
as a glycosyltransferase family 2 of S. equi (accession: WP_012679414.1). 
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3.3.3.1. Collagen-like surface protein 
The first selected gene was annotated as a “collagen-like surface 
protein” in RAST.  The sequence was queried in Pfam, Interpro and 
NCBI Blast to confirm and identified as repeated collagen triple 
helices and a LPXTG cell wall anchor domain, Gram-positive 
LPXTG cell wall anchor and a collagen-like cell surface-anchored 
protein SclH respectively.  A comparison of the amino acid sequence 
(fig 28) of the gene from both phenotypes revealed that in 
40327NMV over half of the sequence has been lost (amino acids 1-
194).  Amino acid sequences for both variants were then compared to 
the NCBI sequence for LPXTG cell wall anchor domain 
(WP_012678932.1), which is 414 amino acids long (not shown).  The 
functional domains for this protein are annotated in NCBI as follows.  
Amino acid range 120-414 is described as DNA polymerase III 
subunits gamma and tau and 374-411 a gram positive anchor.  
Accepting these descriptions indicates that in 40327NMV the DNA 
polymerase region at the N terminus end has been truncated but the 
gram positive anchor domain is intact in both variants.  The LPXTG 
motif is found at amino acids 382-386 and so has not been lost in 
either 40327MV or 40327NMV.  The amino acid sequence from 
40327MV is identical to the sequence from SE4047.  Comparing the 
nucleotide sequences reveals that a total of 576 bases are missing 
from 40327NMV. 
 
Figure 28 Amino acid sequence of collagen-like surface protein from mucoid 
(40327MVclsp) and non-mucoid (40327NMVclsp) variants.  Sequences were identified 
from the RAST annotated genomes of the strains and compared using Multalin software 
(http://multalin.toulouse.inra.fr/multalin/).  More than half of the protein sequence appears to 
be missing in the non-mucoid variant, with only the last 97 amino acids at the C terminal 
present.  
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The upstream sequences of the genes from both phenotypes were 
analysed to identify any differences in gene regulation.  These were 
not homologous between the phenotypes.  The start codon for this 
gene has been lost in 40327NMV as has any identifiable ribosome 
binding site, however -10 and -35 sequences were identified 49 and 
78 bases upstream respectively of the beginning of the truncated gene.  
In 40327MV a possible ribosome binding site (AGCAGG) was 
identified 17 bases upstream from ATG and -10 and -35 sequences 
were identified 174 and 196 bases upstream respectively.  A diagram 
of the located sequences in 40327MV is presented in figure 29.  
 
Figure 29 Upstream sequence of collagen-like surface protein of 40327MV.  The diagram 
displays the regulatory sequences of ribosome binding site (RBS) as well as -10 and -35 
sequences located upstream of the coding sequence for the collagen-like surface protein gene.  
3.3.3.2. M protein trans-acting positive regulator (Mga) 
The second gene investigated was annotated in RAST as M protein 
trans-acting positive regulator (Mga).  This annotation was confirmed 
using NCBI, Interpro and Pfam and genes were also located in the 
middle of contigs and upstream from hasA in both phenotypes.  The 
sole amino acid sequence difference between mucoid and non-mucoid 
phenotypes is a substitution observed at position 17, with 40327MV 
possessing a leucine at this position and 40327NMV a tryptophan.  
The same gene in SE4047 also possesses a leucine at this position of 
the protein.  The region 8-64 of Streptococcal Mga-like regulatory 
protein (WP_012678912.1) is designated a DNA binding helix-turn-
helix (HTH) domain in NCBI and the substitution of leucine for 
tryptophan introduces two aromatic rings in place of methyl groups 
into this sequence region.  Two other genes of 40327MV were 
annotated as Mga by RAST, however these were not confirmed when 
queried in NCBI.  Comparison of the nucleotide sequences reveals 
that the amino acid change is a result of a single nucleotide 
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substitution from a thymine to a guanine at position 50 (data not 
shown).  The Mga operon and regulon has been extensively studied in 
S. pyogenes, but little has been investigated with regards to this 
transcriptional regulator in Group C streptococci.  A diagram of the 
operon identified in SE40327 is presented in figure 30.  In both 
species mga is the first gene in the operon and is immediately 
followed by the gene for antiphagocytic M protein (emm) or M-like 
protein (sem). 
 
Figure 30 The mga operons of S. equi subsp. equi 40327 (SE40327) and S. pyogenes 
TJ11-001 (SPTJ11-001).  A hypothetical protein (hypo) is observed in both strains prior to 
the start of the operon in which mga is the first gene.  In both cases mga is immediately 
followed by the M proteins of the species (sem/emm).  However while C5a peptidase (scp) is 
included in SPTJ11-011 the operon of SE40327 appears to only include a leucine tRNA 
synthase (lts) and more hypothetical proteins.  In SPTJ11-011 drs12, mep and cwh denotes 
streptococcal competence protein, mobile element protein and phage cell wall hydrolase 
respectively.  
3.3.3.3. RNA polymerase sigma-70 factor  
A third gene identified as being different between phenotypes was an 
RNA polymerase sigma-70 factor.  This was confirmed using pfam 
and Interpro as described previously and matched 100% to the NCBI 
accession WP_012679409.1.  A comparison of the amino acid 
sequences between the phenotypes revealed that the 40327NMV 
sequence was missing the first 11 amino acids and the 12th possessed 
a leucine in place of a methionine.  In both phenotypes the gene 
immediately upstream within the same contig from the sigma factor is 
a pullanase. These were also compared between phenotypes and were 
found to be identical, comparing the nucleotide sequences of both 
genes in tandem between phenotypes revealed a gap of 17 nucleotides 
in the non-mucoid phenotype. 
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3.3.4. The hasC genes 
Intact sequences for both paralogs of the hasC genes were not able to be 
identified in SE40327 or any other of our strains of interest apart from 
SEZ20727 so the presence of two copies in these strains have not been 
confirmed.  The complete genomes of S. equi subsp. equi ATCC 39506 
(SEE39506), S. equi subsp. equi 4047 (SE4047), S. equi subsp. 
zooepidemicus ATCC 35246 (SEZ35246) and S. equi subsp. zooepidemicus 
MGCS10565 (SEZMCGS) are available on NCBI. These were uploaded to 
RAST for annotation as reference strains.  A comparison of the amino acid 
sequences of the paralogs of SE4047 shows variation in sequence between 
amino acids 291-308. The hasC2 paralog is also missing the last two amino 
acids upon alignment of the sequences.  In addition to this at position 11 an 
alanine in HasC1 is replaced with a threonine in HasC2 (fig 31), a 
substitution which introduces a hydroxyl group and a methyl group.  A 
comparison of the nucleotide sequences reveals that this substitution is the 
result of a single nucleotide change at position 31 where a guanine in 
hasC1 is substituted for adenine in hasC2.  The sequences are then 
identical until nucleotide position 870 where there is variation until the end 
of the gene sequence (909) and hasC2 is missing the final 5 nucleotides 
present in hasC1.  A comparison of the SE4047 paralog nucleotide 
sequences with their corresponding genes in SEE39506 reveals complete 
identity of the genes between these strains, including the region of variation 
at the C-terminus end.  The amino acid substitution observed between the 
SE4047 paralogs is within a reported active site of HasC.  
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Figure 31 Amino acid sequence of the HasC paralogs in SE4047.  The sequences were identified 
from the RAST annotated genome of SE4047 and compared using Multalin software 
(http://multalin.toulouse.inra.fr/multalin/).  Variation in amino acid sequence is observed at the C 
terminus from amino acid 291.  Additionally, there is a difference in amino acid at position 11.  
The paralog sequences of SEZMGCS are identical until amino acid 291 
where differences are observed.  Comparing the nucleotide sequences 
reveals a number of single and double base substitutions throughout, 
however none of these appear to result in an amino acid change until 
nucleotide 870 where the sequences possess greater variation.  Similar is 
observed for the paralogs of SEZ35246, however only one nucleotide 
substitution is noted at position 861 where a thymine is substituted for 
cystosine in hasC2 prior to the variation in sequences beginning at 
nucleotide 870 as seen in other strains.  Meanwhile SEZ20727 has around 
5 base substitutions between paralogs prior to nucleotide number 870 in 
comparison to 13 substitutions in SEZMGCS.  Comparing the HasC1 
amino acid sequences of all three S. equi subsp. zooepidemicus strains 
reveals only two amino acid differences at positions 223 and 284.  At 223 
SEZ35246 possesses an asparagine whereas SEZ20727 and SEZMGCS 
possess lysine and at 284 the strains possess alanine or threonine 
respectively.  The amino acid sequences of SEZ20727 and SEZMGCS are 
identical.  However by comparing the nucleotide sequences of these strains 
it becomes clear that differences exist which may not affect the amino acid 
sequence.  A comparison of the hasC1 sequences of SEZ20727 and 
SEZ35246 revealed 15 nucleotide differences.  Whereas SEZ20727 and 
SEZMGCS have 11 differences between them and SEZMGCS has 14 
nucleotides different from SEZ35246.  Similar can be said for the hasC2 
paralog sequences of these strains with 16 differences observed between 
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SEZ20727 and SEZ35246, 6 differences between SEZ20727 and 
SEZMGCS and 22 between SEZ35246 and SEZMGCS.  In both paralogs it 
appears that SEZ20727 is closer in sequence to SEZMGCS than 
SEZ35246.  However, although numerous differences in nucleotide 
sequences are observed between strains, the amino acid sequences are 
almost identical with only the previously mentioned amino acid differences 
observed.   
3.3.5. The MurA paralogs  
The sequences of the MurA paralogs in all the strains were identified from 
the RAST annotated genomes.  Each paralog for the S. equi strains of 
interest (SE40327, SEE20561, SEZ20727 and SER17037) were compared 
at protein and nucleotide levels along with the sequences from S. equi 
subsp. equi 4047 (SEE4047) and S. equi subsp. zooepidemicus ATCC 
35246 (SEZ35246) which were used as reference strains as the whole 
genome sequences are available for both. 
3.3.5.1.   MurA1 
The amino acid sequence of MurA1 in the strains is presented in Fig 
32.  The sequences of SE40327, SEE20561 and SEE4047 were 
identical to each other, as were SEZ20727 and SEZ35246.  The 
sequence of SER17037 possessed 99.52 % identity to the S. equi 
subsp. equi strains and 99.05 % identity to S. equi subsp. 
zooepidemicus strains.  A total of 6 differences in amino acid 
sequences were observed between the equi and zooepidemicus strains.  
SER17037 matched the equi strains sequences in four of these 
instances (positions 163, 247, 286 and 360) but matched 
zooepidemicus strains in the other two (positions 80 and 318).  The 
MurA1 sequence of SE40327 identified 100% with an S. equi 
sequence for UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
(reference WP_012679232.1).  According to the NCBI record for this 
sequence the active sites of the enzyme are found at amino acid 
positions 23, 92, 96, 121, 126, 162, 165, 166 and 306.  None of the 
amino acid substitutions observed between S. equi subsp. equi and S. 
equi subsp. zooepidemicus occur at these positions.  Additionally, 
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none of these substitutions occur at positions designated ‘hinge sites’.  
A comparison of the nucleotide sequences of this gene between 
strains reveals the amino acid changes to be the result of single base 
differences throughout the gene.  
 
Figure 32 Amino acid sequences of MurA1 of S. equi strains.  Sequences were identified 
from RAST annotations of the genomes and compared using Multalin software 
(http://multalin.toulouse.inra.fr/multalin/).  Amino acid substitutions are observed between S. 
equi subsp. equi strains compared to S. equi subsp. zooepidemicus strains.  S. equi subsp. 
ruminatorum matches the equi strains at four of these positions and zooepidemicus strains at 
two.  
A phylogenetic tree was constructed using the murA1 gene sequences 
of the strains mentioned above and S. equi subsp. zooepidemicus 
MGCS10565 in order to visualise the relationship between strains (fig 
33).  From this a clear distinction between S. equi subsp. equi species 
and S. equi subsp. zooepidemicus species is observed and S. equi 
subsp. ruminatorum possesses greater relation to the equi species.  
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Figure 33 Phylogenetic tree constructed using the murA1 nucleotide sequences from the 
S. equi strains.  Sequences were aligned and trees were constructed using the MAFFT online 
alignment software (https://mafft.cbrc.jp/alignment/server/) and viewed using Phylo.io.  A 
clear differentiation is observed between S. equi subsp. equi strains (40327, SEE20561 and 
SE4047) and S. equi subsp. zooepidemicus strains (SEZ20727, SEZ35246 and 
SEZMGCS10565).  The murA1 gene of S. equi subsp. rumintorum (SER17037) appears to be 
more closely related to the equi strains than the zooepidemicus.  
3.3.5.2.   MurA2 
A BLAST search of the MurA2 amino acid sequence from SE40327 
resulted in a maximum identity of 99.76% with S. equi UDP-N-
acetylglucosamine 1-carboxyvinyltransferase (WP_012679395.1).  A 
comparison of the amino acid sequences of the S. equi species along 
with reference strains described above and the NCBI reference 
sequence is presented in fig 34.  From this it is observed that a single 
amino acid difference is present between SE40327 and 
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WP_012679395.1 at position 180.  Additionally, when all are aligned 
it is observed that the sequence for SEZ20727 possesses an extra four 
amino acids at the N terminus and a valine in place of a methionine at 
what is designated position one for all the other strains.  The active 
sites for this sequence according to the NCBI record are at positions 
24, 96, 100, 125, 126, 127, 128, 129, 130, 164, 167, 168 and 309 and 
so the amino acid changes noted are not within an active region of the 
protein nor are they located at positions designated ‘hinge sites’.  The 
substitution described at position 180 appears to only be present in 
SE40327 where the amino acid present is a proline as opposed to an 
alanine.  An additional 5 variations in amino acids between the 
sequences are present at positions 10, 57, 153, 271 and 294.  Once 
again SER17037 appears to differ slightly from both S. equi subsp. 
equi and S. equi subsp. zooepidemicus species at different amino acid 
positions.  A comparison of the nucleotide sequences showed 
SEZ20727 to possess 12 extra nucleotides at the beginning of the 
sequence.  A series of single and double base substitutions are 
observed throughout the genes, some of which are possibly the cause 
of the amino acid differences observed between the protein sequences.   
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Figure 34 Amino acid sequences of MurA2 of S. equi strains and NCBI sequence 
WP_012679395.1.  Sequences were identified from RAST annotations of the genomes or 
from NCBI and compared using Multalin software (http://multalin.toulouse.inra.fr/multalin/).  
SEZ20727 is observed to possess four extra amino acids compared to the other strains as well 
as a valine in place of a methionine at what corresponds to position 1 of the protein in the 
other strains. A series of amino acid substitutions between some of the strains are present 
throughout the sequences.  
A phylogenetic tree was constructed using nucleotide sequences as 
described previously in order to visualise the relationship between 
strains based on murA2 (fig 35).  From the tree it is noted that 
SER17037 diverges from the other S. equi strains.  S. equi subsp. equi 
sequences are closely clustered whereas – in contrast to MurA1 – the 
separation between the equi and zooepidemicus is not evident.  
Instead, MurA2 appears to be undergoing gradual divergence within 
S. equi subsp. zooepidemicus.  
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Figure 35 Phylogenetic tree constructed using the murA2 nucleotide sequences from the 
S. equi strains.  Sequences were aligned and trees were constructed using the MAFFT online 
alignment software (https://mafft.cbrc.jp/alignment/server/) and viewed using Phylo.io.  S. 
equi subsp. ruminatorum (SER17037) appears to be separate from the other S. equi strains.  
The sequences of strains of S. equi subsp. equi (40327, SEE20561 and SE4047) are grouped 
together as seen in the tree for murA1, however they also appear to be more closely related to 
the S. equi subsp. zooepidemicus strains than the murA1 sequences.  
3.4. Discussion 
3.4.1. Hyaluronidases of Streptococci 
‘Hyaluronidase’ was previously used as a general term to describe enzymes 
which degrade HA, though their activity is often not entirely specific to HA 
alone (Hynes and Walton, 2000).  Thus hyaluronidases are a family of 
enzymes which have been established to comprise of three main groups, 
one of which is designated the bacterial hyaluronidases or hyaluronate 
lyases (Menzel and Farr, 1998).  Hyaluronidases are speculated to 
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contribute to the pathogenicity of bacteria through degradation of HA 
within host tissues and as such are considered virulence factors (Starr and 
Engleberg, 2006).  In bacteria there are different types of hyaluronidases, 
which are either chromosome-encoded extracellular enzymes thought to 
have roles in host invasion or enzymes encoded by integrated phage DNA 
in the bacterial genome (Hynes, Hancock and Ferretti, 1995).   
The phages of hyaluronic acid producing bacteria are thought to encode 
hyaluronidase enzymes in order to facilitate access to the cell through the 
capsule (Mylvaganam et al., 2000).  Hyaluronidases of both bacterial and 
phage origin have been found to vary greatly in sequence length and 
molecular weight (Girish and Kemparaju, 2007) and sequence comparisons 
have found the bacterial hyaluronidases to diverge substantially in some 
cases, whereas bacteriophage hyaluronidases possess a high degree of 
homology (Hynes and Walton, 2000).  Despite claims that several bacterial 
hyaluronidases are well characterised, the use of different names to identify 
the same enzymes results in confusion around whether an enzyme is a 
phage hyaluronidase or not and the significance of the differences between 
them is left unclear.   
Similar enzymes between strains are labelled as hyaluronidases, phage 
hyaluronidases, hyaluronate lyases and hyaluronoglucosaminidases, and 
the same sequence is often characterised as more than one of these 
depending on the database used to search and compare.  This results in 
difficulty in knowing whether enzymes identified in newly sequenced 
genomes may be true bacterial hyaluronidase genes or hyaluronidases from 
bacteriophage DNA.  Fig 36 shows the amino acid sequences of all 
annotated hyaluronidase genes in S. pyogenes strain SSI-1.  The genes are 
annotated in NCBI as either putative hyaluronidase, putative hyaluronidase 
(phage associated) or putative hyaluronoglucosaminidase.  A comparison 
of the sequences indicates areas of homology between all bar two of the 
genes, those annotated hyaluronidase (SSI-1_hyal) and putative 
hyaluronidase (phage associated) (SSI-1_putphagehyal3).   
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Figure 36 Amino acid sequences of hyaluronidase genes of S. pyogenes strain SSI-1.  All 
sequences were identified from NCBI where they were annotated as either putative hyaluronidase 
(hyal), putative hyaluronidase (phage associated) (putphagehyal) or putative 
hyaluronoglucosaminidase (puthyalgluco).  Areas of sequence identity are present between most of 
the sequences apart from SSI-1_putphagehyal3 and SSI-1_hyal which are longer and do not possess 
areas of homology to either each other or the other sequences.  Sequences were aligned using 
Multalin software (http://multalin.toulouse.inra.fr/multalin/).  
Having identified a number of genes annotated as hyaluronidases in the 
SE40327 genome by RAST it was necessary to be confident that 
investigations involved ‘true’ enzymes going forward.  Thus the use of 
three separate protein databases to confirm the identification of the genes 
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provided a means of ensuring certainty of the original annotations.  While 
not full proof, this method uses current knowledge of the hyaluronidase 
families as a first step towards confirmation and resulted in identification 
of two genes to concentrate initial analyses.  
3.4.1.1. SE40327hyal1 and SE40327hyal2, true hyaluronidases? 
The two accepted hyaluronidase sequences of SE40327 were 
compared to the sequences isolated from SSI-1.  The greatest match 
for SE40327hyal1 was to putative hyaluronidase (phage associated) 
(NCBI: SPs0648) which matched 100% of the query cover at an 
identity of 75.47%.  Upon comparing SE40327hyal1 against genes of 
S. equi subsp. equi ATCC 39506 it was found to match 88.14% to 
100% of the sequence for the gene SE071780_01756 which is 
annotated in NCBI as a hyaluronoglucosaminidase. A comparison of 
the amino acid sequences of SE40327hyal1, Sps0648 and 
SE071780_01756 is presented in fig 37.  The majority of the 
differences observed between the sequences appear to be towards the 
N terminal of the proteins and SPs0648 is missing a section of 
approximately 30 amino acids.   
 
Figure 37 Amino acid sequences of hyaluronidase genes of SE40327 (SE40327hyal1), S. 
equi subsp. equi ATCC 39506 (SE071780_01756) and S. pyogenes strain SSI-1 
(SPs0648).  SE40327hyal1 was identified using the RAST annotated genome of SE40327 
and the sequences of the other strains were identified from the nucleotide sequences in NCBI 
(https://www.ncbi.nlm.nih.gov/).  Sequences were aligned using Multalin software 
(http://multalin.toulouse.inra.fr/multalin/). 
75 
 
The second SE40327 hyaluronidase sequence (SE40327hyal2) 
matched 83.75% to 95% query cover of a separate putative 
hyaluronidase (phage associated) of SSI-1 (SPs0927).  Whereas when 
compared to the sequences of S. equi subsp. equi ATCC 39506 it 
matched 100% of the whole query to the gene SE071780_02165 
which is annotated as a hyaluronoglucosaminidase.  The amino acid 
sequences are compared in fig 38.  The S. equi strains appear to have 
an extra 14 amino acids at the N-terminus, however aside from this 
observation there appears to be minimal discrepancy between the S. 
equi and S. pyogenes strains.  
 
Figure 38 Amino acid sequences of genes from SE40327 (SE40327hyal2), S. equi subsp. 
equi ATCC 39506 (SE071780_02165) and S. pyogenes SSI-1 (SPs0927).  SE40327hyal2 
was identified using the RAST annotated genome of SE40327 and the sequences of the other 
genes were identified from the nucleotide sequences in NCBI 
(https://www.ncbi.nlm.nih.gov/).  Sequences were aligned using Multalin software 
(http://multalin.toulouse.inra.fr/multalin/).  
Previously it has been claimed that S. pyogenes possesses two 
hyaluronidase genes, one bacterial, designated the name hylA and one 
which is encoded by phage DNA (Hynes et al., 2000).  However there 
are seven genes annotated as hyaluronidases or 
hyaluronoglucosaminidases in the NCBI entry for S. pyogenes strain 
SSI-1.  This is another example of either the vast differences between 
enzymes within strains of bacteria or of the lack of confirmatory 
information and consistency when identifying hyaluronidase 
enzymes.  As previously mentioned the many names associated with 
hyaluronidases of both bacterial and phage origin leads to confusion 
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surrounding what is a true hyaluronidase enzyme and what is not.  
The annotation of most hyaluronidase genes appears still to be mainly 
speculative and much more is yet to be unveiled about the variety and 
function of these enzymes in different bacteria.  
Previously it was stated that the molecular weight of bacteriophage 
hyaluronidases is generally 36-40 kDa, with chromosomal bacterial 
hyaluronidases averaging above this (Hynes, 2000).  Both 
SE40327hyal1 and SE40327hyal2 are approximately 40 kDa in 
weight, indicating that they are consistent with phage-associated 
enzymes.  The first Streptococcal hyaluronidase enzyme to be 
sequenced was L20670 from S. pneumoniae which is 949 amino acids 
long and possesses a molecular weight of above 100 kDa.  
SE40327hyal1 and SE40327hyal2 possess less than 35% homology to 
this sequence, further suggesting their origins are phage rather than 
bacterial.  Whether these enzymes possess any functionality is 
unknown and experimental data would be required.  In addition, the 
other enzymes annotated by RAST which did not meet the criteria for 
further investigation may be being overlooked due to ambiguity 
around the general annotation of bacterial hyaluronidases.  However 
the two confirmed sequences provide a place to start in the evaluation 
of hyaluronidase activity in this strain of S. equi.  No confirmed 
hyaluronidase genes were identified in either SEZ20727 or SER17037 
to compare the SE40327 genes to.  However two genes were 
identified in SEE20561 by the RAST annotation and confirmed as 
described previously.  These were labelled SEE20561hyal1 and 
SEE20561hyal2.  At amino acid level SE40327hyal1 and 
SEE20561hyal1 possessed 67.39% identity and as observed between 
SE40327 and S. equi subsp. equi ATCC 39506 the greatest variation 
between sequences was observed at the N terminal end of the protein.  
Whereas the hyal2 genes of SE40327 and SEE20561 were completely 
identical.  No data on the active sites for these enzymes are available 
and so it is not possible to speculate whether the areas of variation 
between S. equi strains are significant with regards to enzyme 
function.  However now that these phage hyaluronidase genes have 
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been identified within the S. equi strain of interest and appears to also 
be present in other strains this provides a platform for moving forward 
with establishing functionality and possible effects on HA capsule 
production in this strain.  
3.4.1.2. Beta-N-acetylglucosaminidases 
While hyaluronidase enzymes were not identified for SEZ20727 and 
SER17037 by RAST, all strains of interest (SE40327, SEE20561, 
SEZ20727 and SER17037) were found to possess an enzyme 
matching to β-N-acetylglucosaminidase (bNAG).  These enzymes are 
another member of the family of glycoside hydrolases (EC 3.2.1) 
which includes hyaluronidases (Zhang et al., 2018).  A comparison of 
the amino acid sequences of these genes is presented in fig 39.  A 
high degree of homology is apparent with only 28 amino acids which 
vary between strains observed of 564.  The sequences of SE40327 and 
SEE20561 are identical and as seen in other protein sequences 
SER17037 differs from both S. equi subsp. equi and S. equi subsp. 
zooepidemicus strains at different amino acid positions.   
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Figure 39 Amino acid sequences of genes annotated as β-N-acetylglucosaminidases in 
strains SE40327 (SE40327bNAG), SEE20561 (SEE20561bNAG), SEZ20727 
(SEZ20727bNAG) and SER17037 (SER17037bNAG).  Sequences were identified from the 
RAST annotations of the genomes and compared using Multalin software 
(http://multalin.toulouse.inra.fr/multalin/).   A high degree of homology between the strains is 
observed and S. equi subsp. equi strains are completely identical.  
Previously it was observed that SER17037 did not exhibit 
hyaluronidase activity but both SEE20561 and SEZ20727 did (Speck 
et al., 2008).  In the case of SER17037 this claim is confirmed by a 
lack of hyaluronidase gene identification.  It is possible that the lack 
of hyaluronidase genes identified in SEZ20727 is due to the 
sequencing method meaning that some genes which fall between or at 
the end of contigs may be lost, as well as those which possess 
multiple repeats within the genome.  Whilst there has been 
speculation that bNAGs possess the ability to degrade hyaluronan, the 
lack of hyaluronidase activity observed in SER17037 would indicate 
that this is not the case for this enzyme.  This conclusion is supported 
by previous observations in Streptoccocus species where bNAGS 
were found to have no effect on hyaluronan (Sheldon et al., 2006; Sun 
et al., 2015).  Due to this, whilst the apparent conservation of this 
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enzyme between subspecies of S. equi is interesting, it is outwith the 
scope of this project and was not investigated further.  
3.4.2. Identification of hyaluronic acid associated genes and the has operon 
HA production in S. equi species involves the following five enzymes, 
hyaluronan synthase (hasA), UDP-glucose dehydrogenase (hasB), UDP-
glucose pyrophosphorylase (hasC/galU), (hasD/glmU) and 
phosphoglucoisomerase (hasE/pgi) following the biosynthetic pathway 
presented in Figure 40 (Chapter 4).  Hyaluronan synthase is responsible for 
assembling the HA chain and the other enzymes are responsible for 
producing the two precursors (Chen et al., 2009b).  Previously it has been 
described that the has operon of S. equi subspecies differs between 
zooepidemicus and equi in that all five genes are encoded within a single 
contiguous operon in zooepidemicus but in equi the operon contains only 
hasA, hasB and hasC, with hasD and hasE being organised within a 
separate operon (Blank, Hugenholtz and Nielsen, 2008).  Unfortunately in 
all of the genes of interest the beginning of the has operon was at the end of 
contigs and so the structure of the operon could not be confirmed as 
previously described.  Due to the fragmentation of the DNA during paired-
end sequencing, genes may be lost and operons may be split between 
contigs which prevents the analyses of operon structure (Alkan, Sajjadian 
and Eichler, 2011; Denton et al., 2014).  Completion of the genome would 
require further rounds of sequencing which unfortunately the budget for 
this project would not allow.  
3.4.3. Gene discrepancies between phenotypes 
Whilst no obvious discrepancies were observed in the genomes of the two 
phenotypes of SE40327 in terms of genes involved directly in HA 
production a number of variations were observed in other genes.  Deciding 
which genes were of interest and confirming the variation between 
phenotypes was challenging, however three genes were eventually 
identified and investigated further.  
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3.4.3.1. Collagen-like surface protein 
This gene was selected for investigation initially due to the fact it is 
located on the same contig and upstream of the has operon.  
Following further analysis it was discovered that the sequence 
matched to an LPXTG motif.  LPXTG motifs are commonly found in 
surface proteins of Streptococci and are recognised by sortases during 
the covalent attachment of complete surface proteins such as 
virulence factors like M protein to the cell wall (Scott and Barnett, 
2006).  It has previously been observed that in mutants deficient in the 
LPXTG motif surface proteins fail to associate with the cell wall, 
highlighting its importance in the sorting and arrangement of surface 
proteins (Novick, 2000).  The nucleotide sequence of the gene from 
40327MV matches 100% to the collagen-like cell surface-anchored 
protein sclH of S. equi subsp. equi (accession: VEH29797.1).  The 
lack of identifiable start codon or ribosome binding site in 
40327NMV suggests that transcription of this gene may have been 
lost in this phenotype.  Another enzyme involved in the placement of 
surface proteins is foldase which is discussed in chapter 5.  
3.4.3.2. M protein trans-acting positive regulator Mga 
Mga is a regulator of multiple genes that functions to activate the 
transcription of virulence factors in response to environmental stimuli 
(McIver, Thurman and Scott, 1999). The introduction of aromatic 
rings into a protein by amino acid substitution is likely to promote 
changes to the structure, stability, flexibility and hydrophobicity.  As 
the substitution appears to have occurred within the DNA binding 
helix-turn-helix region it is possible this could impede DNA binding 
and regulation of transcription.  “Phase-locked” variants of 
Streptococcus with respect to M protein and HA capsule were often 
observed to have accumulated deletions in the mga genes (Cleary et 
al., 1998).  Whilst the evidence points to HA production being 
regulated by other means than Mga (Falaleeva et al., 2014; Velineni 
and Timoney, 2018), previously it has been observed that S. pyogenes 
strains maintained in prolonged stationary phase (3-5 days) present 
with ceased or reduced expression of multiple virulence factors 
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including Mga, M protein and capsule (Leonard, Woischnik and 
Podbielski, 1998).  Mga is a transcriptional regulator and it has been 
observed that it possesses more than one DNA binding domain which 
has lead to speculation that it is capable on acting on numerous 
promoter targets (McIver and Myles, 2002).  Whilst none of these 
observations indicate a direct link between capsule production and 
Mga regulation, the observation of this mutation between mucoid and 
non-mucoid phenotypes in conjunction with the accepted notion that 
capsule is a virulence factor could be considered cause for further 
investigation into the effects of Mga function on phenotype with 
respect to capsule.  The majority of research into the mga operon and 
regulon has been conducted in S. pyogenes however a comparison of 
the operons indicates that the role of this regulator may differ slightly 
in S. equi.  
3.4.3.3. RNA polymerase sigma-70 factor family 
The missing stretch of sequence at the beginning of the gene in 
40327NMV does not appear to affect either of the regions identified 
in pfam as promoter recognition or binding regions.  Sigma factors 
provide yet another mechanism for pathogenic bacteria to respond to 
changes in environmental conditions such as pH and temperature and 
also have been found to have a role in the transcription of virulence 
factors (Opdyke, Scott and Morgan Jr, 2001).  Members of the sigma-
70 family of sigma factors associate with RNA polymerase in order to 
direct the enzyme to the relevant promotor sequences and thus is 
essential for transcription initiation (Paget and Helmann, 2003).  
Whilst they have been associated with regulation of virulence factors, 
sigma-70 family includes the “housekeeping” sigma factor as well as 
members specifically associated with stress responses (Kazmierczak, 
Wiedmann and Boor, 2005) and capsule production has been 
associated with response to stress stimuli such as pH changes and 
oxidative stress (Cleary and Larkin, 1979; Liu et al., 2008; 
Henningham et al., 2015; Chiang-Ni et al., 2016).  It has been 
claimed that a promoter motif for sigma-70 factor has been identified 
upstream of the hasE/pgi gene in S. equi species, speculating that this 
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gene is under the regulation of more than one operon due to its 
essentiality in other cellular processes (Blank, Hugenholtz and 
Nielsen, 2008). Thus it is not illogical to speculate that sigma factors 
play a role in regulation of capsule production.  Whether the loss of 
sequence at the beginning of the RNA polymerase sigma-70 factor 
gene in 40327NMV plays a role in loss of HA production is uncertain 
since as previously mentioned the loss has not occurred within 
conserved regions.  Further investigation in this case is outwith the 
scope and resources of this project.  
3.4.4. The hasC paralogs 
Due to the sequencing and annotation challenges described above both 
paralogs were not successfully identified from the RAST annotated 
genomes of the strains of interest apart from SEZ20727 and in some cases 
such as SEE20561 neither were identified.  As such the S. equi subsp. equi 
reference strain 4047 (SE4047) was used as the complete genome of this 
strain is available.  The hasC paralogs were previously observed and 
analysed in S. equi subspecies zooepidemicus and equi as part of a study 
analysing the evolution of the has operon (Blank, Hugenholtz and Nielsen, 
2008).  In this work it was observed that both S. zooepidemicus and S. equi 
HasC paralogs were identical apart from a portion of the sequences at the C 
terminal.  While this study did confirm this for S. equi subsp. 
zooepidemicus strain MGCS10565 the same was not found for either 
ATCC 35246, SEZ20727 or SE4047.  
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3.4.4.1. S. equi subsp. equi 4047 HasC paralogs 
As described above (3.3.4.) the paralogs of this strain were almost 
identical, however an amino acid substitution was observed at 
position 11 which introduces two new molecular groups to the 
protein.  The substitution of amino acids within proteins can cause 
conformational changes which may destabilise the structure or 
prevent correct folding and modification of the molecule, or in the 
case of a substitution within an active site the accessibility and 
binding affinity of an enzyme may be hindered or altered (Teng et al., 
2010).  The substitution observed between the paralogs of SE4047 are 
found in a predicted active site as annotated in NCBI.  This could 
indicate a change in binding capacity or activity between the two 
enzymes.  Whether and to what extent both paralogs are active in S. 
equi species has not been investigated and activity would need to be 
assessed in order to determine whether the amino acid substitution 
observed in this strain might have an effect on capsule production.   
3.4.4.2. S. equi subsp. zooepidemicus strain HasC paralogs 
The sequences of the paralogs in S. equi subsp. zooepidemicus strains 
were all identical when compared to each other at amino acid level.  A 
comparison of the HasC1 paralogs revealed two amino acid 
substitutions between SEZ35246 and the other two strains.  Whilst 
neither of these changes were located within active sites of the 
enzymes there is still a possibility that activity may be affected due to 
changes in protein stability and confirmation.  Unlike for SE4047 in 
which the paralogs were almost indistinguishable at nucleotide level, 
a comparison of the nucleotide sequences of the hasC1 and hasC2 
paralogs in S. equi subsp. zooepidemicus strains displayed a series of 
single base substitutions throughout the sequence length which were 
not found to be translated into amino acid changes.  Previously it was 
suggested that continual homologous recombination occurred within 
the S. equi subsp. zooepidemicus paralogs (Blank, Hugenholtz and 
Nielsen, 2008), which may explain the variation in nucleotide 
sequences observed in this study.  As with SE4047, the activities of 
either HasC paralog and whether they differ has not been investigated. 
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3.4.5. The murA paralogs 
As will be discussed in more detail in Chapter 4, the enzyme UDP-N-
acetylglucosamine enolpyruvyl transferase (MurA) is essential to the 
formation of peptidoglycan, a key component of the cell wall in bacteria 
(Zoeiby, Sanschagrin and Levesque, 2003).  It is responsible for catalysing 
the first step in the pathway where it transfers an enolpyruvate residue from 
a phosphoenolpyruvate molecule to N-acetylglucosamine (NAG) 
(Eschenburg et al., 2005).  As a result it competes directly with the 
hyaluronan synthase enzyme for NAG and so is an enzyme of interest in 
this study.  Two paralogs of MurA exist in gram positive bacteria (Kedar et 
al., 2008).  This was originally discovered in S. pneumoniae, where both 
paralogs were observed to be active to varying degrees as well as 
differentially susceptible to the antibiotic Phosphomycin, which is specific 
to this enzyme (Du et al., 2000).   
Both paralogs were identified in our strains of interest and when compared 
between species displayed a large degree of identity which is indicative of 
the enzyme essentiality.  Comparing the S. equi paralogs to those of S. 
pneumoniae strain R6 displayed a high degree of similarity in amino acid 
sequences.  The MurA1 paralogs possessed 80.19% identity to one another.  
Several amino acid substitutions were present and although none were in a 
reported active site, one substitution of a valine in SE40327 to an 
isoleucine in R6 occurred within a designated hinge site.  Hinge sites 
within proteins are areas of flexibility and are often difficult to predict 
(Flores et al., 2007).  The MurA enzyme of E. coli has previously been 
described to undergo severe conformational changes when bound to its 
substrate as detected by Small-angle X-ray scattering (SAXS) and 
fluorescence spectroscopy (Zoeiby, Sanschagrin and Levesque, 2003).  
Whether a change of amino acid at a hinge site may affect the flexibility 
and ease of these conformational changes upon binding and thus effect the 
enzyme activity could be speculated.  The MurA1 paralog in S. 
pneumoniae R6 was described as the more catalytically active of the two 
enzymes (Du et al., 2000), however this may not necessarily be the case in 
S. equi and so cannot be inferred especially if the amino acid content of the 
hinge sites differ between these species.  A comparison of the MurA2 
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paralogs between these two species shows homology of 79.76% and no 
amino acid substitutes within active or hinge sites.  
The murA paralogs of SE40327 possess 47.47% homology and a 
comparison of the amino acid sequences indicates that amino acid 
differences exist within active sites.  This observation may explain the 
differences in activity observed between the two enzymes.  The sequences 
of the murA paralogs of S. equi were identified in order to facilitate the 
design of gene expression analyses which will be discussed in chapter 4.  
The observation that the enzymes differ in sequence from those of S. 
pneumoniae R6 indicates that assumptions on their expression and activity 
cannot be made from the data presented in that study.  
3.4.6. Conclusions 
The sequencing of the genome of SE40327 provided the means to compare 
between other strains of S. equi and confirm the identity of the strain.  The 
genomes of SEE20561 and SEZ20727 were not previously available but 
now can be utilised in other genome comparison analyses.  Whilst the 
separate sequencing of the mucoid and non-mucoid phenotypes of 
SE40327 did not result in the revelation of any obvious functionally 
relevant differences with respect to the genes directly involved in HA 
production or provide information on the has operon structure of the 
strains, it has provided some avenues for continued investigations.  In 
addition the sequence information of the MurA enzymes in these strains 
may be useful for future analyses.  
Suggestions for investigations and analyses going forward will be 
discussed in chapter 6.  
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4. Competing Metabolic Pathways of Hyaluronic Acid Synthesis 
4.1. Introduction 
There are two precursors involved in the synthesis of HA: UDP-Glucuronic 
acid and UDP-N-acetylglucosamine and both are derived from glucose through 
two separate pathways which involve conversion into glucose-6-phosphate and 
fructose-6-phosphate (see figure 40).  Glucose-6-phosphate is also involved in 
the production of other cell wall components, lactic acid and accumulation of 
biomass.  As previously discussed, it is converted to HA component UDP-
Glucuronic acid (Sze, Brownlie and Love, 2016).  Fructose-6-phosphate is 
converted through several steps into one of the precursors to HA, UDP-N-
acetylglucosamine which itself is also utilised in the synthesis of peptidoglycan, 
the key component of the cell walls of gram positive bacteria (Yamada and 
Kawasaki, 2005).  Thus HA production is constantly in competition with other 
necessary cellular processes.  With regards to UDP-Glucuronic acid and UDP-
N-acetylglucosamine, it has previously been reported that the latter is the 
pivotal precursor relating to increasing HA molecular weight, with increased 
concentrations of it associated with increased molecular weight (Chen et al., 
2009b).  Following this it was discovered that this effect was only observed 
upon overexpression of hasD and hasE, the genes responsible for synthesising 
this precursor rather than with supplementation of the media with precursors 
themselves and that a cut off concentration exists where increasing expression 
past this does not result in further increases to molecular weight (Chen et al., 
2014).  As a result of that research it was observed that the presence of the 
empty vector plasmid  pNZ8148 also induced an increase in HA molecular 
weight and yield and upon investigation of this effect it was discovered that the 
cause could be attributed to upregulation of HasD which is responsible for the 
last steps of N-acetylglucosamine synthesis and unexpectedly, downregulation 
of the enzyme responsible for the first step of peptidoglycan synthesis MurA 
which is not directly involved in any stage of HA synthesis and directly 
competes with HasA for UDP-N-acetylglucosamine (Marcellin, Chen and 
Nielsen, 2010).  
Peptidoglycan is a fundamental component of the bacterial cell wall which 
protects the cell from mechanical and osmotic stress and aids in maintaining 
cell shape (Zoeiby, Sanschagrin and Levesque, 2003; Hrast et al., 2014).  It is 
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essential to bacterial viability and so enzymes involved in its synthesis are often 
targets for development of new antibiotics (Eschenburg et al., 2005).  The first 
step of its synthesis involves the transfer of an enolpyruvyl component from 
phosphoenolpyruvate to UDP-N-acetylglucosamine which is catalysed by the 
enzyme UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA) 
(Barreteau et al., 2008).  There are two copies of MurA in gram positive 
bacteria, thought to have arisen by gene duplication and both of which are 
active enzymes (Du et al., 2000).  The enzyme contains two globular domains 
with the active site lying between them.  This site is open, but becomes closed 
upon binding of the substrates (Klein and Bachelier, 2006).  The active sites 
include Cys115 which is thought to be involved in release of the product and 
can be substituted with an aspartic acid without loss of catalytic activity 
(Eschenburg et al., 2005).  Also important is Lys22 residue which is involved in 
the binding of phosphoenolpyruvate and the initiation of the conformational 
change of the enzyme (Samland, Amrhein and Macheroux, 1999).  The Cys115 
residue is the target for the only currently established antibiotic targeting MurA, 
Phosphomycin.  This antibiotic works by binding covalently to the Cys115 
residue and impeding the release of the reaction product thus halting the 
synthesis of peptidoglycan (Jukic, Gobec and Sova, 2019).  Some species of 
bacteria such as Mycobacterium tuberculosis are naturally resistant to 
Phosphomycin which is due to the absence of a cysteine at residue 115 
(Eschenburg et al., 2005; Engel et al., 2013).  The other mechanisms of 
Phosphomycin resistance include mutations which impede the uptake systems 
of which there are two, the α-glycerolphosphate and glucose-6-phosphate 
uptake systems.  Mutations in these systems prevent entry of the antibiotic into 
the cell.  Additionally, upregulation of murA expression promotes resistance 
(Michalopoulos, Livaditis and Gougoutas, 2011; Silver, 2017).  There are 
investigations ongoing to identify alternative MurA inhibitors to Phosphomycin 
such as terreic acid or the PEP 1354 peptide, however for now it remains the 
only confirmed antibiotic with specificity to MurA (Molina-López, Sanschagrin 
and Levesque, 2006; Abbott et al., 2010; Han et al., 2010).   
As the reduction of MurA was associated with increased HA molecular weight 
this work tested the hypothesis that inhibition of MurA activity by 
Phosphomycin at sub-lethal levels might result in increased availability of 
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UDP-N-Acetylglucosamine for HA synthesis by HasA and subsequently 
increase the yield and/or molecular weight of the HA produced.  There are no 
EUCAST (http://www.eucast.org) minimum inhibitory concentration (MIC) 
breakpoint data available for Phosphomycin for Streptococcus spp. of any strain 
as it is not recommended for use in this species of bacteria.  Marcellin, Chen 
and Nielsen (2010) reported that concentrations of Phosphomycin as low as 0.5 
ng/mL were lethal to S. zooepidemicus ATCC 35246 and so did not report on 
the effects of antibiotic supplementation on HA production and molecular 
weight.  The set of experiments described in this chapter aimed to assess the 
MICs of Phosphomycin for the S. equi mucoid and non-mucoid strains of 
interest in this study and if possible assess any effects on HA production 
induced by the presence of Phosphomycin in the culture media.   
 
Figure 40 Hyaluronic acid production pathway precursors in order of synthesis with enzyme 
designations.  The figure also displays pathways which are competing for precursors with Hyaluronic acid 
synthesis.  Enzymes found within the has operon are underlined.  
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4.2. Materials and Methods 
4.2.1. Preparation of antibiotic stocks 
4.2.1.1. Phosphomycin 
Phosphomycin disodium salt was obtained from Sigma Aldrich. Stock 
solutions of 1mg/mL (5.5 mM) were prepared in deionised water and 
sterilised.  The stock solution was then stored refrigerated for up to 2 
weeks.  
4.2.1.2. Ampicillin 
Ampicillin sodium salt was obtained from Sigma-Aldrich.  Stock 
solutions of 1mg/mL (2.7 mM) were prepared by dissolving the solid 
in deionised water and sterilising by syringe filtering through 0.22 μm 
into aliquots. The aliquots were stored at -20 °C and defrosted at room 
temperature prior to use in minimum inhibitory concentration assays.  
4.2.2. Antibiotic Minimum Inhibitory Concentration determination 
Growth curves in the presence of antibiotic were analysed in accordance 
with EUCAST guidelines for determining minimum inhibitory 
concentrations of antibiotics (http://www.eucast.org), where the MIC of a 
antimicrobial substance is identified as the lowest concentration that 
inhibits visible bacterial growth.  Bacterial growth in broth microdilution 
assays is observed as either turbidity or an accumulation of cells at the 
bottom of the wells depending on the type of organism.      
Bacterial stocks were inoculated into 50 mL of BHI media which was pre-
equilibrated to 37°C.  The inoculum was then incubated overnight at 37°C 
with shaking at 150 RPM.  A 96-well plate was seeded in columns with 
100 μL of Brain Heart Infusion media. The layout of the plate is observed 
in figure 41.  The maximum concentration of antibiotic to be analysed was 
prepared by diluting the stock in BHI media to the desired concentration 
and pre-equilibrating to 37°C.  Antibiotic in BHI solution was seeded 200 
μL into the empty column.  Serial dilutions were performed by drawing 
100 μL and mixing into the adjacent well, one column was left antibiotic 
free.  Inoculum optical density was measured at 660 nm and corrected to 
0.05 before 100 µL was seeded into each well with the blank column left 
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uninoculated.  The plates were sealed with Breathe-Easy® sealing 
membranes and placed in the Omega FLUOstar plate reader (BMG 
Labtech) and incubated for 20 hours at 37°C.  Optical density 
measurements at 660 nm were made every 30 minutes following 200 RPM 
shaking for 1s.  Concentrations of Phosphomycin at which final OD was 
significantly different from the control was determined by One-Way 
ANOVA analyses and concentrations which differed significantly between 
each other were determined by Tukey test.  
 
Figure 41 Layout of the 96-well plate for Phosphomycin MIC determination.  The antibiotic 
concentrations in each column are in µg/mL.  A blank column (B) of uninoculated media and a 
negative (N) column of bacteria in media without antibiotic were also seeded to provide controls.   
4.2.3. Capsule production analysis 
Inoculum was prepared as previously described (2.2.2.1.) and used to 
prepare and culture 96-well plates as previously detailed (2.2.2.2).  Bacteria 
were grown in BHI media supplemented with the chosen concentration of 
phosphomycin in order to assess any effects on growth and HA production.  
Following growth, samples for HPLC analyses were prepared as previously 
detailed (2.2.5.) and stored frozen at -20 °C until analysis.   
4.2.4. RNA extraction 
Bacteria stocks of 40327MV and 40327NMV were streaked onto SLA 
plates and incubated at 37°C for 48 hours.  Single colonies were selected 
and inoculated into 10 mL of BHI media and grown at 37°C with 150 RPM 
shaking overnight before 1 mL of inoculum was added to 10 mL of BHI 
and grown at 37°C and 150 RPM shaking for 8 hours.  Following this time 
40327MV was treated with 10 mL 3.6 mM hyaluronidase (Sigma-Aldrich) 
in BHI media and incubated for 20 minutes at 37°C.  The cultures were 
centrifuged at 4969 x g for 10 minutes, the pellets were washed 3 times in 
PBS (GibcoTM) and stored at -80°C until they were freeze dried.  Five 2.4 
1 2 3 4 5 6 7 8 9 10 11 12
A B N 0.0293 0.0586 0.1172 0.2344 0.4688 0.9375 1.875 3.75 7.5 15
B B N 0.0293 0.0586 0.1172 0.2344 0.4688 0.9375 1.875 3.75 7.5 15
C B N 0.0293 0.0586 0.1172 0.2344 0.4688 0.9375 1.875 3.75 7.5 15
D B N 0.0293 0.0586 0.1172 0.2344 0.4688 0.9375 1.875 3.75 7.5 15
E B N 0.0293 0.0586 0.1172 0.2344 0.4688 0.9375 1.875 3.75 7.5 15
F B N 0.0293 0.0586 0.1172 0.2344 0.4688 0.9375 1.875 3.75 7.5 15
G B N 0.0293 0.0586 0.1172 0.2344 0.4688 0.9375 1.875 3.75 7.5 15
H B N 0.0293 0.0586 0.1172 0.2344 0.4688 0.9375 1.875 3.75 7.5 15
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mm metal beads (Fisherbrand™) were added to each tube of freeze dried 
pellets and the tubes placed in a Precellys Evolution Homogenizer (Bertin 
Instruments) and beaten at 4500 RPM for 30 seconds.  To extract RNA 500 
µL of Trizol reagent (Ambion®) was added to each tube on ice and mixed 
by inversion before being incubated for 5 minutes at room temperature.  
Following incubation 100 µL of chloroform was added to each tube and the 
tubes shaken vigorously for approximately 15 seconds then incubated at 
room temperature for 5 minutes.  Samples were centrifuged at 12 000 x g 
for 15 minutes at 4°C to separate into phases.  The upper aqueous phase 
was removed by pipette and transferred to a fresh RNase free Eppendorf 
tube without contaminating with the intermediate phase, 500 µL of 
isopropanol was added to each sample of aqueous phase and the tubes 
inverted several times to mix before being incubated at room temperature 
for 10 minutes.  The tubes were centrifuged at 12 000 x g for 10 minutes at 
4°C.  The supernatant was removed and 500 µL 75% ethanol was added.  
Samples were briefly vortexed and centrifuged at 7500 x g for 5 minutes at 
4°C.  The ethanol was removed and the tubes left horizontally to air dry.  
Once visibly dry 50 µL of nanopure water (HycloneTM) was added to each 
tube and mixed thoroughly by pipette before being placed in incubation at 
55°C for 10 minutes to aid dissolution, the samples were then placed on ice 
prior to DNase treatment.  All reagents for DNase treatment were sourced 
from Thermofisher Scientific.  To each tube, 5 µL of 10X reaction buffer 
with MgCl2 was added followed by 2 µL of RNase free DNase.  Samples 
were incubated at 37°C for one hour.  To inactive the DNase 5 µL of 50 
mM EDTA was added and the tubes were heated to 65 °C for 10 minutes.  
To re-extract the RNA 5 µL of 3M sodium acetate solution (Sigma-
Aldrich) was added, followed by 65 µL of isopropanol.  Samples were 
incubated at -20°C overnight before being centrifuged at 20 000 x g for 30 
minutes at 4°C.  The supernatant was removed without disturbing the pellet 
and 500 µL ice cold 70% ethanol was used to wash the pellet, the tubes 
were vortexed briefly and centrifuged at 20 000 x g for 10 minutes at 4°C.  
The ethanol was removed and the tubes left horizontally to air dry.  Once 
visibly dry 50 µL of nanopure water was added and the tubes incubated at 
55°C for 10 minutes.  The tubes were stored on ice until purity 
measurements were made with the NanoDropTM 2000.  Acceptable purity 
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criteria were a minimum of 100 ng/µL, a 260/280 ratio of 1.8-2.2 and a 
260/230 ratio of 1.5-2.4.  The RNA samples were then stored at -80°C until 
required for use where they were defrosted and stored on ice.  Samples 
were run on a 2% agarose gel with SYBR® Safe DNA gel stain 
(Invitrogen) in order to confirm purity and samples were included or 
excluded from cDNA synthesis and subsequent PCR based on this result.  
4.2.5. cDNA synthesis 
The synthesis of cDNA from the RNA samples was carried out using the 
High-Capacity RNA-to-cDNATM kit from Applied Biosystems.  Reactions 
were set up and carried out as per the manufacturer’s instructions on ice.  
The reaction mix was aliquoted into Eppendorf tubes and centrifuged 
briefly to remove any bubbles and to mix contents.  The tubes were then 
placed in incubation at 37°C for one hour.  The tubes were then wrapped in 
parafilm and placed in a water bath at 95°C for 5 minutes to inactivate the 
reverse transcriptase enzyme before being frozen at -20°C until required 
for use in PCR reaction. 
4.2.6. Primer design for RT PCR 
Primers were designed using Primer3Plus 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) with 
the following criteria.  Primers must be 20-24 bases in length, product size 
must be 80-120 bases in length and the GC% must be 40-50.  The optimum 
annealing temperature (Tm) was 60 °C.  Primers were designed with G or 
C as the final nucleotide at the 3’ end.  Two housekeeping genes were used, 
the first was NAD-dependent glyceraldehyde-3-phosphate dehydrogenase 
(plr) and the second DNA gyrase subunit A (gyrA).  The genes of interest 
investigated were hasA, murA1 and murA2.  The final sets of primers 
designed for the genes of interest are presented in Table 10.  Primers were 
ordered from Eurofins (https://www.eurofinsgenomics.eu) as custom DNA 
Oligos in tubes and were reconstituted and stored as per manufacturer’s 
instructions.  
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Table 10 Primers designed using Primer3Plus for the respective genes of interest.  The primers 
were designed and used for real time PCR to determine transcript levels of the respective genes of 
interest in mucoid and non-mucoid phenotypes. 
4.3. Results 
4.3.1. Phosphomycin MICs of S. equi strains of interest 
In order to determine the Phosphomycin MIC for each S. equi strains the 
bacteria were cultured in varying concentrations of the antibiotic in BHI 
media.  Conventionally, MICs are assessed visually at a growth endpoint 
(16-20 hours) – in this instance, growth was monitored continually and the 
results are presented in the following graphs.  Figure 42 displays the 
growth results for SE40327.  A dramatic reduction in growth is observed at 
a Phosphomycin concentration of 15 µg/mL, however the reduction in final 
OD reached seen at concentrations of 7.5, 3.75, 1.875 and 0.9375 µg/mL is 
significant also (p = 0.000).  Final OD at concentrations 0.9375 and 1.875 
µg/mL were not significantly different from each other whereas 
concentrations 3.75, 7.5 and 15 µg/mL were all significantly different (p = 
0.000).  Lower concentrations than this did not result in a significant 
reduction in final OD or a visible absence of growth compared to the 
control.  Turbidity was observed for all concentrations apart from 15 
µg/mL following the incubation period. 
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Figure 42 Phosphomycin MIC of SE40327 in BHI media.  Concentrations of Phosphomycin are 
in µg/mL. The curves plotted are optical density at 660 nm over time.  Points on the graph are 
representative of mean values over 3 biological replicates and error bars are standard deviation. 
Figure 43 displays the MIC results for SEE20561.  Most noticeable is the 
absence of growth observed at 15 µg/mL, although there is an apparent 
increase in OD in the first 4 hours according to the graph this did not result 
in visible turbidity following 20 hours of incubation.  A significant 
reduction in final OD was observed at 7.5, 3.75 and 1.875 µg/mL 
compared to the control (p = 0.000) and the final OD for each of these 
concentrations also differed significantly from each other.  Visible turbidity 
was observed following 20 hours of incubation for all concentrations bar 
15 µg/mL.  
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Figure 43 Phosphomycin MIC of SEE20561 in BHI media.  Concentrations of Phosphomycin are 
in µg/mL. The curves plotted are optical density at 660 nm over time.  Points on the graph are 
representative of mean values over 3 biological replicates and error bars are standard deviation. 
Figure 44 shows the MIC results for SEZ20727.  Once again there is an 
evident inhibition of growth at 15 µg/mL with any apparent increase in OD 
observed on the graph being indiscernible by eye following 20 hours of 
incubation.  Growth of this strain in 7.5 µg/mL Phosphomycin appears to 
be variable with a reduced average maximum optical density but large error 
bars indicating variance between biological replicates at this concentration.  
Significant differences in growth compared to the control were observed at 
concentrations as low as 0.0293 µg/mL (p = 0.000) however wells were 
observed to be turbid following the incubation period at all concentrations 
apart from 15 µg/mL demonstrating that these concentrations were not 
inhibitory according to EUCAST guidelines.  
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Figure 44 Phosphomycin MIC of SEZ20727 in BHI media.  Concentrations of Phosphomycin are 
in µg/mL. The curves plotted are optical density at 660 nm over time.  Points on the graph are 
representative of mean values over 3 biological replicates and error bars are standard deviation. 
Figure 45 displays the MIC results for SER17037.  Inhibition of growth 
was evident by lack of visible turbidity at 15 µg/mL as observed with the 
other strains and this appears to be supported by the curve in the graph. 
Another pronounced feature of the graph is that while inhibition of growth 
is observed at 7.5 µg/mL the size of the error bars indicate considerable 
variation between biological replicates with regards to this concentration.  
When manually reading the MIC’s in some of the biological replicates 
turbidity was prominent in the 7.5 µg/mL whereas in others there was 
barely visible turbidity, this variation is supported by the large error bars.  
The final OD’s were significantly different to the control for 
Phosphomycin concentrations as low as 0.0293 µg/mL however growth 
was visually observed for all concentrations below 15 µg/mL.  
Unexpectedly, no significant difference was found between final OD of the 
control and that of concentration 0.2344 µg/mL despite the values at 
concentrations below this being significantly decreased compared to the 
control (p = 0.000).  An additional observation was that the shape of the 
growth curves at concentrations 1.875-7.5 µg/mL appeared different from 
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the others with what can be described as a ‘dip’ occurring in the latter half 
of log phase.  
 
Figure 45 Phosphomycin MIC of SER17037 in BHI media.  Concentrations of Phosphomycin are 
in µg/mL. The curves plotted are optical density at 660 nm over time.  Points on the graph are 
representative of mean values over 3 biological replicates and error bars are standard deviation. 
From the results of the growth experiments in varying Phosphomycin 
concentrations it can be deduced that the minimum inhibitory concentration 
in BHI media is 15 µg/mL.  This is in accordance with the MIC criteria 
from EUCAST which dictates that the lowest concentration which results 
in no visible growth of an organism may be recorded as the MIC.  The lack 
of visible growth in the wells containing 15 µg/mL Phosphomycin were 
confirmed upon analysis of growth curve data which showed considerably 
reduced growth curves.  In addition to this result, the observation that the 
final OD reached is significantly different at concentrations much lower 
than the inhibitory concentration when compared to the control provides 
useful information as to the effect of Phosphomycin supplementation at 
below growth inhibitory concentrations.  The lack of visible growth 
inhibition at concentrations of 7.5 µg/mL indicates that growth in the 
presence of µg/mL concentrations of Phosphomycin is possible for all 4 
strains of interest.  
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4.3.2. Capsule production in the presence of Phosphomycin 
In order to investigate the effects of Phosphomycin on capsule production, 
the bacteria were cultured in the presence of 2 and 7.5 µg/mL (1/2 and 
1/12th MIC) of the antibiotic and the HA concentration of the culture media 
measured by HPLC.  As described previously, the concentrations from 
each biological replicate were corrected to the maximum OD achieved in 
order to normalise the data.  The HA retention time was slightly higher 
than in BHI media without Phosphomycin with the average retention time 
being 4.1 minutes compared to 3.9 minutes in BHI alone.  The results of 
the HPLC analyses are displayed in table’s 11 and 12.  HA concentration 
whilst appearing relatively consistent also appears to be reduced when 
compared to the concentration in BHI media alone (Tables 7 and 8, 
Chapter 2).   
The data was analysed by One-Way ANOVA, the results of which were as 
follows, SE40327 df = 1, 4, f = 0.90. p = 0.396 and SER17037 df = 1, 4, f = 
0.07, p = 0.798.  For both strains there was no significant difference in HA 
production between Phosphomycin concentrations 2 and 7.5 µg/mL as 
indicated by the p values being greater than 0.05.  The results were then 
compared to the HA production results in BHI media alone (Tables 7 and 8 
Chapter 2.3.4) for each strain.  A significant reduction in HA concentration 
was observed when SE40327 was cultured in BHI containing either 
concentration of Phosphomycin compared to that of BHI media alone 
(One-Way ANOVA, df = 2, 6, f = 21.14, p = 0.002), the same was 
observed for SER17037 (One-Way ANOVA, df = 2, 6, f = 11.09, p = 
0.010).   
 
Table 11 Hyaluronic acid concentration produced by SE40327 in BHI media supplemented 
with Phosphomycin.  The table displays the results of HPLC analyses on cell stripped media 
following 8 hours of growth in BHI supplemented with either 2 or 7.5 µg/mL Phosphomycin.  Final 
optical density values are displayed along with the measured hyaluronic acid concentration and 
retention time for each analysed sample.  Concentrations were corrected to the maximum OD 
SE40327
Phos conc. µg/mL Retention time (min) HA concentration (µg/ml) Final OD660 Corrected concentration to max OD (µg/ml)
2 4.095 52.05 0.46 56.07
2 4.194 60.62 0.5 60.62
2 4.105 49.61 0.25 100.84
7.5 4.171 69.34 0.52 69.34
7.5 4.116 48.28 0.06 602.11
7.5 3.86 52.55 0.47 58.62
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reached for each media.  Each entry represents a single biological replicate of 15 pooled technical 
replicates.  
 
 
Table 12 Hyaluronic acid concentration produced by SER17037 in BHI media supplemented 
with Phosphomycin.  The table displays the results of HPLC analyses on cell stripped media 
following 8 hours of growth in BHI supplemented with either 2 or 7.5 µg/mL Phosphomycin.  Final 
optical density values are displayed along with the measured hyaluronic acid concentration and 
retention time for each analysed sample.  Concentrations were corrected to the maximum OD 
reached for each media.  Each entry represents a single biological replicate of 15 pooled technical 
replicates. 
4.3.3. RT-PCR analysis of murA paralog gene expression between 
phenotypes 
Attempts to develop RT-PCR to determine any differences in expression of 
hasA, murA1 and murA2 between mucoid phenotypes were made. RNA 
isolation and purification was carried out as described (4.2.4.)  Despite 
multiple attempts to optimise all stages such as RNA purification, primer 
design, template and RT enzyme concentration and RT-PCR method, it 
was not possible to obtain sufficient or consistent results.  Specific aspects 
in this development and mitigation approaches are discussed below (4.2.3 
and following sections).  
4.4. Discussion and Conclusions 
As previously mentioned, UDP-N-acetylglucosamine is considered the pivotal 
precursor for molecular weight control of HA produced by S. equi subsp. 
zooepidemicus.  This precursor is also used for the synthesis of peptidoglycan 
which is a crucial component of bacterial cell walls (Barreteau et al., 2008).  
UDP-N-acetylglucosamine is the substrate for the enzyme involved in the first 
step of this pathway MurA and as such this enzyme competes directly with 
HasA.  Due to this direct competition it was theorised that reducing the action 
of MurA would increase the availability of this precursor for HA synthesis.  
SER17037
Phos conc. µg/mL Retention time (min) HA concentration (ug/ml) Final OD660 Corrected concentration to max OD (µg/ml)
2 3.985 66.72 0.45 77.13
2 4.229 61.83 0.47 67.88
2 4.215 66.82 0.52 66.82
7.5 4.113 62.63 0.4 71.09
7.5 4.174 70 0.45 70
7.5 4.158 60.92 0.41 67.95
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The study by Chen et al. (2010) identified that a reduction in MurA enzyme 
was associated with an increase in HA molecular weight produced by S. equi 
subsp. zooepidemicus ATCC 35246 and this was thought to be due to the fact 
MurA competes directly with HasA for the HA precursor UDP-N-
acetylglucosamine. Phosphomycin is an antibiotic in which the mechanism of 
action is inhibition of MurA specifically.  It was hypothesised that 
supplementation of culture media with Phosphomycin at a less than inhibitory 
concentration may reduce the activity of MurA and as a result increase the 
availability of the precursor for HA production.  The first step to assess this was 
to determine the MIC’s of Phosphomycin in the strains of interest.  Following 
this HA production in sub-inhibitory concentrations was assessed.  
4.4.1. Phosphomycin MIC’s in S. equi strains 
Marcellin et al. (2010) reported that Phosphomycin concentrations as low 
as 0.5 ng/mL were lethal to the S. zooepidemicus strain of interest in their 
study.  This indicates extremely potent antimicrobial activity which is more 
typically in the µg/mL range.  Phosphomycin MICs for other gram positive 
species such as methicillin susceptible S. aureus strains were found to 
range 0.5-32 µg/mL with methicillin resistant strains being as high as 128 
µg/mL and in the same study overall from the 590 common bacterial 
species tested the Phosphomyin MICs varied 0.25-512 µg/mL (Lu et al., 
2011).  Due to the variation in MIC’s observed between strains the effects 
of Phosphomycin on growth of the strains of interest in this study were 
investigated as it was postulated that they may not be as low as claimed by 
Marcellin et al. (2010).  Phosphomycin is transported into the cell via two 
uptake systems, the first is the L-α-glycerophosphate uptake system and the 
second is the glucose-6-phosphate (G6P) uptake system (Zoeiby, 
Sanschagrin and Levesque, 2003).  Due to this, when testing the 
susceptibility of Phosphomycin the media is often supplemented with G6P 
in order to enhance the antimicrobial activity (Lu et al., 2011; 
Michalopoulos, Livaditis and Gougoutas, 2011; Falagas et al., 2016).  
However for the purpose of this study it was not necessary to do this as the 
ultimate aim was to investigate the possibility of introducing 
Phosphomycin into the current fermentation process for HA production in 
our strains of interest.  From the results it can be concluded that the 
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visually observed MIC for all four strains is 15 µg/mL in BHI media, a 
large contrast to the reported lethal concentration of 0.5 ng/mL observed 
for S. zooepidemicus ATCC 35246.  No EUCAST breakpoint data for 
Streptococcus groups A, B, C and G are available as these organisms are 
not recommended targets for Phosphomycin treatment, however it has been 
claimed MIC values for Phosphomycin of ≤ 64 µg/mL are considered 
susceptible (Michalopoulos, Livaditis and Gougoutas, 2011).  Accepting 
this criteria it can be concluded that all four strains of interest are 
susceptible to Phosphomycin in BHI media.  Growth curves are not a 
EUCAST requirement for susceptibility testing however they were 
performed in order to provide a range of concentrations which did not 
inhibit growth for the purpose of this project.  Due to the previously 
reported low lethal concentration of Phosphomycin on S. zooepidemicus 
MIC assays were originally set up with a maximum concentration of 0.5 
µg/mL Phosphomycin however no effect on growth was observed so the 
maximum concentration was increased to 1, 3, 5 and 10 µg/mL before 
arriving at the concentration of 15 µg/mL (Data not shown).  In addition, 
MIC’s of Ampicillin were determined for each strain as a control.  
Breakpoint data from EUCAST declare that MIC’s for Ampicillin in group 
A, B, C and G Streptococcus of ≤ 0.25 µg/mL indicate susceptibility.  
Inhibition of growth was observed manually at 0.0156 µg/mL for SE40327 
and SER17037, 0.0625 µg/mL for SEE20561 and 0.0313 µg/mL for 
SEZ20727 indicating that all strains were susceptible to Ampicillin in BHI 
(Data not shown).  As previously mentioned the aim was to establish a 
range of below inhibitory concentrations of antibiotic to investigate further.   
4.4.2. Capsule production in the presence of Phosphomycin 
It has previously been reported that N-acetylglucosamine (NAG) is the 
limiting precursor with regards to HA molecular weight (Chen et al., 2009; 
Chen et al., 2014).  As Phosphomycin specifically targets MurA which 
directly competes with HasA for NAG, it was hypothesised that 
supplementing the media with a non-inhibitory concentration of the 
antibiotic would result in an increase in HA production and or molecular 
weight as it would increase NAG availability.  The highest concentration of 
Phosphomycin which did not result in visible inhibition of growth in the 
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strains was 7.5 µg/mL and so this was chosen as a concentration for 
analysis of HA production with Phosphomycin.  With regards to 
SER17037 the large error bars observed for 7.5 µg/mL were considered an 
indication of variation between biological replicates, possibly due to the 
MIC being nearer to 7.5 than 15 µg/mL, however as turbidity was 
manually observed in all replicates this concentration was not considered 
inhibitory by EUCAST guidelines and so was tested in SER17037 
regardless of the variation observed in the growth curve.  Since an aim was 
to assess the highest Phosphomycin concentration possible without 
inflicting a marked change to the growth of the strains, a concentration of 2 
µg/mL was selected in addition.  This was chosen after analysing the 
growth curve data the concentration of 1.875 µg/mL was considered to be 
the highest concentration reached before the curves differed markedly 
compared to the control curve. Bacteria cultures were set up and grown as 
previously described (2.2.5) in order to ensure results would be comparable 
to non-antibiotic supplemented growth.   
From the results of the HPLC analyses this was not the case however with 
both capsule producing strains displaying significantly reduced HA 
concentrations compared to when cultured in BHI media alone. In addition 
to the reduced concentration, although the HPLC was not set up to measure 
molecular weight the slightly increased retention time may indicate that the 
HA molecular weight is also reduced compared to that produced in BHI 
media alone.   
The reduced HA production in the presence of Phosphomycin was an 
unexpected result.  It is possible that this observation is the result of the 
emergence of a tolerance strategy in these strains.  Mechanisms of 
resistance to Phosphomycin include mutational changes in either MurA 
which lowers the affinity to the antibiotic or in the uptake systems which 
reduces entry of Phosphomycin into the bacterial cells. Additionally, 
increasing MurA expression is another means of developing resistance 
(Falagas et al., 2016; Silver, 2017).  It was previously reported that over 
expression of either of the copies of murA lead to a reduction in HA 
molecular weight (Marcellin, Chen and Nielsen, 2010) and so it is possible 
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that to counteract the presence of Phosphomycin in the media, expression 
of murA is increased resulting in reduced HA production.   
4.4.3. Gene expression of the MurA paralogs between phenotypes 
In gram positive bacteria there are two paralogs of the MurA enzyme 
which compete with HasA for UDP-N-acetylglucosamine.  Both paralogs 
were found to be active to different degrees and both are susceptible to 
inhibition by Phosphomycin (Du et al., 2000).  While it has been described 
that the paralogs have different levels of activity, there has been no 
consideration as to whether the genes are expressed concurrently and – if 
so - at the same level and whether changes in expression occur between 
mucoid and non-mucoid phenotypes.   In order to assess this attempts were 
made to measure expression levels of the genes during log phase using RT-
PCR. 
RT-PCR is a commonly used method for analysing gene expression as it 
utilises mRNA as the template thus giving a representation of the levels of 
a target gene within a sample (Wacker and Godard, 2005).  It can be 
carried out in either one step or two step reactions and involves the 
conversion of the mRNA template to cDNA prior to amplification in the 
PCR reaction (Jalali, Zaborowska and Jalali, 2017) 
4.4.3.1. Primer design 
As previously mentioned primer design was carried out using 
Primer3Plus software.  The criteria for primers was product size 80-
120 bases, primer length 20-22 bases, GC content 40-60%, and 
containing a G or C at the 3’ end of the sequence.  In addition primers 
with three or more repeats of a single nucleotide within were avoided 
where possible to reduce instances of primer dimers or hair pins.  
Melting temperatures (Tm) of 57-62° were considered acceptable.  All 
primers were checked for specificity using NCBI BLAST and by 
searching the nucleotide sequences in RAST genome annotations.    
The housekeeping gene selected was DNA gyrase A (gyrA) and 
primer sequences for this gene detailed previously in S. equi subsp 
equi were used (Steward, Robinson and Waller, 2016).  Streptococci 
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possess low GC content in their genomes (33.75-43.40%) (Gao et al., 
2014).  This causes some difficulties in primer design as ideally the 
GC content of primers and amplicons should be as close to 50% as 
possible to ensure stability (Bustin and Huggett, 2017).  The genes of 
interest (murA1, murA2 and hasA) were 39-47% GC which meant 
designing primers with a desirable content and containing minimal 
base repeats was difficult as often the more GC rich areas of the 
sequences contained a large number of repeats.  Whilst Primer3Plus 
was a useful tool for selecting areas of the genes where sequences 
might be suitable for primers, the majority of the initial primers 
suggested were not considered suitable, either due to similarities in 
sequences between the forward and reverse primers which was 
predicted to increase the chances of primer dimer formation, or due to 
containing an unacceptable number of repeats which was predicted to 
increase the chances of hair pins forming.  In the case of hasA three 
sets of primers were designed and obtained and following testing the 
second set was selected as the final primers for PCR.  The murA 
paralogs provided additional complication.  The nucleotide sequences 
are 53.9% identical as calculated by EMBOSS needle 
(https://www.ebi.ac.uk/Tools/psa/) and have very similar GC content.  
Areas of the sequences which possessed less identity were AT rich 
making them less suitable for primer design.  The similarity of the 
two sequences to each other meant that designing primers which 
would be specific to the single paralogs was complicated as there was 
an increased risk of nonspecific annealing and double PCR product 
formation.  As a result two sets of primers were designed for each 
paralog.  The first primer set designed and ordered for murA1 were 
specific for the target as indicated by single peaks in the melt curve.  
However the first primer set for murA2 appeared to not be specific 
enough under the original conditions tested and so a second set was 
designed.  Another issue identified with the use of Primer3Plus for 
primer design was that the predicted Tm of the primers was often not 
the same as that detailed on the product report provided by the 
manufacturer and so the Tm of the primers for each gene of interest 
differed to a greater extent than was predicted during their design.  
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However all fell within the accepted range and so attempts to design 
the assay were continued.  
In addition to the previously mentioned genes of interest primers for 
additional genes were designed to investigate their expression within 
the two phenotypes, however in practice these primers were not 
suitable as they were not specific enough and did not result in 
amplification of the target.  As a result these were omitted from the 
development of the PCR assay with the aim of returning to the targets 
in future.  However, investigation of expression was continued with 
the housekeeping gene gyrA and the three main genes of interest 
hasA, murA1 and murA2 as these were the most important to the 
questions being posed.  
In conclusion the primer design for the genes of interest in S. equi 
subsp equi 40327 was not straight forward using the criteria selected 
due to both the low GC content of the genes as well as a large number 
of areas of repeats.  In addition the design of specific primers for 
murA1 and murA2 is challenging due to great similarity between the 
nucleotide sequences.  For murA2 the ideal primers fell within an area 
of sequence which is too similar to murA1 to be confident that 
expression of this paralog alone is being measured.  
4.4.3.2. PCR assay optimization 
Initially, gene expression between phenotypes was attempted to be 
measured using the RNA extracted and purified and the Power 
SYBR® Green RNA-to-CT™ 1-Step Kit (Thermofisher) as this was 
available within the lab and had been successfully utilised for gene 
expression analyses in E. coli.  One-Step RT-PCR involves 
performing the reverse transcription (RT) and subsequent PCR 
reaction within the same tube, resulting in reduced handling of 
samples and a simplified set up which may reduce chances of 
contamination (Wacker and Godard, 2005).  However for the purpose 
of this study the results from One-Step PCR method overall lacked 
the desired precision with replicates being inconsistent in the majority 
of targets.  A drawback of the One-Step RT-PCR method is that 
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optimized mixtures are provided in kits which can be costly and are 
often optimized using only one target gene and one template source, 
in the case of the mastermix used in this study it appears that 
optimisation was carried out on the gene for GAPDH in the human 
kidney cell line BOSC23 which has a GC content of 59%.  In 
addition, both reactions occurring in the same tube reduces the 
likelihood of the conditions being optimal for either single reaction 
and troubleshooting is hindered due to a lack of control of the 
sequential steps (Prediger, 2012).  One possible reason for the 
variation was that all target genes are present in the genome in a 
single copy and so the initial quantity of 5 ng RNA did not provide 
enough starting material.  The kit used was compatible with a 
maximum concentration of 100 ng RNA and so the concentration 
used was increased to 10 and then 50 ng both with and without 
adjusting the RT enzyme concentration.  However this did not 
decrease Ct values as anticipated, indicating that some form of 
inhibition may be present.  The RNA quantity and purity had 
previously been measured following extraction using the NanodropTM 
2000 and so further analyses of purity were carried out where the 
samples were all run on an agarose gel (Results in appendix B).  None 
of the samples appeared to be significantly degraded, however in 
some of the samples smearing was observed and the presence of some 
form of contaminant remained in the wells, this was speculated to be 
ethanol contamination from the final RNA pellet wash.  Following 
this only the samples which did not have evidence of any 
contamination were used.  Another assay was performed in which a 
series of dilutions (1/2, 1/5 and 1/10) of 10 ng of the RNA was used in 
the reactions.  The results demonstrated similar amplification curves 
for all template dilutions which suggested inhibition was present 
within the reaction.  One-step RT-PCR is considered to be less 
sensitive than two-step due to the inability to optimise both reactions 
independently of each other (Bioline, 2015).  In particular it can be 
difficult to troubleshoot the RT reaction.  It was investigated whether 
a two-step approach would be more suited to the purpose of this study 
as this approach is advantageous if there is limited quantity of sample 
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and maximal optimisation of both steps is required (Takara, 2018).  
The High-Capacity RNA-to-cDNATM kit (Applied Biosystems) was 
used to convert RNA samples to cDNA samples of 100 ng/µL which 
were then stored at -20 °C until use.  PCR was then attempted with 
the One-Step master mix previously described without addition of the 
RT enzyme as it was speculated that the results using this would 
indicate whether the RT reaction was the limiting stage.  The 
housekeeping gene gyrA was used to set up a dilution series of the 
cDNA, 50 ng of neat sample was used and then dilutions of this of 
1/10, 1/100 and 1/1000 were made.  This dilution series did not 
indicate the same inhibition seen with the one step reaction.  Precision 
was improved between replicates however the Ct values were slightly 
higher than those seen in the one-step reaction.  As previously 
mentioned the maximum sample concentration advised for this master 
mix is 100 ng RNA.  Assuming full translation into cDNA occurs it 
can be assumed that 100 ng cDNA is the maximum allowed.  Primer 
concentrations were originally 200 nM.  An assay was set up using 10 
or 100 ng cDNA template and both 200 nM primers or 500 nM 
primers.  Results indicated that using both 100 ng cDNA and 500 nM 
primer concentration was preferable to any other combination for 
precision and Ct, however the Ct values still fell within the range of 
29 to 36 which was still high, although the negative controls indicated 
that this was amplification of the target.  As previously mentioned all 
target genes including gyrA are single copy genes.  To attempt to 
demonstrate this primers for 16S rRNA were used (Velineni and 
Timoney, 2015) as multiple copies of this gene are present in the S. 
equi genome.  It was expected that the Ct values for this target would 
be lower, indicating that the later values for the genes of interest were 
due to the low copy number.  The 16S rRNA primers were used in a 
PCR assay alongside gyrA, hasA and both murA paralogs.  The Ct 
values were lower for 16s rRNA than the other target genes although 
not by as much as expected, however the precision was also greatly 
improved compared to the target genes which suggests that both copy 
number and primer efficiency were issues.  The annealing temperature 
was adjusted from 59 °C to 60 °C as amplification of the gyrA primers 
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which had the highest Tm was variable and the annealing time was 
lowered from 30 seconds to 20 seconds to reduce the chance of primer 
dimers which were observed in some of the replicates.  At this point 
the stock of the one-step master mix was exhausted and an alternative 
was sourced.  The PowerUpTM SYBRTM Green Master Mix (Applied 
Biosystems) was obtained and used for subsequent PCR optimisation.  
An optimised reaction using one master mix will not always be 
successful with a new one and so changing the master mix requires 
optimal conditions to be re-established (Bustin and Huggett, 2017).  
The new master mix did not appear to be as compatible with 
conditions used prior to it.  Previously hasA expression was not 
detected in the non-mucoid phenotype samples, however 
unexpectedly this changed and amplification was observed in some of 
the replicates.  This was speculated to be a result of contamination of 
the sample.  As the RNA samples which previously appeared to 
contain some form of solvent contamination were omitted from 
analyses an alternative sample for this phenotype was not readily 
available.  Purification of the previously omitted samples was 
attempted through re-precipitation and thorough drying of the pellet 
prior to reconstitution.  Use of a different sample confirmed the 
presence of contamination in the original however precision and high 
Ct values continued to be a problem in this phenotype which possibly 
indicated inhibiting contamination was still present within the 
samples.  Fresh bacteria pellets were prepared and RNA extracted as 
described previously.  Fresh RNA samples were measured by 
NanoDropTM 2000 and were assessed using a 2% agarose gel as 
described previously.  Unexpectedly the samples were found to be 
degraded following extraction.  This had not been a problem prior to 
this and was hence attributed to contamination within some of the 
reagents used to precipitate RNA following DNase treatment.  
However upon performing another extraction omitting the DNase 
treatment step the samples were degraded again.  Prior to conducting 
further troubleshooting the quantity of master mix left was assessed 
and it was concluded that there was not a sufficient amount to allow 
the optimisation of the assay and the obtaining of reliable results.  
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Unfortunately budget constraints meant that more PCR master mix or 
reagents for RNA extraction could not be obtained.  
In conclusion, the design of primers for the low GC content genes of 
S. equi is challenging and the primers utilised for this project were 
likely not optimal.  In addition to this the low copy number of the 
target genes likely contributed to the low precision and high Ct values 
obtained.  Beyond budget constraints it would be desirable to start 
from scratch in order to take the time to test variations in primer 
criteria and their effectiveness.  Also rather than using a commercial 
master mix kit it would be preferable to attempt to design a bespoke 
master mix where the concentrations of components such as 
magnesium (Mg+2) which can affect the efficiency of DNA 
polymerase enzyme may be adjusted as required and possibly the 
maximum template concentration may be higher than 100 ng.  
Different DNA polymerases are also more or less resistant to 
inhibitors and so the ability to find the appropriate enzyme for the 
purpose of this study would improve the likelihood of success.  
PCR and RT-PCR has been utilised frequently for the identification of 
S. equi species in both diseased and asymptomatic horses (Webb et 
al., 2013; North et al., 2014; Boyle et al., 2016; Pusterla et al., 2018).  
They have also been employed for transcription analyses for a variety 
of genes including those involved in HA synthesis (Chen et al., 
2009b; Prasad, Ramachandran and Jayaraman, 2012; Steward, 
Robinson and Waller, 2016).  Where possible (such as for gyrA), 
primer sequences previously detailed in literature were used under the 
premise that they were adequate due to their acceptance for 
publication, as details of their efficiency had not been described.  It 
has been suggested that methods in studies utilizing RT-PCR and 
qPCR fail to be adequately reported in detail such that they might be 
useful, despite the publication of MIQE guidelines for reporting of 
PCR experiments (Bustin et al., 2009; Bustin, 2017).  The lack of 
information available on specific conditions such as primer efficiency 
and volumes of reaction components in studies involving the S. equi 
species reinforces this notion.  Therefore whilst the genes involved in 
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HA production have previously been analysed using PCR methods, 
not enough information was available to assist in the development of 
the assay for this study.  In addition, whilst PCR has been utilised to 
amplify both murA paralogs for mutagenesis and overexpression (Du 
et al., 2000; Marcellin, Chen and Nielsen, 2010), the real time gene 
expression of the paralogs has not yet been investigated, possibly due 
to the complexity of specific primer design experienced within this 
study.  
Despite the difficulties in obtaining gene expression results the work 
in this chapter was able to demonstrate that whilst the S. equi species 
can be classed as susceptible to Phosphomycin under the conditions 
tested it is possible to supplement the media with non-inhibitory 
concentrations in order to test the effects of the antibiotic on other 
metabolic pathways.  Whilst supplementation of growth media with 
the antibiotic did not have the expected effects on HA production, it is 
possible this was due to the implementation of resistance mechanisms 
and further work is needed to examine this.  Future work will be 
discussed in Chapter 6. 
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5. Targeted proteomic comparison of S. equi strains 
5.1. Introduction 
Subspecies of Streptococcus equi are responsible for severe instances of disease 
in domesticated animals.  Whilst S. equi subsp. equi is restricted to horses, S. 
equi subsp. zooepidemicus is a commensal organism and opportunistic 
pathogen in a wide range of hosts and instances of human infection have 
occurred (Timoney, 2010).  S. equi subsp. equi is the pathogen responsible for 
Strangles, the most commonly observed infectious disease in horses, which 
affects lymph nodes in the head and neck and is highly contagious (Waller, 
Paillot and Timoney, 2011).  Following the resolution of symptoms the bacteria 
are capable of persisting within the guttural pouch of the animal for up to 6 
weeks in 50% of cases without detection unless by an invasive method such as  
lavage (Harrington, Sutcliffe and Chanter, 2002).  S. equi subsp. zooepidemicus 
is capable of causing Strangles in horses, however it is also responsible for 
causing a variety of diseases in an array of hosts, such as mastitis in sheep, 
goats and cattle and respiratory diseases like pneumonia in ruminants, pigs and 
dogs and nephritis, septicaemia and meningitis in humans whom it may be 
transmitted to through contaminated dairy products (Steward et al., 2017).   
Virulence factors of S. equi subsp. equi include the HA capsule, Streptokinase, 
Streptolysin S and antiphagocytic M protein (SeM).  These are also present in 
S. equi subsp. zooepidemicus with the exception that an M-like protein (SzP) is 
present instead of SeM and the two proteins function slightly differently from 
each other.  In addition, homologues of other surface proteins are present in 
both subspecies (Timoney, 2004).  Both subspecies share around 80% genome 
homology with the human pathogen S. pyogenes (Holden et al., 2009) and 
upwards of 96% genome homology with each other (Timoney, 2004).  As such 
it has been speculated that S. equi subsp. equi and S. equi subsp. zooepidemicus 
evolved from a common ancestor (Waller, Paillot and Timoney, 2011).    
In 2004, a previously unclassified gram positive cocci with >70% genetic 
identity with S. equi subsp. equi and S. equi subsp. zooepidemicus was isolated 
during a routine bacteriological study investigating causative agents of mastitis 
in small ruminants. Following phenotypic, biochemical and genetic analysis the 
organism was proposed to be a new species and designated Streptococcus equi 
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subsp. ruminatorum (Fernandez et al., 2004). Following that publication the 
strain was attributed to Strangles-like disease affecting spotted hyenas and 
plains zebras in Tanzania, where several clones of the strain were identified 
throughout the wild population (Honer et al., 2006). A study following these 
strains then attempted to establish differences and similarities of these wildlife 
strains to the originally isolated strain by Fernandez et al. (2004) as well as type 
strains of S. equi subsp. equi and S. equi subsp. zooepidemicus using 
biochemical and molecular biological methods. Previously in this study it was 
revealed through HPLC assessment of culture media that SER17037 is a 
competent producer of HA capsule and competes sufficiently with the currently 
used industrial strain in terms of production according to OD (Chapter 2, Table 
8).  Whilst further investigation into SER17037 fermentation is required, the 
results suggest it may be a suitable strain for industrial production of hyaluronic 
acid and further characterisation is warranted.   
Protein composition (proteome) is a useful way to assess phenotype variations 
and differences between strains.  Differences and similarities in chemical 
characterisation, 16S rRNA sequence and M-like protein sequence between S. 
equi subsp. ruminatorum and the other S. equi strains were reported previously 
(Speck et al., 2008), however the comparison of protein profiles were not 
presented and little more has been published about this novel subspecies of S. 
equi.  S. equi subsp. ruminatorum DSMZ strain 17037 was obtained as a 
comparison strain in this work.  Notably, phenotypic variants have been 
observed in this work (Chapter 2) for both SE40327 and SER17037 and the 
protein profiles of variants were analysed to compare whole cell protein profiles 
between strains of S. equi as well as differences between capsulated and un-
encapsulated variants.  Both SEE20561 and SEZ20727 have previously 
behaved as non-producers of HA under the conditions used in this study.  
The most established method for analysing the protein content of bacteria cells 
is SDS-PAGE gel, (Emerson et al., 2008).  The resulting profile is a series of 
bands, often each band corresponds to more than one type of protein of similar 
size.  The method has been successfully used in the analyses of both surface 
and internal proteins of bacteria (including Streptococci) as well as being used 
as a tool for distinguishing between and within bacterial species (Sheriff and 
Mahendraku, 2015).  Using this method to identify bacteria species has been 
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described as fast, easy and inexpensive, and there have been reports that results 
of SDS-page profiling correspond to results of DNA/DNA or 16S rRNA based 
hybridization assays (Singhal, Maurya and Virdi, 2019).  
In this Chapter the whole cell protein profiles of the strains described in 
Chapter 2 were compared along with an additional mucoid strain obtained from 
Hyaltech Ltd designated WS2/37. As previously mentioned, two phenotypes 
have been observed for SE40327 and SER17037, these were designated mucoid 
variants (MV) and non-mucoid variants (NMV).  The phenotypes were 
separated and repeatedly passaged on agar to determine whether reversion to 
the alternate phenotypes occurred (data not shown).  Agar was also switched 
between sulphur limited, 5% horse blood and BHI media.  No phenotype 
switching was observed following up to 9 passages.  The whole cell protein 
profiles of both types were separately compared for each of these strains.  
5.2. Materials and Methods 
5.2.1. Protein extraction 
Bacteria were grown on sulphur limited agar plates at 37°C for 48 hours.  
Single colonies were inoculated into 50 mL of 37°C BHI media and 
incubated over night with 150 RPM shaking.  The optical density at 660 
nm was measured and each culture was corrected to 0.5-0.6 in 37°C BHI 
media.  For the mucoid strains, 1x volume of 0.2 mg/mL hyaluronidase in 
BHI was added and the cultures incubated for a further 30 minutes to 
remove capsule.  The cultures were then centrifuged at 4969 x g for 10 
minutes.  Pellets were washed twice in 500 µL PBS with centrifugation at 
4969 x g in between washes.  Pellets were then resuspended in 200 µL lysis 
buffer (60mM Tris, pH 8; 10mM MgCl2; 50μM CaCl2; 20μL/mL DNase 
and RNase) and 10 µL (250 U) of Mutanolysin (Sigma-Aldrich) was 
added.  Following 1 hour incubation at 37°C the samples were placed in -
80°C for 1 hour.  Samples were thawed at 37°C and a further 4 µL of 
DNase and RNase was added and incubated at 37°C for 30 minutes.  SDS 
(20 µL) was added to a final concentration of 0.5 % and the samples were 
placed in a water bath at 90 °C for 30 minutes.  Remaining debris was 
removed by centrifugation at 4969 x g for 5 minutes and the supernatant 
was transferred to a fresh 1.5 mL Eppendorf tube.  The same volume of 
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Tris-Glycine SDS sample buffer (2X) (NovexTM) was added and the 
samples were boiled for 2 minutes before being stored at -20°C until use.  
Samples were run on 12% Tris-Glycine Plus Midi gels (Invitrogen) at 175 
V for 1 hour and 30 minutes.  A PageRulerTM unstained protein ladder 
(Thermofisher) was used, 5 µL of ladder and 10 µL of protein sample was 
used for each well.  Completed gels were washed three times for 5 minutes 
in deionised water and stained with SimplyBlue™ SafeStain 
(Thermofisher) overnight.  The stain was then removed and the gels 
washed in deionised water until the background was clear and the bands 
were visible.  Gel were imaged using a Gel Doc EZ Imaging System and 
photographs taken with Image Lab Software (Biorad). 
5.2.2. Proteomic analysis 
The selected strains from the whole protein profile gels were SEZ20727 
and SER17037 both mucoid and non-mucoid phenotypes.  These were run 
on a separate gel under the same conditions but with empty lanes 
separating them as per figure 42 to minimise potential sample spillover.  
The gel samples were then submitted to the Moredun Proteomic Facility 
(MPF) for analysis of the highlighted bands by ion trap liquid 
chromatography-mass spectrometry (LC-MS/MS) using an electrospray 
ionisation (ESI) interface.  This was carried out using methods detailed 
previously (Hamilton et al., 2018).  The gel bands of interest were isolated 
by cutting from the gel before being destained, reduced, alkylated and 
digested using trypsin as per the procedure used by Shevchenko et al., 
(1996).  The digested protein samples were then transferred to low-protein-
binding high-performance liquid chromatography (HPLC) sample vials.  
The LC-MS/MS-ESI was carried out using the Ultimate 3000 nano-HPLC 
system (Dionex) containing a WPS-3000 well-plate micro auto sampler, a 
UVD-3000 UV detector, a FLM-3000 flow manager and column 
compartment,  an LPG-3600 dual-gradient micro-pump and an SRD-3600 
solvent rack controlled by the chromatography software Chromeleon™ 
(Dionex).  Sample volumes of 4µL were directly injected.  The final flow 
rate was maintained at 3 μl/min-1 through a 5 cm × 200 μm ID 
(polystyrene-divinylbenzene) monolithic reversed phase column (Dionex) 
sustained at 50 °C.  Peptides were eluted using a 15 min linear gradient 
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from 8–45% solvent B (80% acetonitrile, 0.1% (v/v) formic acid) and were 
conducted through a 3 nl UV detector flow cell.  For the process of ESI an 
interface of a 3-D high capacity ion trap mass spectrometer (amaZon-ETD, 
Bruker Daltonics) with a low-volume stainless steel nebuliser (50 μl/min-1 
max)  (Agilent).  Tandem MS parameters utilised in this study are 
previously described (Batycka et al., 2006).  Proteins were identified using 
both the NCBI eubacteria database and the RAST annotated genomes of 
the strains of interest (See Chapter 3).  Protein identifications were 
accepted if a minimum of two peptides were successfully identified and 
these peptides were represented by a minimum of four amino acid residues 
as an unbroken series of either b or y ions. 
5.3. Results 
5.3.1. Whole cell protein profile of S. equi strains 
Figure 46 displays the whole cell protein profiles for the strains of interest 
in this study (SE40327, SEE20561, SEZ20727 and SER17037), labelled by 
their respective numbers, as well as mucoid (MV) and non-mucoid (NMV) 
variants of two of the strains (SE40327 and SER17037).  Strains 40327, 
40327MV, 40327NMV and WS3/37 are all working stocks of the same 
strain used in the industrial production of HA.  From the figure it is 
observed that 40327 has a highly similar protein profile to 20561 and no 
obvious differences exist between 40327, 40327MV, 40327NMV and 
WS2/37.  The profile of 20727 while also similar to 40327 appears to be 
slightly divergent in some areas, with the most obvious difference being the 
presence of bands higher up in the profile 85-100 kDa than for 40327 
indicating the presence of some larger proteins, and a few areas of 
increased band thickness and clustering.  Strain 17037 appears to possess 
slight variations in profile from both S. equi subsp. equi and S. equi subsp. 
zooepidemicus strains.  Most notably there is the presence of two very 
thick, intense bands between 10-15 kDa size mark as well as a greater 
number of bands present below 10 kDa than in the other strains.  No 
obvious differences in banding pattern are observed between 40327 mucoid 
and non-mucoid phenotypes.  However the mucoid and non-mucoid 
variants of 17037 displayed some differences in profiles, most obviously 
the presence of a band in the mucoid variant about midway between 
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markers for 25 and 40 kDa which is not mirrored in the non-mucoid variant 
but appears to also be present at that approximate position in SEZ20727. 
  
 
Figure 46 Whole cell protein profiles of S. equi strains of interest.  Strains investigated were 
SE40327, SEE20561, SEZ20727, both mucoid (MV) and non-mucoid (NMV) phenotypes of 
SER17037 and SE40327 as well as a working stock which was claimed to have produced HA of 4.2 
MDa (WS2/37).  
5.3.2. Protein identification in bands of interest 
As a result of the whole cell protein profiling of the strains a few bands of 
interest were noted and targeted for further investigation.  The first was the 
band present in the mucoid phenotype of SER17037 but not in the non-
mucoid phenotype of this strain.  Secondly the distinctly intense bands at 
around 10-15 kDa size mark in both phenotypes of SER17037 which were 
not evident in any of the other strains.  Hence these bands were selected for 
protein identification.  The equivalent bands on SEZ20727 were also 
selected for analyses in order to compare the two strains.  The gel 
submitted to Moredun Proteomic facility is displayed in figure 47 and the 
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bands isolated for protein identification are highlighted and assigned 
identifications.  
 
Figure 47 Protein gel of SEZ20727 and SER17037 mucoid and non-mucoid strains for 
proteomics analyses.  Samples were run with single lane spaces between them to facilitate band 
isolation and extraction.  The bands of interest isolated from the gel are indicated by the red boxes 
and arrows. 
Table 13 and 14 display the proteins identified by both NCBI and RAST 
for the corresponding bands SEZ20727-1 and SER17037-1.  Foldase PrsA 
was identified in both bands using both databases.  SEZ20727-1 was also 
established to contain ATP-dependent 6-phosphofructokinase, a 
ribonucleotide reductase and a dipeptidase by NCBI and in addition the 
RAST annotation identified an enolase and a branched-chain amino acid 
aminotransferase.  In SER17037-1 a peptidase and a hypothetical protein 
was identified using both databases and a peptidase identified using NCBI. 
Meanwhile the RAST annotated genome identified a protein matching to 
peg1459 was which corresponds to an antiphagocytic M protein.  
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Table 13 Protein identifications for band SEZ20727-1.  This table displays the list of proteins 
identified from the RAST annotation of the SEZ20727 genome sequence as determined using 
Mascot 2.5.1 with MOWSE scores, % sequence cover and number of peptides identified. 
 
 
Table 14 Protein identifications for band SER17037-1.  This table displays the list of proteins 
identified from the RAST annotation of the SER17037 genome sequence as determined using 
Mascot 2.5.1 with MOWSE scores, % sequence cover and number of peptides identified. 
A larger number of proteins were identified in SEZ20727-2 (Table 15) 
compared to SEZ20727-1.  Along with two hypothetical proteins and two 
proteins assigned as elongation factor Tu, NCBI Eubacteria database 
identified superoxide dismutase, Gls24 family stress protein, ribosomal 
protein L4 and a Uracil phosphoribosyltransferase.  These four proteins 
were also identified in the RAST annotation as well as a ribosome 
recycling factor, alkyl hydroperoxide reductase protein C, an elongation 
factor Tu and a predicted 4-deoxy-L-threo-5-hexosulose-uronate ketol-
isomerase.  Superoxide dismutase was also identified in SER17037-3 and 
SER17037-5 as well as partial sequence being identified in SER17037-2.  
Additionally for SER17037-2 an YSIRK-type signal peptide containing-
protein and another hypothetical protein were identified using the NCBI 
Eubacteria database whereas RAST only identified a hypothetical protein 
and antiphagocytic M protein.  SER17037-2 and SER17037-4 are 
corresponding bands between mucoid and non-mucoid phenotypes of 
SER17037.  The proteins identified in SER17037-4 were YSIRK-type 
signal peptide containing-protein, ribosomal protein s4 and a hypothetical 
protein as well as antiphagocytic M protein identified using the RAST 
SEZ20727-1
RAST identification MOWSE score % Cover No. peptides
6-phosphofructokinase 968.70 68.50 8
Foldase protein prsA 1 precursor 224.37 25.20 3
Ribonucleotide reductase of class Ib, beta subunit 215.84 16.90 3
Branched-chain amino acid aminotransferase 160.42 25.30 2
Proline dipeptidase 84.23 6.60 2
Enolase 64.07 8.50 2
SER17037-1
RAST identification MOWSE score % Cover No. peptides
Antiphagocytic M protein 755.72 22.80 10
FIG01118337: hypothetical protein 391.49 31.70 4
Foldase protein prsA 1 precursor 126.31 13.20 2
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annotated genome.  This corresponds partially to the identifications of the 
proteins in SER17037-2.   
SER17037-3 and SER17037-5 are also corresponding bands on the protein 
gel between phenotypes.   The following proteins were identified in both 
bands.  Superoxide dismutase, antiphagocytic M protein, YSIRK-type 
signal peptide containing-protein, ribosome recycling factor and general 
stress proteins of the Gls24 family.  Additionally identified in SER17037-5 
were ribosomal protein L4, elongation factor Tu and hypoxanthine 
phosphoribosyltransferase.  Both bands also contained a hypothetical 
protein.  
 
Table 15 Protein identifications for band SEZ20727-2.  This table displays the list of proteins 
identified from the RAST annotation of the SEZ20727 genome sequence as determined using 
Mascot 2.5.1 with MOWSE scores, % sequence cover and number of peptides identified. 
 
 
Table 16 Protein identifications for band SER17037-2.  This table displays the list of proteins 
identified from the RAST annotation of the SER17037 genome sequence as determined using 
Mascot 2.5.1 with MOWSE scores, % sequence cover and number of peptides identified. 
 
 
Table 17 Protein identifications for band SER17037-3.  This table displays the list of proteins 
identified from the RAST annotation of the SER17037 genome sequence as determined using 
Mascot 2.5.1 with MOWSE scores, % sequence cover and number of peptides identified. 
SEZ20727-2
RAST identification MOWSE score % Cover No. peptides
Manganese superoxide dismutase 643.69 68.70 9
General stress protein, Gls24 family 458.90 51.40 6
Ribosome recycling factor 372.10 49.20 5
predicted 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase 364.04 34.30 5
LSU ribosomal protein L4p (L1e) 327.41 41.10 4
Uracil phosphoribosyltransferase 183.99 21.40 4
Translation elongation factor Tu 124.96 5.80 2
SER17037-2
RAST identification MOWSE score % Cover No. peptides
Antiphagocytic M protein 1007.05 24.20 5
FIG01118337: hypothetical protein 207.52 15.30 2
SER17037-3
RAST identification MOWSE score % Cover No. peptides
Antiphagocytic M protein 962.99 22.80 6
Manganese superoxide dismutase 777.26 67.70 10
Ribosome recycling factor 364.73 43.80 2
General stress protein, Gls24 family 190.26 27.90 3
FIG01118337: hypothetical protein 108.66 6.90 2
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Table 18 Protein identifications for band SER17037-4.  This table displays the list of proteins 
identified from the RAST annotation of the SER17037 genome sequence as determined using 
Mascot 2.5.1. 
 
 
Table 19 Protein identifications for band SER17037-5.  This table displays the list of proteins 
identified from the RAST annotation of the SER17037 genome sequence as determined using 
Mascot 2.5.1. 
 
5.4. Discussion 
Whole cell protein profiling is an approach which can be used to distinguish 
within bacteria species or strains.  The most established method involves 
running extracted proteins on an SDS-PAGE gel which separates them based on 
molecular weight and produces a pattern of bands as seen in fig 41 (Emerson et 
al., 2008).  As previously mentioned, S. equi subsp. ruminatorum is a novel 
strain which was originally isolated in 2004 from mastitis found in small 
ruminants (Fernandez et al., 2004).  Since then it has not been mentioned often 
in literature.  A study in 2008 which isolated and identified this strain in hyenas 
and zebras performed some characterization of this strain, however not all 
results were reported in full, including the results of whole cell protein profiling 
(Speck et al., 2008).  For the purpose of this study S. equi subsp. ruminatorum 
CECT 5772 was acquired from DSMZ (DSMZ no. 17037) as a comparison 
strain to SE40327 as it is reportedly mucoid in phenotype.  Upon receipt and 
culture of this strain it was observed that two phenotypes were present (2.3.1 
figure 6).  The strains displaying both phenotypes were separated and passaged 
SER17037-4
RAST identification MOWSE score % Cover No. peptides
Antiphagocytic M protein 892.43 22.40 7
SSU ribosomal protein S4p (S9e) 328.59 33.50 4
FIG01118337: hypothetical protein 81.11 8.70 2
SER17037-5
RAST identification MOWSE score % Identity No. peptides
Manganese superoxide dismutase 1019.76 82.10 8
Antiphagocytic M protein 831.16 22.40 7
LSU ribosomal protein L4p (L1e) 428.12 41.10 6
General stress protein, Gls24 family 358.41 32.40 5
Ribosome recycling factor 320.69 39.50 4
Translation elongation factor Tu 140.94 13.80 3
Hypoxanthine-guanine phosphoribosyltransferase 89.56 11.10 2
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multiple times on a variation of sulphur limited agar, brain heart infusion agar 
and horse blood agar, however no reversion was seen in either case.  As 
previously mentioned, mucoid and non-mucoid phenotypes have also been 
observed for SE40327.  Comparison of these two variants formed part of this 
preliminary proteomic investigation.  
5.4.1. Protein profiles of S. equi strains 
Since two strains displayed more than one phenotype, both mucoid and 
non-mucoid phenotypes were compared as well as comparing the protein 
profiles of SE40327 to SEE20561, SEZ20727 and SER17037.  WS2/37 
was a working stock donated from Hyaltech which had produced HA of 4.2 
MDa on two separate occasions during production.  It was hypothesised 
that SE40327 would produce a migration band pattern most similar to S. 
equi subsp. equi strain and that SEE20561, SEZ20727 and SER17037 
would all produce different banding patterns.  This was the first time 
protein profiling data had been presented comparing S. equi subsp. 
ruminatorum to other S. equi subspecies.  All strains were similar in 
banding pattern, with SE40327 most closely matching SEE20561 as 
expected.  Whilst SEZ20727 and SER17037 were similar to SE40327 and 
SEE20561 there were subtle differences such as prominent bands at smaller 
molecular weights (<80 kDa) in SEZ20727 which were not present in S. 
equi subsp. equi strains.  SER17037 presented banding patterns which were 
different to both S. equi subsp. equi strains and SEZ20727.  This result was 
considered to support conclusion that SE40327 is a strain of S. equi subsp. 
equi when considered alongside the results of the genome sequencing 
previously described.  One of the stand out features of the migration pattern 
of SER17037 was the presence of particularly thick and intense bands 
around 10-15 kDa in size which were not nearly as prominent in any of the 
other strains.  Whilst no obvious differences between mucoid and non-
mucoid phenotypes in SE40327 were observed, in SER17037 there was a 
band observed 40-45 kDa in the mucoid phenotype which did not appear to 
be present in the non-mucoid.  This band coincided with a band in the 
SEZ20727 profile indicating similar sized proteins within this strain.  As a 
result of these observations the bands described were submitted for 
proteomic analysis using LC-MS/MS.    
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5.4.2. Protein identification in selected SDS-page bands 
The use of ESI-MS for protein identification increases the accuracy over 
other methods such as matrix-assisted laser desorption/ionisation time-of-
flight mass spectrometry (MADLI-TOF-MS) because it is possible to 
perform more than one fragmentation on the sample, allowing for a peptide 
fingerprint to be determined and compared to a database of proteins 
(Emerson et al., 2008).  Moredun Proteomics Facility has provided 
proteomics support for many similar investigations of bacteria (Bannoehr 
et al., 2011; Watson et al., 2014a; Watson et al., 2014b; Shahin et al., 
2018). As indicated in these publications and previously explained, protein 
identifications were only considered accurate if a minimum of two peptides 
were identified by a series of four or more amino acid residues represented 
by as an unbroken series of either b or y ions.  The search engine used was 
Mascot 2.5.1 (Matrix Science) which is a software for identification, 
characterisation and quantitation of proteins using mass spectrometry data. 
It was used to search NCBI Eubacteria database as well as the RAST 
annotations of the sequenced genomes.  In some cases the proteins 
identified were different between databases.  As the RAST annotation is 
specific to the genomes of the strains investigated this was regarded as the 
more accurate tool for protein identification from the amino acid sequences 
determined by ESI-MS, with the NCBI identifications provided as 
supplementary material (Appendix C).  
5.4.2.1. Foldase PrsA 
A protein which was identified in both the band from the mucoid 
strain of SER17037 (SER17037MV) and the corresponding band in 
SEZ20727 was foldase PrsA precursor.  This protein is found 
ubiquitously in all gram-positive bacteria and is responsible for 
folding exported proteins into their final functional configurations 
(Scott and Barnett, 2006).  Whilst there is not an abundance of 
literature about PrsA in Streptococcus it has been investigated briefly 
in S. mutans where it was found that strains deficient in this protein 
displayed diminished early biofilm formation as well as indications 
that PrsA deficiency affected glucosyltransferases (Guo et al., 2012).  
Whilst it is accepted that protein folding is crucial for correct 
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localisation of membrane proteins and for the successful export of 
fully functioning external proteins, the mechanisms for processing the 
surface proteins of Streptococci are not entirely understood (Crowley 
and Brady, 2016) and so the relevance of the presence of foldase PrsA 
precursor in the 17037MV and SEZ20727 bands and subsequent 
absence of this band in 170327NMV is uncertain.  The few studies in 
S. mutans referenced have produced knockout mutants of PrsA and 
assessed their impact on growth and morphology as well as the effect 
on functionality of excreted proteins and biofilm formation.  As the 
PrsA-deficient mutant of S. mutans developed by Guo et al. (2012) 
presented reduced synthesis of glucan, which was thought to be 
caused by impeded translocation of glucosyltransferase enzymes 
involved in production of glucan and other extracellular 
polysaccharides, the development of a knockout mutant of PrsA in S. 
equi would help determine whether this protein may also play a role 
in hyaluronic acid production through modulation of the enzymes 
involved either directly with its synthesis or in competing pathways.  
Hyaluronan synthase is a membrane integrated glycosyltransferase 
(Bi et al., 2015) but the process of its integration into the membrane 
upon synthesis has not previously been revealed.  Foldases such as 
PrsA are responsible for the maturation and folding of proteins 
destined for the cell membrane (Jakob et al., 2015), so it could be 
speculated that foldases may play a role in the membrane integration 
of the hyaluronan synthase enzyme.   
5.4.2.2. Antiphagocytic M-like protein 
In addition, SER17037-1 was identified as containing Antiphagocytic 
M-protein.  The molecular weights of M-like protein in S. equi subsp. 
zooepidemicus and S. equi subsp. equi were previously found to be 39 
and 59 kDa respectively (Timoney, Artiushin and Boschwitz, 1997), 
however the SER17037-1 band is below 40 kDa in size, indicating 
that either the M-like protein of S. equi subsp. ruminatorum is smaller 
than that of other S. equi species or that this band contains a 
fragmented molecule.  The  identified sequence in SER17037-1 did 
not appear to align well with the sequence previously characterised as 
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M-like protein in this strain (Appendix D) (Speck et al., 2008), 
however the sequence previously characterised is only partial and as 
discussed below divergence of the sequences of this protein is not 
uncommon.  A BLAST of the RAST annotated sequence in NCBI 
resulted in a 100% match of 100% query cover to a protein in S. equi 
subsp. ruminatorum CECT 5772 annotated as “streptococcal 
protective antigen” (accession number KED04751.1).  Additionally 
the sequence matched 100% to 90.44% of the query to a sequence for 
M-like protein in S. equi subsp. zooepidemicus (accession number 
AHA95473.1).   The M protein has been found to vary significantly in 
size between serotypes and even between strains within serotypes, an 
occurrence which is speculated to be due to the large number of 
repeats present within the gene (Fischetti, 2016).  Also the 
hypervariability of the M protein sequence has in the past allowed for 
differentiation between strains of S. pyogenes (Metzgar and Zampolli, 
2011), suggesting that significant variation between subspecies is not 
an unusual occurrence. A comparison of the proteins sequences of 
genes annotated in RAST as M-like proteins for strains of S. equi 
species is presented in Figure 48.  
 
125 
 
 
Figure 48 Protein sequence comparison of M-like proteins of S. equi species.  Protein 
sequences of S. equi subsp. equi strain 4047 (SEE4047), S. equi subsp. zooepidemicus ATCC 
35246 (SEZ35246) and S. equi subsp. ruminatorum (SER17037) were identified using RAST 
annotated genomes and compared using Multalin online software.  The position of the LPST 
motif is indicated by underlining at positions 566-569. 
As previously mentioned the data from whole cell protein profiling of 
this strain was described but not presented, therefore this is the first 
demonstration of the protein profile of S. equi subsp. ruminatorum.  
The high intensity of the bands observed in both phenotypes of 
SER17037 at 10-15 kDa prompted investigation by ESI-MS as this 
was distinctive to this strain.  SER17037-2 and SER17037-4 were 
corresponding bands between mucoid and non-mucoid phenotypes of 
SER17037 respectively.  Antiphagocytic M protein was identified in 
both of these bands, as was a protein which was confirmed as 
hypothetical in both the RAST annotation and NCBI eubacteria 
database.  Once again the molecular weight of this band is far below 
that expected for Antiphagocytic M protein which possibly suggests 
fragmentation or processing.  SER17037-3 and SER17037-5 
correspond to the lower intense bands in the mucoid and non-mucoid 
phenotypes respectively and antiphagocytic M protein was also 
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identified in these bands but not in the corresponding sized band in 
SEZ20727-2.   
The M protein is a surface protein identified in Group A 
Streptococcus (GAS) such as S. pyogenes and has been widely studied 
due to its established role as one of the main virulence factors 
(Smeesters, McMillan and Sriprakash, 2010).  The GAS M protein 
covers the surface of the cell and provides protection from innate 
immune responses.  This protective ability is further enhanced by the 
hypervariable region located at the N terminus of the protein which is 
a target for antibodies but varies in sequence between serotypes 
(Ghosh, 2018).  It also has a role in colonisation and adhesion during 
the establishment of infection within the host (Brouwer et al., 2016).  
S. equi subsp. equi and S. equi subsp. zooepidemicus also produce 
proteins which show homology to the M protein of S. pyogenes, these 
are designated M-like proteins (Harrington, Sutcliffe and Chanter, 
2002).  Similarly to S. pyogenes, these proteins have been shown to 
play a role in virulence by means of augmenting evasion of host 
immune system and adherence and colonisation of the host (Libardoni 
et al., 2013).  Whilst the sequence detected in the protein bands of 
interest in SER17037 were identified by RAST as Antiphagocytic M 
protein, a number of other genome sequences were annotated as M or 
M-like proteins in this strain.  These sequences have been annotated 
in NCBI as various proteins such as protective antigen-like protein, 
Emm-like cell surface protein, antiphagocytic M-like protein, YSIRK-
type signal peptide containing protein, cell surface-anchored protein 
and fibrinogen-binding cell surface anchored protein highlighting 
inconsistency in annotations.  The sequence identified in the 
SER17037 protein band and the sequence which was RAST annotated 
as antiphagocytic M-like protein were searched in NCBI Blast with 
the search constrained to S. pyogenes and interestingly the former 
identified more closely with an S. pyogenes M protein at 37.92% 
identity of 46% query cover compared to 29.32% identity of 29% 
query cover.  This indicates that although the latter sequence was 
annotated as an antiphagocytic M-like protein and the protein band 
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sequence as a protective streptococcal antigen of S. equi subsp. 
ruminatorum in NCBI, the streptococcal antigen protein is actually 
closer in sequence to the M protein of S. pyogenes.  Whilst the 
genome of S. pyogenes strain TJ11-001 contains only one gene 
designated as M-protein, the genomes of all the S. equi strains 
possessed many genes which are annotated as M-like proteins.  Of the 
genes annotated this way in SER17037 none possess more than 
25.65% identity to 98% of the S. pyogenes sequence.  Similar results 
were seen when comparing the sequences from SEE4047 and 
SEZ35246 (data not shown).  It is possible that not all of the genes 
annotated in the S. equi species are functional, however as it has been 
previously reported that S. equi subsp. equi possesses two types of M-
like protein (Segura and Gottschalk, 2005), it is possible that other 
similar proteins exist with unknown functions. Although analysis of 
M-proteins was not an intended aim of this work, this has highlighted 
the need for a more systematic consideration of these significant 
surface proteins of Streptococci.  
5.4.2.3. Superoxide dismutase 
In addition to Antiphagocytic M protein, a Manganese superoxide 
dismutase was identified in SER17037-3 and SER17037-5.  
Superoxide dismutases (SODs) are enzymes involved in protecting 
cells from oxidative stress, they convert potentially damaging 
superoxide ions to hydrogen peroxide (H2O2) and molecular oxygen 
(O2) and whilst bacteria produce many different types of SODs, only 
manganese superoxide dismutase (Mn-SOD) has been identified in 
Streptococci (Staerck et al., 2017).  Evidence suggests that Mn-SOD 
is a virulence factor in group B Streptococcus species S. agalactiae, 
with deficient mutants exhibiting increased susceptibility to bacterial 
killing by macrophages in a mouse model of infection (Poyart et al., 
2001).  Macrophages produce reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) through a mechanism called oxidative 
burst in order to kill bacteria which they have engulfed into 
compartments named phagosomes and so the ability to neutralise 
reactive species may allow the bacteria to persist within the cells 
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(Slauch, 2011).  The presence of this protein is presumably due to the 
fact the strains were grown aerobically with shaking.  Previously a 
proteome analysis of S. equi subsp. zooepidemicus ATCC 35246 
identified SOD in a spot of a 2-DE gel (Marcellin et al., 2009) and 
proteomic analyses of other Streptococcus species have also identified 
SOD under standard growth conditions (Chaussee et al., 2006; Wang 
et al., 2012).   
5.4.2.4. General stress proteins 
Another notable protein identified in SER17037-3 and SER17037-5 
was a General stress protein from the Gls24 family.  The genome for 
SER17037 is available in NCBI (CECT5772) and this sequence is 
annotated as a hypothetical protein (KED05407.1).  A second paralog 
of this gene is also present within the SER17037 genome which is 
also annotated as hypothetical protein (KED05405.1), the two 
paralogs possess 62.59% identity over 60% sequence cover.  A 
BLAST of both sequences results in 100% identity to 100% query 
cover Asp23/Gls24 family envelope stress response protein of S. equi, 
indicating that the corresponding proteins in SER17037 could be 
reannotated.  The definitive function(s) of Gls24 are still obscure.  
However its expression has been associated with multiple stresses 
including those caused by glucose starvation, exposure to bile salts 
and cadmium chloride (CdCl2) as well as zinc and copper exposure 
and oxidative stress and additionally virulence in an endocarditis 
model in mice (Hartke et al., 1998; Svensater, Sjogreen and Hamilton, 
2000; Nannini et al., 2005; Stoyanov et al., 2010).  Proteins within 
this family have an average homology of 60% and in addition they 
have been found to have an average of 30% homology to the alkaline 
stress protein 23 (Asp23) which was discovered in Staphylococcus 
aureus (Giard et al., 2002).  Thus this family of proteins has been 
characterized as the Asp23/Gls24 superfamily and it has been 
speculated that due to their position within operons they may have 
properties as transcriptional regulators (Ferrandiz et al., 2019).  Due 
to the uncertainty around the function of the Gls24 proteins the 
significance of their presence in the distinct protein bands of 
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SER17037 is unclear.  The sequences identified in the RAST 
annotation as Gls24 family stress proteins were identified in the NCBI 
Eubacteria database as a hypothetical protein and a transcriptional 
regulator.  However a BLAST of the sequence corresponding to the 
RAST peg number resulted in a 100% match to Asp23/Gls24 family 
envelope stress response protein of S. equi (accession 
WP_037578388.1).  This protein was also identified in the 
corresponding band of SEZ20727-2, as the cultures were grown to 
stationary phase prior to protein extraction it is not unusual to see the 
presence of this protein as general stress proteins are upregulated 
during this phase of growth (Gottesman, 2019).  It is possible the 
presence of this gene product is detected due to the bacteria being 
grown in batch culture and the proteins being extracted during 
stationary phase where glucose starvation may occur and pH decline 
may induce stress responses.  Previously it has been suggested that 
some stress proteins are involved in responses to multiple stresses 
such as starvation and acid shock (Svensater, Sjogreen and Hamilton, 
2000).  
5.4.3. Major surface structures of S. equi 
Although no obvious links to HA production were observed in the protein 
bands investigated in this chapter the proteins identified appeared to be 
primarily surface based and/or virulence factors.   
5.4.3.1. M-like protein and superoxide dismutase 
Both M protein and HA capsule have long been considered virulence 
factors in S. equi species (Timoney, 2004).  Both have been found to 
be necessary for protection against phagocytosis by immune cells 
(Dale et al., 1996b; Timoney et al., 2014) and HA has been found to 
mediate the adherence of group A Streptococcus cells to human 
keratinocytes through binding of M protein to CD46 (Schrager, 
Rheinwald and Wessels, 1996).  Both of these virulence factors have 
been found to contribute to phase switching to the hyperinvasive 
serotype of S. pyogenes designated M1T1 (Cole et al., 2010) and S. 
equi isolated from asymptomatic horses displayed truncated M 
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proteins and as a result an increased susceptibility to phagocytosis, 
indicating that M protein plays a role in both colonization and 
virulence (Chanter et al., 1999).  The M protein is considered a 
stereotypical example of a surface protein which anchors to the cell 
wall via C-terminal LPXTG motifs (Fischetti, 2016).   
Due to its previously described protective action against bacteria 
killing within the phagosome the superoxide dismutase (SOD) is also 
considered a virulence factor, with mutants deficient in the SodA gene 
suffering enhanced susceptibility to killing by macrophages, 
sensitivity to oxidative stress and decreased pathogenesis in a mouse 
model (Poyart et al., 2001).   As previously mentioned this protein 
could be present due to the conditions used to culture the bacteria.  
5.4.3.2. Foldase PrsA 
Although not considered in itself relevant to HA production, the 
presence of foldase PrsA may be significant due to its involvement in 
post-translational processing of proteins in the extracytoplasmic 
region of the cell (Scott and Barnett, 2006).  PrsA is reportedly found 
in all gram positive bacteria and its functions have been attributed to 
biofilm formation, processing of stress response proteins including 
molecules involved in antibiotic resistance, assembly of virulence 
factors, integration of surface proteins into the cell envelope and even 
the production of polysaccharides such as glucan (Guo et al., 2012; 
Crowley and Brady, 2016).  Hyaluronan synthase is a progressive 
glyosyltransferase which is integrated into the membrane where it 
both synthesises and exports the HA chain (Bi et al., 2015).  HA has 
previously been considered a virulence factor (Wessels et al., 1991; 
Stollerman and Dale, 2008) and whilst the mechanism of its 
production have been extensively studied, little information is 
available on the mechanisms surrounding the synthesis and 
integration of the HAS enzyme.  Whether foldases such as PrsA play 
a role in the folding and cell membrane integration of HAS is 
unknown but could be speculated due to the observed presence in the 
band in the mucoid variant of SER17037 but not the non-mucoid.  
The approximate molecular weight of PrsA is 36 kDa (Jakob et al., 
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2015) which corresponds to the position of the band in the protein gel 
from this study.   
5.4.4. Conclusions 
Despite numerous investigations of HA production by various 
Streptococci, the factors influencing HA production are not all clear.  As 
previously mentioned it has been linked to virulence, but also 
environmental stressors such as glucose availability, oxidative stress, 
mineral availability and pH have been described as influential aspects 
(Chong et al., 2005; Huang, Chen and Chen, 2006; Duan et al., 2008; Liu 
et al., 2008; Don and Shoparwe, 2010; Pires, Eguchi and Santana, 2010).  
Thus it is entirely possible that many factors influencing the production of 
HA in pathogenic bacteria have not been considered.  Whilst the process of 
HA production is a good place to start, it would also be logical to 
investigate the role of the mechanisms involved in the production and 
placement of the enzyme responsible for HA production.  
Whilst the work in this chapter did not provide obvious avenues to follow 
in the elucidation of the mechanism of HA production, it has introduced 
ideas and questions surrounding hyaluronan synthase production, 
processing and integration into the membrane.  Whilst many streptococcal 
surface proteins are anchored to the cell wall at the C terminal using the 
LPXTG motif (Fischetti, 2016), the HAS enzyme possesses numerous 
domains (6 in total) which are associated with the cell membrane (Weigel 
and Baggenstoss, 2012).  The post-translocational folding and integration 
of an enzyme to the membrane at so many domains is likely to be a delicate 
process and whether mis-integration of some of the domains could impair 
function may be speculated.  It has previously been identified that HAS 
activity is regulated by the presence of cardiolipin molecules which are 
associated with the active enzyme (Tlapak-Simmons et al., 1998) however 
the point at which this association occurs and how it is regulated is not 
known.  It is possible that these are aspects concerning HA production 
which have not been investigated in full and further clarification of the 
processes surrounding optimal enzyme function would be beneficial.  
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6. Discussion and Conclusions 
6.1. Fermentation of S. equi species for HA production 
Since its identification in the bovine vitreous humour in 1934, HA has been 
produced through a variety of methods including extraction from human 
umbilical cords, animal sources such as the combs of roosters and most recently 
fermentation of naturally HA producing bacteria (Necas et al., 2008).  As a 
valuable product in the pharmaceutical, cosmetic and biomedical industries 
(Sze, Brownlie and Love, 2016) the development of optimal manufacturing 
procedures is an important area of research.  This study aimed to evaluate HA 
production in a variety of S. equi strains, including a strain currently utilised by 
Hyaltech Ltd in the manufacture of hyaluronic acid based medical devices, S. 
equi NCIMB 40327 and the following strains from DSMZ, S. equi subsp. equi 
20561, S. equi subsp. zooepidemicus 20727 and S. equi subsp. ruminatorum 
17037.   
6.1.1. Advantages and disadvantages over animal production 
Whilst the biotechnological production of HA has predominantly taken 
over from animal extraction, there are a few caveats to it (Badri et al., 
2017) and the extraction of HA from animal sources still continues.  
Rooster combs contain a high concentration of high molecular weight HA, 
however due to ethical concerns, difficulties with the purification processes 
and an increased awareness of threat of cross species virus transmission 
and immune complications resulting from contamination with animal 
protein, the use of HA derived from animal sources is undesirable (Boeriu 
et al., 2013).  Bacterial HA production using pathogenic Streptococci has 
also received some criticism due to risk of contamination from pro-
inflammatory molecules (Liu et al., 2011).  In addition, there are 
limitations to the fermentation process due to the high viscosity of the 
media upon hyaluronic acid secretion, meaning maximum concentrations 
are only 5-10 g/L and the average molecular weight of bacterial HA is 
often lower than that of animal derived (Blank, Hugenholtz and Nielsen, 
2008).  The polydispersity of HA produced by bacteria can pose a 
challenge for the manufacture of products containing the polysaccharide as 
the immunoreactivity of it is specific to the molecular weight, with low 
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molecular weight HA inducing pro-inflammatory responses and high 
molecular weight HA providing anti-inflammatory properties (Cyphert, 
Trempus and Garantziotis, 2015).   
As such there are advantages and disadvantages to HA derived from both 
animals and bacteria.  Most certainly in order to remain ethical the use of 
animals should cease.  There appears to be promise in the area of 
biosynthetic HA production using non-pathogenic bacteria such as B. 
subtilis, L. lactis and E. coli engineered with the HA synthesis machinery 
from naturally producing strains (Yu and Stephanopoulos, 2008; Sheng et 
al., 2009; Kaur and Jayaraman, 2016; Zhang et al., 2016), however while 
HA is produced successfully the concentrations and molecular weights of 
the product are often greatly reduced compared to production in the 
indigenous species.   
Therefore the fermentation of natural HA producers such as Group C 
Streptococci is at present considered the most adequate option for HA 
production for a variety of products.  Many studies have been conducted on 
HA production in Streptococcus species concerning media type and culture 
conditions such as temperature, pH and dissolved oxygen content as well as 
other parameters such as shear stress and nutrient levels (Armstrong, 
Cooney and Johns, 1997; Duan et al., 2008; Liu et al., 2008; Velineni and 
Timoney, 2015; Zakeri and Rasaee, 2016), however many of these studies 
have focussed on an engineering approach.  The fact that HA production 
likely did not develop in the bacteria being investigated for the purpose of 
human interest appears to have been largely ignored.   
For this reason the present study aimed to attempt to return to the question 
of HA production by Streptococci from the bacteriological perspective in a 
bid to unravel the role of HA production in the complex system of 
pathogenic bacteria.  
6.1.2. The fastidious nature of Streptococcus 
Fastidious bacteria are those which have specific requirements for growth.  
Streptococci are facultative anaerobes which vary in nutritional 
requirements between strains due to the variation in the hosts targeted 
(Timoney, 2010).  Both group A and C Streptococci are particularly 
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demanding with regards to organic nitrogen requirements, resulting in yeast 
extract, casein hydrolysate and peptones being common components for 
culture media for these bacteria alongside supplementation such as 
phosphate salts and magnesium (Armstrong, Cooney and Johns, 1997).  
Whilst these components are present in the media used in this study, 
occasions of absence of growth did occur and was likely due to reasons 
such as the media temperature when inoculated or the fitness of the cultures 
prior to frozen stock preparation.  In the case of the original master stock of 
SE40327, the freeze dried culture was revived at NCIMB 
(https://www.ncimb.com/) where the collection was catalogued and 
delivered in two agar slants.  Upon receipt of the slants growth was 
extremely minimal and only the growth from one of the slants was 
successfully transferred to and grown in liquid media before glycerol 
stocks were prepared.  With regards to the other strains the bacteria were 
grown overnight in media for the preparation of glycerol stocks meaning 
they were likely in stationary phase of growth at time of freezing.  Due to 
any number of the above mentioned conditions on some occasions frozen 
stocks were unsuccessfully revived on agar plates.  On some occasions 
growth on agar was successful but upon colony transfer to liquid media 
growth was then absent following a period of culture time, an occurrence 
which is also experienced during the industrial process which can cause 
delays to production.  Although not deemed a requirement at the outset, a 
recommendation would be the adoption of more standardised stock culture, 
storage and starter culture procedures to improve batch-to-batch 
consistency.  
6.1.3. Current production procedure and its challenges 
As previously discussed, fermentation of HA by Streptococci is most often 
carried out using a batch mode of fermentation (Armstrong and Johns, 
1997; Liu et al., 2011).  However the process modelled in this study is 
carried out in continuous culture for reasons mentioned in chapter 2.  
Whilst in theory this is an appropriate approach, in practice it has been 
observed that HA production declines after a period of time regardless of 
maintenance of growth rate in continuous culture.  As working stocks of 
the bacteria are frequently prepared from samples of culture from the 
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fermenter taken during a ‘run’, it is possible that this approach could affect 
the production during future runs, particularly if the decline has been 
caused by the development of mutations resulting in the non-mucoid 
phenotype such as observed in chapter 2.  This poses the question as to 
whether continuing operating with a continuous culture is worthwhile or 
whether a batch culture system with options such as buffering would be 
more suitable and less costly than running a fermenter which is unreliable 
in producing HA.  Another option could be running the fermenter for less 
time than the 20 days which is currently standard practice.  The purification 
process is extensive with many filtration steps of the culture media prior to 
HA precipitation, due to the concerns mentioned above.  Often this results 
in an approximately 30% yield of the initial concentration of HA in the 
culture media (personal communication, Hyaltech production staff - data 
not available).  While not within the scope of this study, it is possible that 
an optimised purification procedure may allow for the use of batch 
fermentation in place of the current continuous method.  
Another interesting observation of this study was that production did not 
appear to be significantly different between the currently used 
multicomponent fermentation media and off-the-shelf BHI media.  This 
brings into question whether it is necessary in this case to use such a 
complex media for fermentation.  Whilst previously it has been found that 
a high glucose concentration promotes greater molecular weight and higher 
concentration of product (Pires and Santana, 2010), this did not appear to 
be the case for production under the conditions used in this study.  In 
addition to this the use of sulphur limited media to promote a mucoid 
phenotype was not supported in this study due to the observation that 
mucoid phenotype was enhanced on BHI agar compared to sulphur limited 
agar.  In addition to greater mucoidy, bacteria inoculated onto BHI media 
required 24 hours to grow compared to a minimum of 48 on sulphur 
limited media, indicating that time could be saved in the preparation of 
inoculum if BHI media were used instead of sulphur limited and 
fermentation media.  
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6.1.4. S. equi subsp. ruminatorum as a candidate for HA production 
The most commonly utilised native HA producing bacteria species are still 
S. equi subsp. equi and S. equi subsp. zooepidemicus (Kim et al., 1996; 
Chen et al., 2009a; Choi et al., 2014).  As it is a novel species, S. equi 
subsp. ruminatorum had not previously been investigated as a candidate 
strain for HA production.  From the results of this study it would appear 
that this species is capable of producing similar concentrations of HA as 
the currently used strain.  Although molecular weight was not specifically 
investigated due to technical difficulties, the similar retention times during 
HPLC could indicate similar molecular weights between the SER17037 
and the currently used strain.  More detailed characterisation of S. equi 
subsp. ruminatorum HA production through further studies might indicate 
whether this, too, could be useful in biomanufacture.  
6.1.5. Future work 
The results of this study suggest that changes to the current procedure 
could be appropriate following further investigation.  The production and 
molecular weight of HA within BHI cultures compared to the current 
media on a pilot scale would provide more information on the possibilities 
of this media being used in its stead.  The use of sulphur limited broth 
could possibly be omitted and the effects of this change assessed.  In 
addition, further comparisons of SER17037 to the current strain are 
required, such as molecular weight of the HA product and whether there is 
an increased production of possibly contaminating molecules such as 
exotoxins compared to SE40327.  These analyses would provide more 
information as to the suitability of this strain as a candidate for industrial 
production of HA.  
6.2. Comparative genomics for insight into HA synthesis regulation 
The sequencing of the genomes of the strains of interest in this study was 
carried out for a number of reasons.  The genome of SE40327 had not 
previously been sequenced and this would allow updated characterization of the 
strain and support molecular experiments.  In addition the ability to compare the 
genomes of the S. equi strains as well as compare them in practice provided 
multiple angles for investigations.  The ability to compare the genome of S. equi 
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subsp. ruminatorum to the other species assisted in further characterisation of 
this novel strain which had not previously been carried out.   
6.2.1. Challenges of DNA extraction of S. equi species 
Gram positive bacteria such as Streptococci possess dense layers of 
peptidoglycan around their cell membrane (Silhavy, Kahne and Walker, 
2010).  Subsequently they have been found to possess greater resistance to 
cell lysis than gram negative bacteria, including resistance to lysis enzymes 
such as lysozyme (Chassy and Giuffrida, 1980).  As a result the extraction 
of DNA from these bacteria can involve harsh reagents which are costly or 
required physical methods which, depending on what the DNA is required 
for (Moreira et al., 2010), are more or less suitable.   
Several methods were attempted in this study to extract DNA for genome 
sequencing.  Initial attempts used lysozyme (1mg/mL) followed by 
extraction using the Qiagen DNeasy Blood and Tissue kit as this was 
readily available and widely used, however extracted DNA concentrations 
were too low for sequencing.  Variations to the kit were attempted such as 
increasing the cell pellet used, however this blocked the spin columns.  
Incubation time with lysozyme was increased but did not have the desired 
effect.  Sonication within the initial Qiagen lysis buffer prior to spin 
column processing was trialled but did not result in greater DNA quantity.  
In attempts to improve cell lysis, an SDS based lysis buffer was prepared 
containing 200mM Tris-HCl pH 7.5, 250mM NaCl, 25mM EDTA and 
0.5% SDS.  This has been used in a protocol for DNA extraction from plant 
cells and involved vortexing and incubating the cell pellet in the lysis 
buffer for up to one hour before centrifugation of sample and precipitation 
of the DNA in the supernatant using isopropanol and purification using 
70% ethanol.  Whilst greater concentrations of DNA were achieved they 
were not found to be pure enough to pass the initial quality control checks 
for sequencing carried out at Edinburgh Genomics.   
The MasterPure™ DNA Purification Kit described in Chapter 3 methods 
had been successfully used for DNA extraction in E. coli within the lab.  
Following the challenges encountered with the Qiagen DNeasy Blood and 
Tissue kit, the Epicentre kit was sourced and extraction attempted with it.  
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While not perfect, this kit resulted in greater DNA concentration following 
extraction than had been previously achieved.  A larger bacterial pellet was 
required for extraction than the protocol advised and so the volume of 
reagents were doubled.  Thus the extraction of DNA from the S. equi 
strains was challenging and following the experiences of this study it may 
be stated that kit type and mechanical lysis techniques should be 
considered when extracting DNA from gram positive bacteria.  
In addition to difficulties in DNA extraction another observation from this 
study is the over estimation of nucleic acids observed by the NanoDropTM 
2000.  On several occasions the samples measured on this instrument 
appeared to be of adequate concentration and purity with regards to the 
criteria set out by Edinburgh Genomics.  However upon submission of the 
samples they were found not to pass the criteria when analysed using 
EdGen quality control methods which include Qbit in measurements.  The 
guidelines for NanoDropTM 2000 do suggest that at low concentrations, 
readings may be inaccurate.  This would suggest that whilst an efficient 
method for nucleic acid and protein quantification, the results of 
NanoDropTM 2000 readings should perhaps be considered an 
overestimation.   
6.2.2. Annotation, mis-annotation and assembly 
The presence of contigs within the sequenced genomes of the strains of 
interest presented challenges with regards to evaluating the structure of the 
has operon due to the resulting lack of all genes being located and 
annotated.  In all instances the has operons in the strains were split across 
two or more contigs, most often following hasB.  The likelihood of this 
happening could have been increased by the duplication of hasC which 
following a comparison of the flanking sequences of the two paralogs is 
speculated to be the reason for the existence of the two copies (Blank, 
Hugenholtz and Nielsen, 2008).  The presence of repeat sequences 
increases the likelihood that a contig will end at that gene as well as the 
likelihood of either one or both copies being lost (Treangen and Salzberg, 
2011).  As a result of this, in none of the strains sequenced was the whole 
of the has operon isolated to a single contig, meaning assessment of the 
structure could not be made as planned.  In order to complete this the 
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whole genome of the strains would need to be resequenced in long read 
format which is outside of the resources of this study.  
In addition to challenges posed by genome assembly, the variation between 
annotations from different databases and in different strains of the same 
sequences resulted in the time consuming task of confirming the identity of 
genes of interest.  Whilst the use of multiple database annotations identify 
the true integrity of the RAST annotation is a start, there remains 
uncertainty, particularly as to whether the hyaluronidase genes identified 
are bacterial or phage genes.  Until annotations between databases are 
coordinated this will continue to be a challenge in genomic and proteomic 
studies which require sequence confidence to be as certain as possible in 
absence of experimental evidence.    
6.2.3. Selection of putative HA production-related targets 
The genomes of mucoid and non-mucoid strains of SE40327 were 
compared in order to reveal potentially relevant genetic differences.  A 
total of 47 genes were found to be less than 100% identical between the 
two phenotypes.  For the purpose of this study genes contained within the 
same contig as the hyaluronic acid production machinery were the main 
focus.  In addition to this the focus was concentrated around possible 
regulators of surface molecules and virulence factors due to previously 
mentioned associations between HA capsule and virulence, as well as the 
fact that the hyaluronan synthase enzyme is reported to be a surface 
membrane bound glyosyltransferase.  However there were other genes 
found to be differentially regulated such as histidine protein kinases and 
transcriptional repressors which may be of interest however were deemed 
outwith the criteria for analysis in this study.   
6.2.4. Future work  
In order to confidently make comparisons and assumptions the whole 
genomes of the strains of bacteria should be sequenced should resource 
allow.  An increased number of both HA producing and non-producing 
strains would make identification of targets for analysis to occur.  In 
addition to this it would allow for the development of greater 
understanding of the structure of HA producing genetic machinery and its 
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regulators.  It has been speculated by Blank, Hugenholtz and Nielsen 
(2008) that hasD and hasE are under control of more than one promoter 
and this is an avenue to be investigated further alongside the identification 
of the regulator of the second hasC paralog.  
Further investigations into the genes identified as non-identical between 
mucoid and non-mucoid SE40327 may reveal other avenues of interest out 
with the general HA synthesis machinery, widening the scope for research 
into HA production regulation. 
Comparative genomics is a useful tool for the identification of genetic 
targets for experimental investigation and can provide a copious amount of 
information to decipher and speculate over, allowing for more questions to 
be asked and hypotheses posed.  Analyses of the genomes of the strains of 
interest should be continued alongside the design of experimental analyses.  
6.3. The HA production pathway in competition with essential biosynthetic 
processes 
Streptococcal HA production is facilitated through two pathways which 
produce the two precursors UDP-glucuronic acid (UDP-GlcA) and UDP-N-
acetylglucosamine (UDP-GlcNAc) (Yamada and Kawasaki, 2005).  However 
bacteria are efficient organisms and so a number of the products of the 
intermediate steps of these pathways are constituents for other cell wall 
products such as teichoic acids, antigenic polysaccharides and peptidoglycan, as 
well as being involved in other cellular processes such as the pentose phosphate 
pathway and glycolysis (Chong et al., 2005).   In the case of fermentation, lactic 
acid production also competes with HA synthesis for carbon source and 
increasing concentrations of lactic acid in cell culture inhibit both growth and 
HA production (Liu et al., 2011).  Therefore capsule production is consistently 
outweighed by other more essential processes and the ability to tip the balance 
with regards to emphasis on HA synthesis may result in elevated levels of 
production or a higher molecular weight product.  Thus the regulation of the 
competing pathways of HA synthesis are an important area of research.  
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6.3.1. The MurA enzymes as a target  
The identification of the relationship between increased molecular weight 
of HA and the downregulation of MurA by Marcellin, Chen and Nielsen 
(2009) highlighted the relevance of other pathways in the topic of HA 
synthesis by bacteria.  As previously described, MurA competes directly 
with the hyaluronan synthase enzyme for the HA precursor GlcNAc.  
Considering the observation that GlcNAc is the limiting precursor with 
regards to molecular weight (Chen et al., 2009b) it is logical that a 
reduction of MurA expression or activity could result in increased yield 
and/or molecular weight of HA due to greater availability of this precursor.  
Therefore the investigation into MurA and its function as an aspect of HA 
regulation is an important area for investigation. 
As peptidoglycan is an essential component of the bacterial cell, 
interference with MurA is a delicate affair as complete inhibition of 
peptidoglycan synthesis will inhibit growth.  Conveniently, gram-positive 
bacteria such as Streptococci possess more than one active copy of this 
enzyme and so the option exists to identify the most appropriate target out 
of two copies.  
6.3.2. The use of phosphomycin for MurA inhibition 
As previously mentioned in chapter 4, phosphomycin is a specific inhibitor 
of MurA.  Whilst it had previously been claimed that it was inhibitory to 
Streptococci at concentrations of ng/mL this appeared to be implausibly 
potent and so investigating the MIC in the strains of interest was the 
reasonable first step.  The observation that at lower concentrations in 
µg/mL phosphomycin does not inhibit growth of the strains of interest 
resulted in the opportunity to assess the influence of its presence on 
hyaluronic acid production.  Whilst it was hypothesised that the presence of 
phosphomycin may result in increased production and molecular weight 
this did not appear to be the case upon observation of the results.  This was 
postulated to be due to increased expression of murA as a mechanism for 
resistance, however this would need to be confirmed by additional analyses 
including gene expression analyses in the presence of phosphomycin.  Due 
to challenges discussed below and in chapter 4 this remains to be 
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concluded.  Furthermore, if phosphomycin had resulted in an increase in 
molecular weight of HA there could be challenges to introducing it into 
industrialised fermentation processes due to the fact it is an antibiotic and 
the issue of antibiotic resistance is an important topic in today’s society.  
Whilst phosphomycin inhibition occurs through covalent binding of the 
antibiotic to the MurA enzyme (Silver, 2017) thus neutralising itself, the 
presence of free phosphomycin within fermentation waste may raise 
questions about the suitability of this method.  This would need to be 
carefully investigated prior to establishing a fermentation method and a 
protocol for monitoring put in place.  
6.3.3. Challenges due to paralog sequence similarity 
Whilst the activities of the MurA paralogs in S. pneumoniae have been 
observed and found that MurA1 possess greater enzymatic activity than 
MurA2 (Du et al., 2000) this has not been confirmed to be the case for S. 
equi species.  On the assumption that the case is similar, the differences in 
expression of the murA genes has not been elucidated and it may be the 
case that one undergoes greater expression than the other.  Due to the 
similarities of the paralog nucleotide sequences design of specific primers 
for RT-PCR were challenging and the presence of non-specific binding and 
double products which were apparent due to the observation of more than 
one peak in the melt curves, did not allow for confidence in results.  Three 
rounds of primer design were attempted with only one pair found to be 
consistently specific for murA1.  Due to the requirements for RT-PCR such 
as product lengths of no longer than 120 bases, primer lengths of 
approximately 20 bases, as few single base repeats as possible and 
preferably primers located within the middle of a gene the design of 
primers specific to the murA paralogs future attempts at primer design will 
not be straight forward.   
6.3.4. Future work 
The development of specific primers for expression analyses of both murA 
paralogs is important for future investigation into the differences between 
the two in terms of function.  Following this task the effect of the presence 
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of phosphomycin in the culture media would be investigated in order to 
establish whether upregulation of the genes occur.  
Whilst out with the available resources of this study it would be useful to 
develop a knockout mutant of each of the copies of MurA following 
confirmation that both are expressed.  As it has been observed to be the less 
active copy, MurA2 would be the initial target as it is hypothesised the 
absence this copy would have a more minor effect on growth.  Initiation of 
planning for an allelic exchange experiment was considered however a 
suitable plasmid could not be sourced within the resources of this study.  
6.4. Proteomic tools for distinguishing S. equi species 
Whole cell protein profiling for identification of bacteria types is a simple and 
well established method based on the assumption that different bacteria species 
and sometimes strains produce different banding patterns from each other and 
that the same species/strain will produce reproducible patterns under lab 
conditions (Singhal, Maurya and Virdi, 2019).  The protein profiles of the novel 
species S. equi subsp. ruminatorum were reportedly compared to strains of S. 
equi subsp. equi and S. equi subsp. zooepidemicus (Speck et al., 2008), however 
the resulting profiles were never presented by those authors.  In addition to this, 
the observation of both mucoid and non-mucoid phenotypes present from 
stocks of the same strain prompted the protein profiles of the strains of interest 
in this study to be investigated.  
6.4.1. Challenges of protein extraction of S. equi species 
Extraction of proteins from S. equi subspecies was challenging for the same 
reasons described above for DNA extraction (6.2.1.).  Cell disruption was 
attempted using sonication for physical disruption and lysis buffer with 
mutanolysin an enzyme discovered to be capable of lysis of Streptococci 
(Yokogawa et al., 1974).  In addition the MasterPureTM kit (Epicentre) was 
adapted to attempt to isolate proteins rather than DNA, however this was 
unsuccessful.  The protocol ultimately used was adapted from a protocol 
for the extraction of lipopolysaccharides (LPS) from the cell wall of gram 
negative bacteria.  Hyaluronidase was required prior to centrifugation as 
the presence of capsule inhibited the formation of a firm bacterial pellet at 
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less than 40,000 x g.  The adapted protocol detailed in this study (chapter 
5) would be suitable for other resilient bacteria species.  
6.4.2. Proteomics for subspecies differentiation 
From the results of SDS-PAGE analysis, variation in protein banding 
profiles were observed between species but were not notably different 
between strains of S. equi subsp. equi.  Therefore it can be stated that 
protein profiling is suitable only for differentiation between S. equi 
subspecies and not strains of the same subspecies.  While variation in 
protein profiles between phenotypes of SE40327 was not observed, the 
absence of a band in the non-mucoid phenotype of SER17037 which was 
present in the mucoid phenotype was noted and so was investigated further 
using proteomic analyses.  The presence of variation between the 
phenotypes in only SER17037 suggests that it may not be applicable to 
other subspecies.  However as this study has shown SER17037 appears 
initially promising as a HA production candidate and so any insight into 
HA production in this strain may be useful.  
6.4.3. Evidence of M-like protein processing or degradation 
The results of the proteomics analyses revealed Antiphagocytic M-like 
protein to be present in numerous bands within SER17037.  The presence 
of this protein in multiple bands attributed to small sized proteins indicates 
the presence of fragmented proteins, presumably specifically cleaved by a 
protease.  Whilst there have been many studies surrounding the function 
and presentation of the M proteins and M-like proteins (Smeesters, 
McMillan and Sriprakash, 2010; Metzgar and Zampolli, 2011; Brouwer et 
al., 2016; Ghosh, 2018), little appears to be known about the processes 
involving M-protein turnover.  It could be that in stationary phase 
degradation of M-protein occurs.  Whilst it may be that turnover of M-like 
protein is not particularly relevant to this study, due to the previously 
mentioned associations between M-like protein and HA capsule with 
regards to virulence and the presence of larger fragments of M-like protein 
within the mucoid phenotype but not the non-mucoid phenotype, it may not 
be excessive to suggest a greater link exists between these two virulence 
factors than has previously been considered.  Additionally considering the 
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variation in sequence observed between the M protein regulator Mga 
between phenotypes of SE40327 (Chapter 3), this may be an avenue worth 
further consideration.  
6.4.4. Future work 
Whilst it is a great first step tool to analysing protein profiles, due to the 
presence of more than one protein within a band SDS-PAGE often does not 
reveal all in terms of protein variation between samples.  The step up from 
this technology is Two-Dimensional Difference Gel Electrophoresis (2D-
DIGE) which allows for the separation of single proteins and the 
comparison of more than one sample (Arentz et al., 2015).  Whilst this has 
previously been carried out on HA producing S. equi subsp. zooepidemicus 
(Marcellin et al., 2009) the comparison of different phenotypes of the same 
strain could provide valuable detailed information about protein expression 
differences relevant to capsule. Higher resolution proteomics using LC-
MS/MS as performed with other streptococci (Gao et al., 2019; Qiao et al., 
2019) would provide greater coverage in addition to quantitation. 
6.5. Overall conclusions 
Whilst many studies have been conducted into hyaluronic acid capsule 
production in Group A and C streptococci, until now the emphasis has either 
been on the engineering aspect of fermentation parameters or on the genetic 
machinery but with the narrow scope of the enzymes immediately responsible 
and their regulation.  It would not be arbitrary to suggest that perspective has 
been lost in terms of recognition of the innate evolutionary reasoning for HA 
synthesis in these pathogenic bacteria.  This study has aimed to return the 
emphasis to this aspect of HA production research.  The results from this study 
open the scope of research for means to improve yield and characteristics of 
biomanufactured HA beyond alteration of fermentation parameters and 
overexpression of the has operon.  
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Appendix A.  Box plots of HA concentration comparison between SE40327 
and SER17037 in Fermentation media (FM), Buffered fermentation media 
(BFM) and Brain heart infusion media (BHI). 
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Hyaluronic acid concentration produced by SE40327 compared to SER17037 in 
fermentation media (A), brain heart infusion media (B) and buffered 
fermentation media (C). 
Appendix B. Agarose gel for RNA sample integrity assessment. 
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Appendix C. Tables of NCBI database identifications of proteins in 
bands from SDS-PAGE gel. 
 
 
 
 
 
 
 
 
  
SEZ20727-1
NCBI identification MOWSE score % Cover Strain No. peptides
ATP-dependent 6-phosphofructokinase 968.70 68.50 S. equi 7
ribonucleotide-diphosphate reductase subunit beta 194.78 7.20 S. equi 2
foldase PrsA 167.99 12.90 S. equi 2
dipeptidase 84.23 6.60 S. equi 2
SER17037-1
NCBI identification MOWSE score % Cover Strain No. peptides
peptidase 682.46 20.10 S. equi 8
hypothetical protein 391.49 26.90 S. equi 4
foldase PrsA 126.32 13.2 S. equi 2
SEZ20727-2
NCBI identification MOWSE score % Cover Strain No. peptides
superoxide dismutase 599.53 48.30 S. equi 8
hypothetical protein 389.78 37.40 S. equi 5
50S ribosomal protein L4 327.41 41.10 S. equi 2
Uracil phosphoribosyltransferase PyrR 183.99 16.20 S. equi 3
elongation factor Tu 102.89 12.40 S. pneumoniae 2
elongation factor Tu 90.46 8.10 S. pneumoniae 2
hypothetical protein 368.88 17.80 S. equi 3
SER17037-2
NCBI identification MOWSE score % Cover Strain No. peptides
hypothetical protein 207.52 11.7 S. equi 2
superoxide dismutase, partial 138.91 17.5 S. zooepidemicus 3
peptidase 785.45 12.9 S. equi 4
SER17037-3
NCBI identification MOWSE score % Cover Strain No. peptides
superoxide dismutase 777.26 67.7 S. equi 10
peptidase 756.29 15.4 S. equi 6
ribosome recycling factor 313.31 29.2 S. pyogenes 2
hypothetical protein 190.26 27.9 S. equi 3
SER17037-4
NCBI identification MOWSE score % Cover Strain No. peptides
peptidase 728.04 15.20 S. equi 6
30S ribosomal protein S4 295.15 15.30 S. equi 3
hypothetical protein 81.11 8.70 S. equi 2
SER17037-5
NCBI identification MOWSE score % Identity Strain No. peptides
superoxide dismutase 1019.76 82.10 S. equi 8
peptidase 631.01 15.10 S. equi 5
50S ribosomal protein L4 428.12 35.70 S. equi 5
transcriptional regulator 358.41 24.60 S.equi 3
ribosome recycling factor 273.77 29.20 S. pyogenes 3
elongation factor Tu 122.15 6.50 S. equi 2
hypoxanthine phosphoribosyltransferase 89.56 11.10 S. equi 2
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Appendix D. SER17037 M-like protein amino acid sequence alignment 
to the sequence identified by Speck et al., (2008) using Multalin.  
 
Antiphagocytic M-like protein identified in this study (SER17037-1) 
compared to M-like protein identified previously (CECT5772M), NCBI 
accession number (EU069409.1). 
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